
<html lang="en"     class="pb-page"  data-request-id="696cc62b-a6b4-4206-854f-eeff83a7eb2c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2012.55.issue-15;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm300411k;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5-a]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach" /></meta><meta name="dc.Creator" content="Tomomi  Kosugi" /></meta><meta name="dc.Creator" content="Dale R.  Mitchell" /></meta><meta name="dc.Creator" content="Aiko  Fujino" /></meta><meta name="dc.Creator" content="Minoru  Imai" /></meta><meta name="dc.Creator" content="Mika  Kambe" /></meta><meta name="dc.Creator" content="Shinji  Kobayashi" /></meta><meta name="dc.Creator" content="Hiroaki  Makino" /></meta><meta name="dc.Creator" content="Yohei  Matsueda" /></meta><meta name="dc.Creator" content="Yasuhiro  Oue" /></meta><meta name="dc.Creator" content="Kanji  Komatsu" /></meta><meta name="dc.Creator" content="Keiichiro  Imaizumi" /></meta><meta name="dc.Creator" content="Yuri  Sakai" /></meta><meta name="dc.Creator" content="Satoshi  Sugiura" /></meta><meta name="dc.Creator" content="Osami  Takenouchi" /></meta><meta name="dc.Creator" content="Gen  Unoki" /></meta><meta name="dc.Creator" content="Yuko  Yamakoshi" /></meta><meta name="dc.Creator" content="Vicky  Cunliffe" /></meta><meta name="dc.Creator" content="Julie  Frearson" /></meta><meta name="dc.Creator" content="Richard  Gordon" /></meta><meta name="dc.Creator" content="C. John  Harris" /></meta><meta name="dc.Creator" content="Heidi  Kalloo-Hosein" /></meta><meta name="dc.Creator" content="Joelle  Le" /></meta><meta name="dc.Creator" content="Gita  Patel" /></meta><meta name="dc.Creator" content="Donald J.  Simpson" /></meta><meta name="dc.Creator" content="Brad  Sherborne" /></meta><meta name="dc.Creator" content="Peter S.  Thomas" /></meta><meta name="dc.Creator" content="Naotaka  Suzuki" /></meta><meta name="dc.Creator" content="Midori  Takimoto-Kamimura" /></meta><meta name="dc.Creator" content="Ken-ichiro  Kataoka" /></meta><meta name="dc.Description" content="A novel class of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) inhibitors was discovered through screening a kinase-focused library. A homology model of MAPKAP-K2 was gene..." /></meta><meta name="Description" content="A novel class of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) inhibitors was discovered through screening a kinase-focused library. A homology model of MAPKAP-K2 was gene..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 31, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300411k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300411k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300411k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300411k" /></link>
        
    
    

<title>Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5-a]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300411k" /></meta><meta property="og:title" content="Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5-a]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0031.jpeg" /></meta><meta property="og:description" content="A novel class of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) inhibitors was discovered through screening a kinase-focused library. A homology model of MAPKAP-K2 was generated and used to guide the initial SAR studies and to rationalize the observed selectivity over CDK2. An X-ray crystal structure of a compound from the active series bound to crystalline MAPKAP-K2 confirmed the predicted binding mode. This has enabled the discovery of a series of pyrazolo[1,5-a]pyrimidine derivatives showing good in vitro cellular potency as anti-TNF-α agents and in vivo efficacy in a mouse model of endotoxin shock." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300411k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300411k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300411k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300411k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300411k&amp;href=/doi/10.1021/jm300411k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6700-6715</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300482h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300289k" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm3013954"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5-<i>a</i>]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach<a class="ref internalNav" href="#notes-1" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tomomi++Kosugi">Tomomi Kosugi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dale+R.++Mitchell">Dale R. Mitchell</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aiko++Fujino">Aiko Fujino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Minoru++Imai">Minoru Imai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mika++Kambe">Mika Kambe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shinji++Kobayashi">Shinji Kobayashi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroaki++Makino">Hiroaki Makino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yohei++Matsueda">Yohei Matsueda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yasuhiro++Oue">Yasuhiro Oue</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kanji++Komatsu">Kanji Komatsu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keiichiro++Imaizumi">Keiichiro Imaizumi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuri++Sakai">Yuri Sakai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Satoshi++Sugiura">Satoshi Sugiura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Osami++Takenouchi">Osami Takenouchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gen++Unoki">Gen Unoki</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuko++Yamakoshi">Yuko Yamakoshi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vicky++Cunliffe">Vicky Cunliffe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Frearson">Julie Frearson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Gordon">Richard Gordon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C.+John++Harris">C. John Harris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heidi++Kalloo-Hosein">Heidi Kalloo-Hosein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joelle++Le">Joelle Le</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gita++Patel">Gita Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+J.++Simpson">Donald J. Simpson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brad++Sherborne">Brad Sherborne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+S.++Thomas">Peter S. Thomas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naotaka++Suzuki">Naotaka Suzuki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Midori++Takimoto-Kamimura">Midori Takimoto-Kamimura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ken-ichiro++Kataoka">Ken-ichiro Kataoka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">‡</span> <span class="aff-text">Teijin Institute for Bio-medical Research, Teijin Pharma Ltd., Hino, Tokyo 191-8512, Japan</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">BioFocus, Chesterford Research Park, Saffron Walden, Essex, CB10 1XL, U.K.</span></div><div class="corresp-info"><strong>*</strong>(G.U.) Phone +81-42-586-8267; e-mail: <a href="/cdn-cgi/l/email-protection#d5b2fba0bbbabebc95a1b0bcbfbcbbfbb6bafbbfa5"><span class="__cf_email__" data-cfemail="55327b203b3a3e3c1521303c3f3c3b7b363a7b3f25">[email protected]</span></a>. (D.R.M) Phone: +44-1799-533500; e-mail: <a href="/cdn-cgi/l/email-protection#7713161b12591a1e03141f121b1b37101b07105914181a"><span class="__cf_email__" data-cfemail="7a1e1b161f5417130e19121f16163a1d160a1d54191517">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300411k&amp;href=/doi/10.1021%2Fjm300411k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6700–6715</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 2, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 July 2011</li><li><span class="item_label"><b>Published</b> online</span>31 July 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 August 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300411k" title="DOI URL">https://doi.org/10.1021/jm300411k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6700%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTomomi%2BKosugi%252C%2BDale%2BR.%2BMitchell%252C%2BAiko%2BFujino%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D15%26contentID%3Djm300411k%26title%3DMitogen-Activated%2BProtein%2BKinase-Activated%2BProtein%2BKinase%2B2%2B%2528MAPKAP-K2%2529%2Bas%2Ban%2BAntiinflammatory%2BTarget%253A%2BDiscovery%2Band%2Bin%2BVivo%2BActivity%2Bof%2BSelective%2BPyrazolo%255B1%252C5-a%255Dpyrimidine%2BInhibitors%2BUsing%2Ba%2BFocused%2BLibrary%2Band%2BStructure-Based%2BOptimization%2BApproach%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6715%26publicationDate%3DAugust%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300411k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2491</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">24</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300411k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5-a]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tomomi&quot;,&quot;last_name&quot;:&quot;Kosugi&quot;},{&quot;first_name&quot;:&quot;Dale&quot;,&quot;last_name&quot;:&quot;R. Mitchell&quot;},{&quot;first_name&quot;:&quot;Aiko&quot;,&quot;last_name&quot;:&quot;Fujino&quot;},{&quot;first_name&quot;:&quot;Minoru&quot;,&quot;last_name&quot;:&quot;Imai&quot;},{&quot;first_name&quot;:&quot;Mika&quot;,&quot;last_name&quot;:&quot;Kambe&quot;},{&quot;first_name&quot;:&quot;Shinji&quot;,&quot;last_name&quot;:&quot;Kobayashi&quot;},{&quot;first_name&quot;:&quot;Hiroaki&quot;,&quot;last_name&quot;:&quot;Makino&quot;},{&quot;first_name&quot;:&quot;Yohei&quot;,&quot;last_name&quot;:&quot;Matsueda&quot;},{&quot;first_name&quot;:&quot;Yasuhiro&quot;,&quot;last_name&quot;:&quot;Oue&quot;},{&quot;first_name&quot;:&quot;Kanji&quot;,&quot;last_name&quot;:&quot;Komatsu&quot;},{&quot;first_name&quot;:&quot;Keiichiro&quot;,&quot;last_name&quot;:&quot;Imaizumi&quot;},{&quot;first_name&quot;:&quot;Yuri&quot;,&quot;last_name&quot;:&quot;Sakai&quot;},{&quot;first_name&quot;:&quot;Satoshi&quot;,&quot;last_name&quot;:&quot;Sugiura&quot;},{&quot;first_name&quot;:&quot;Osami&quot;,&quot;last_name&quot;:&quot;Takenouchi&quot;},{&quot;first_name&quot;:&quot;Gen&quot;,&quot;last_name&quot;:&quot;Unoki&quot;},{&quot;first_name&quot;:&quot;Yuko&quot;,&quot;last_name&quot;:&quot;Yamakoshi&quot;},{&quot;first_name&quot;:&quot;Vicky&quot;,&quot;last_name&quot;:&quot;Cunliffe&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Frearson&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Gordon&quot;},{&quot;first_name&quot;:&quot;C.&quot;,&quot;last_name&quot;:&quot;John Harris&quot;},{&quot;first_name&quot;:&quot;Heidi&quot;,&quot;last_name&quot;:&quot;Kalloo-Hosein&quot;},{&quot;first_name&quot;:&quot;Joelle&quot;,&quot;last_name&quot;:&quot;Le&quot;},{&quot;first_name&quot;:&quot;Gita&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;J. Simpson&quot;},{&quot;first_name&quot;:&quot;Brad&quot;,&quot;last_name&quot;:&quot;Sherborne&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;S. Thomas&quot;},{&quot;first_name&quot;:&quot;Naotaka&quot;,&quot;last_name&quot;:&quot;Suzuki&quot;},{&quot;first_name&quot;:&quot;Midori&quot;,&quot;last_name&quot;:&quot;Takimoto-Kamimura&quot;},{&quot;first_name&quot;:&quot;Ken-ichiro&quot;,&quot;last_name&quot;:&quot;Kataoka&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;6700-6715&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300411k&quot;},&quot;abstract&quot;:&quot;A novel class of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) inhibitors was discovered through screening a kinase-focused library. A homology model of MAPKAP-K2 was generated and used to guide the initial SAR studies and to rationalize the observed selectivity over CDK2. An X-ray crystal structure of a compound from the active series bound to crystalline MAPKAP-K2 confirmed the predicted binding mode. This has enabled the discovery of a series of pyrazolo[1,5-a]pyrimidine derivatives showing good in vitro cellular potency as anti-TNF-α agents and in vivo efficacy in a mouse model of endotoxin shock.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300411k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300411k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300411k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300411k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300411k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300411k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300411k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300411k&amp;href=/doi/10.1021/jm300411k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300411k" /></input><a href="/doi/pdf/10.1021/jm300411k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300411k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300411k%26sid%3Dliteratum%253Aachs%26pmid%3D22746295%26genre%3Darticle%26aulast%3DKosugi%26date%3D2012%26atitle%3DMitogen-Activated%2BProtein%2BKinase-Activated%2BProtein%2BKinase%2B2%2B%2528MAPKAP-K2%2529%2Bas%2Ban%2BAntiinflammatory%2BTarget%253A%2BDiscovery%2Band%2Bin%2BVivo%2BActivity%2Bof%2BSelective%2BPyrazolo%255B1%252C5-a%255Dpyrimidine%2BInhibitors%2BUsing%2Ba%2BFocused%2BLibrary%2Band%2BStructure-Based%2BOptimization%2BApproach%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D15%26spage%3D6700%26epage%3D6715%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jmcmar.2012.55.issue-15/production/jmcmar.2012.55.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0031.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel class of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) inhibitors was discovered through screening a kinase-focused library. A homology model of MAPKAP-K2 was generated and used to guide the initial SAR studies and to rationalize the observed selectivity over CDK2. An X-ray crystal structure of a compound from the active series bound to crystalline MAPKAP-K2 confirmed the predicted binding mode. This has enabled the discovery of a series of pyrazolo[1,5-<i>a</i>]pyrimidine derivatives showing good in vitro cellular potency as anti-TNF-α agents and in vivo efficacy in a mouse model of endotoxin shock.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span>†</span> Accession Codes</h4><p class="last">PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3A2C">3A2C</a>.</p></div><div class="extra-info-sec articleNote"><h4><span>⊥</span> Author Present Address</h4><p class="last">GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, U.K.</p></div><div class="extra-info-sec articleNote"><h4><span>#</span> Author Present Address</h4><p class="last">Computational and Structural Chemistry, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Rd., Stevenage, Hertfordshire, SG1 2NY, U.K.</p></div><div class="extra-info-sec articleNote"><h4><span>▽</span> Author Present Address</h4><p class="last">Merck Research Laboratories, 2000 Galloping Hill Rd., Kenilworth, NJ 07033.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tumor necrosis factor-α (TNF-α) is implicated in several inflammatory diseases such as rheumatoid arthritis,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and biological agents such as infliximab, an anti-TNF-α antibody, have proved to be very effective medications for this disabling disease.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2-5)</a> Therefore, inhibition of TNF-α activity represents a most promising target for antiinflammatory therapy. The p38 mitogen-activated protein (MAP) kinase pathway has been shown to play an important role in the production of TNF-α and other cytokines.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> This pathway has therefore been of particular interest for the discovery of new antiinflammatory agents. Previous strategies to intervene in this pathway have been based largely on the development of selective inhibitors of p38 MAP kinase.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Such inhibitors have proved to be effective inhibitors of proinflammatory cytokine production in cell-based assays and animal models of inflammatory disease. However, the p38 MAP kinase gene knockout mouse has proven to be embryonically lethal.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Moreover, cells derived from such embryos have been demonstrated to have a number of abnormalities in fundamental cell responses. These observations may indicate that caution should be paid to long-term therapy with p38 MAP kinase inhibitors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Given these caveats, an attractive alternative strategy for the development of antiinflammatory agents is the inhibition of this pathway at the level of MAPKAP-K2. MAPKAP-K2 is a Ser/Thr kinase located downstream of p38 MAP kinase and is known to be a direct substrate of p38 MAP kinase.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> A role for MAPKAP-K2 in mediating the inflammatory response has been strongly implicated in the observed phenotype of the MAPKAP-K2-deficient mouse (MAPKAP-K2–/−).<a onclick="showRef(event, 'ref13 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref15">(13, 15)</a> This mutant mouse is viable and seems normal except for a significantly reduced inflammatory response. Mice deficient in MAPKAP-K2 produce less TNF-α and IL-6 than control littermates in response to lipopolysaccharide. In addition, MAPKAP-K2 (−/−) mice are protected against lipopolysaccharide-induced septic shock and collagen-induced arthritis.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> Their size, weight, and lifespan are similar to wild-type littermates when kept under germ-free conditions. In contrast to p38 MAP kinase, MAPKAP-K2 is not known to participate in feedback control loops that limit the production of proinflammatory cytokines or control the production of antiinflammatory cytokines.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">As a molecular mechanism to explain its involvement in inflammatory pathways, MAPKAP-K2 has been shown to directly regulate TNF-α by binding to AU-rich elements and thereby affecting its RNA stability and/or translation.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Therefore, MAPKAP-K2 could be a potentially more attractive target for antiinflammatory therapy than p38 MAP kinase.</div><div class="NLM_p">The lack of clinical efficacy of all p38 MAP kinase inhibitors to date is most likely a result of biologic adaptation which results in the rapid reversal of early indications of benefit such as CRP levels.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> Because p38 MAP kinase is highly pleiotropic in its ability to intersect and regulate both proinflammatory and antiinflammatory pathways including JNK, MAP kinase phosphatase, IL-10, and negative feedback on TAK-1, there are multiple routes and mechanisms to allow for reversal of antiinflammatory effects. One could speculate that MAPKAP-K2, by the nature of its more downstream and less pathway convergent position in the network, could escape the majority of the compensatory mechanisms proposed for p38 MAP kinase inhibitors. This hypothesis however can only be proven by the development of well propertied molecules for clinical testing.</div><div class="NLM_p">Several groups have subsequently reported programs also designed to develop antiinflammatory therapies through the generation of inhibitors of MAPKAP-K2.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30">(21-30)</a> Example compounds illustrating the range of structure types reported as inhibitors of MAPKAP-K2 are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported MAPKAP-K2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recent reports have detailed the in vivo activity of MAPKAP-K2 inhibitors, and three examples are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Novartis has reported compounds that inhibited LPS-induced TNFα release in mice and reduced paw swelling in a collagen-induced arthritis study in both rats and mice.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Pfizer has reported oral antiinflammatory efficacy for PF-3644022 in both acute and chronic models of inflammation in rats.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MAPKAP-K2 inhibitors demonstrating in vivo efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">At the inception of this project, there were no reported small molecule inhibitors of MAPKAP-K2 on which to initiate a program, and so it was decided to undertake a high-throughput screening campaign using a diverse set of 100 000 compounds. As this resulted in a very low hit rate, we next screened a focused kinase library<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and identified a pyrazolo[1,5-<i>a</i>]pyrimidine derivative (<b>1</b>), part of a small cluster of related hits that had modest inhibitory activity against MAPKAP-K2. In this paper, we report the discovery of this new class of MAPKAP-K2 inhibitors and describe the optimization of these pyrazolo[1,5-<i>a</i>] pyrimidine derivatives to produce potent and selective compounds.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Screening against MAPKAP-K2 using a 100 000-member diverse library gave only a very low hit-rate of ATP-competitive compounds, and none of these were considered suitable for further development. Thus, a second campaign was conducted using a focused set of compounds designed to inhibit kinases;<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> 5075 compounds from 8 libraries, comprising 11 scaffold chemotypes, were used in this second screen, and 32 active compounds were identified and subjected to full IC<sub>50</sub> determinations. The active compounds were clustered around four distinct library scaffolds, and these clusters showed clear evidence of SAR. Representative compounds were subjected to kinetic determinations to ascertain their competitivity with respect to ATP. The most promising hit compound based on its activity, kinetics, and the potential for follow up was the pyrazolo[1,5-<i>a</i>]pyrimidine <b>1</b>.</div><div class="NLM_p">The pyrazolo[1,5-<i>a</i>]pyrimidine <b>1</b> exhibited inhibition of MAPKAP-K2 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), being marginally less potent than staurosporine (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) but clearly competitive with respect to ATP (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The ATP concentrations of both the MAPKAP-K2 and CDK2 assays were set at the <i>K</i><sub>m</sub> value of MAPKAP-K2, i.e., at 10 μM. In a focused panel of kinases, compound <b>1</b> was found to inhibit CDK2 more potently than MAPKAP-K2 and with either moderate or no activity against the other kinases screened (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). It was therefore decided to select CDK2 as a surrogate kinase for monitoring selectivity during the optimization of the hit compound. The observed activity against CDK2 was not unexpected given that the library SFK03 was designed to target the CDK family of kinases. Interference with the cell cycle via inhibition of cell cycle kinases is, in any event, likely to be an undesirable feature in antiinflammatory compounds.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure and kinase selectivity of hit compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IC<sub>50</sub> analysis of staurosporine and compound <b>1</b>. MAPKAP-K2 assay performed at 30 μM peptide, 10 μM ATP, 0.5 μCi <sup>33</sup>P-γ-ATP/well for 10 min at room temperature. Data shown are mean ± SEM of duplicate determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mechanism of action/<i>K</i><sub>i</sub> determination for compound <b>1</b>. (a) Primary plot: Rate vs [ATP]. (b) Secondary Lineweaver–Burke plot of 1/<i>V</i> vs 1/[ATP]. (c) Secondary plot of 1/Vm<sub>app</sub> vs [I]. (d) Secondary plot of Km<sub>app</sub>/Vm<sub>app</sub> vs [I]. MAPKAP-K2 assay was performed at 30 μM peptide under a matrix range of concentrations of ATP (4–150 μM) and compound (0–20 μM) in the presence of 1 μCi <sup>33</sup>P-γ-ATP/well for 10 min. Reaction rates are expressed as femtomoles of peptide phosphorylated per minute per mU MAPKAP-K2. Data shown are mean of duplicate data points; experiments were conducted across three independent determinations yielding <i>K</i><sub>i</sub> values of 7 μM, 7 μM, and 6 μM, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Some minor modifications to the synthetic route used to prepare the initial hit library (SFK03) from which <b>1</b> emerged were undertaken to allow further substitution of this scaffold and the inclusion of a wider range of substituents. The preparation of the pyrazolo[1,5-<i>a</i>]pyrimidine derivatives described is outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Synthesis began with the condensation of commercially available 3-aminopyrazole (<b>2</b>) and various malonate derivatives to construct the pyrazolo[1,5-<i>a</i>]pyrimidine core. The resulting dihydroxy derivative <b>3</b> was converted to 5,7-dichloropyrazolo[1,5-<i>a</i>]pyrimidine (<b>4</b>) by treatment with phosphorus oxychloride. For the syntheses of the 3-halogenated compounds, the halogen was introduced at this stage using <i>N</i>-chlorosuccinimide or <i>N</i>-bromosuccinimide (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Selective introduction of various anilines at the 7-position to give <b>5</b> was achieved by heating with the respective anilines in the presence of base. Following Boc protection to give <b>6</b>, the subsequent introduction of amines at the 5-position was achieved by heating with an excess of the amine <b>7</b>. For the syntheses of the ether-linked derivatives at the 5-position, the alcohol derivative <b>10</b> was introduced as the alkoxide (generated from the alcohol and sodium hydride). Finally, deprotection of the Boc-protected compounds (<b>8</b> and <b>11</b>) gave the target compounds <b>9</b> and <b>12</b>. For further transformations of the substituents at the 7-position, condensation or coupling reactions were carried out before removal of the Boc groups as shown in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a>–<a class="ref internalNav" href="#sch5" aria-label="5">5</a>. This route was successfully applied to a variety of 3-, 5-, and 7- substituted pyrazolo[1,5-<i>a</i>]pyrimidines.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>6</sup>-CH(COOEt)<sub>2</sub>, EtONa, EtOH, reflux; (b) HCl aq; (c) POCl<sub>3</sub>, Me<sub>2</sub>NPh, reflux; (d) H<sub>2</sub>N-R<sup>7</sup>, Et<sub>3</sub>N, <sup><i>i</i></sup>PrOH, reflux; (e) H<sub>2</sub>N-R<sup>7</sup>, NaH, DMF/THF, room temp to −50 °C; (f) Boc<sub>2</sub>O, DMAP (cat.), 1,4-dioxane, room temp; (g) excess H<sub>2</sub>N-R<sup>5</sup> (<b>7</b>), 90 °C; (h) HO-R<sup>5</sup> (<b>10</b>), NaH, THF, 0 °C to room temp; (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp.</p></p></figure><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (a) <i>N</i>-chlorosuccinimide or <i>N</i>-bromosuccinimide, CHCl<sub>3</sub>, room temp.</p></p></figure><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (a) Pd(OH)<sub>2</sub>/C, H<sub>2</sub>, MeOH; (b) 2-methoxyethanol, PPh<sub>3</sub>, diisopropyl azodicarboxylate in toluene, THF, room temp; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp.</p></p></figure><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (a) NaOH aq, MeOH, room temp then HCl aq; (b) carbonyldiimidazole, cyclopentylamine, DMF, room temp; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp.</p></p></figure><figure id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (a) 5-acetyl-2-thiopheneboronic acid, Pd(OAc)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, PPh<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp.</p></p></figure><div class="NLM_p">Despite the 24-fold inverse selectivity with respect to CDK2, and given the very low screening hit-rate for MAPKAP-K2, compound <b>1</b> was considered to offer promising scope for optimization. An evaluation of the ADME properties of compound <b>1</b> showed the compound to have good properties and to be a suitable scaffold on which to undertake an optimization program. To facilitate the medicinal chemistry efforts, it was considered important to predict the likely binding modes of compound <b>1</b> to MAPKAP-K2 and CDK2. However, at this stage a crystal structure of MAPKAP-K2 was not available and it was therefore necessary to build a homology model of MAPK AP-K2 to enable docking studies to be carried out.</div><div class="NLM_p">A homology model of MAPKAP-K2 was constructed based on the reported X-ray structures of phosphorylase kinase<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and cAMP-dependent protein kinase,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> each of which show ca. 30% sequence identity with MAPKAP-K2 using the Biopolymer Composer module in Sybyl, v6.8.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> As the central scaffold of compound <b>1</b> is structurally very similar to purvalanol B, a known inhibitor of CDK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), compound <b>1</b> was docked in the MAPKAP-K2 model such that the overall geometry was as close as possible to that of purvalanol B in CDK2.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In the resulting docking mode, compound <b>1</b> appeared to form hydrogen bonds with the main chain NH and C═O groups of Leu<sup>141</sup> in the hinge region, and the terminal positively charged amine of the <i>trans</i>-4-aminocyclohexylamino side chain was able to form a hydrogen bond to Asn<sup>191</sup> and a salt bridge to Asp<sup>207</sup>, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of purvalanol B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Predicted binding mode of compound (<b>1</b>) in the MAPKAP-K2 homology model. Equivalent residue numbers in CDK2 are shown in parentheses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As expected, the predicted binding mode of compound <b>1</b> with MAPKAP-K2 was very similar to that seen with CDK2. However, the detailed differences in the residues within the ATP-binding site of the two kinases suggested that the required MAPKAP-K2 selectivity might be achieved by varying the side chains while seeking to retain this overall binding mode. We therefore embarked on a detailed SAR study of a series of pyrazolo[1,5-<i>a</i>]pyrimidine analogues to identify the key functionality responsible for activity against MAPKAP-K2 and selectivity over CDK2.</div><div class="NLM_p">Initial investigations of the effect of 2-position substitution of the scaffold were carried out to test the predicted binding mode of compound <b>1</b> with MAPKAP-K2. This mode suggested that there was little available space to accommodate substituents in this position, as there would be a steric clash with the ATP-site backbone. Indeed, it was found that the introduction of substituents at this position resulted in significant losses in potency against MAPKAP-K2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>: compounds <b>20</b> and <b>21</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values for 2- or 3-Position Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0020.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">MAPKAP-K2 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CDK2 IC<sub>50</sub> μM)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity CDK2/MAPKAP-K2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">0.055</td><td class="colsep0 rowsep0" align="char" char=".">0.042</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>300</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left"><sup><b>t</b></sup>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>300</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">0.0040</td><td class="colsep0 rowsep0" align="char" char=".">0.0013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CI</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">0.0030</td><td class="colsep0 rowsep0" align="char" char=".">0.0004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">0.0034</td><td class="colsep0 rowsep0" align="char" char=".">0.0004</td></tr></tbody></table></div></div><div class="NLM_p">The binding mode of compound <b>1</b> suggested that substitution at the 3-position would offer a means of accessing the hydrophobic subpocket of the ATP site. We considered that suitable substitutents at this position might lead both to an improvement of MAPKAP-K2 activity and selectivity over other kinases, based on the variability of the shape of the hydrophobic subpocket compared with other more conserved regions of the active site. However, all 3-substituted analogues prepared in this study resulted in a reduction of activity against MAPKAP-K2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>: compounds <b>22</b>–<b>24</b>). These results suggested that the hydrophobic subpocket in MAPKAP-K2 was too small to accommodate any substituent at this position of the ligand. Moreover, contrary to our expectations, we found that compounds with halogens (Cl, Br) or a cyano group at this position showed more potent inhibitory activity against CDK2. Recently we have confirmed that a cyano group at the 3-position of such ligands interacts with the phenyl ring of the Phe<sup>80</sup> gatekeeper residue of CDK2 by solving the crystal structure of compound <b>22</b> in complex with CDK2 (unpublished data). Our observations of the improved potency against CDK2 with substituents at this position are consistent with the data published by other groups,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> whereby 3-substituents such as CN, <sup><i>i</i></sup>Pr, and Br improve potency against CDK2.</div><div class="NLM_p">A significant breakthrough in selectivity for MAPKAP-K2 over CDK2 was achieved when substituents were introduced at the 6-position. As seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the addition of a small alkyl group at the 6-position led to a dramatic drop in potency against CDK2 even though the inhibitory activity against MAPKAP-K2 was significantly increased.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for 6-Position Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0021.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>6</sup></th><th class="colsep0 rowsep0" align="center" char=".">MAPKAP-K2 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CDK2 IC<sub>50</sub>(μM<b>)</b></th><th class="colsep0 rowsep0" align="center" char=".">selectivity CDK2/MAPKAP-K2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">l.3</td><td class="colsep0 rowsep0" align="char" char=".">0.055</td><td class="colsep0 rowsep0" align="char" char=".">0.042</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left"><sup>n</sup>Pr</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td></tr></tbody></table></div></div><div class="NLM_p">Although a range of smaller substituents at the 6-position are tolerated, increased steric bulk at this position led to a progressive reduction of the inhibitory activity against MAPKAP-K2. In conclusion, small alkyl groups such as methyl or ethyl were found to be preferred.</div><div class="NLM_p">Encouraged by the beneficial effects of substitution at the 6-position, we investigated the importance of the <i>trans</i>-4-aminocyclohexylamino group at the 5-position. It was found that the presence of the terminal amino group and its orientation and distance from the scaffold were very critical for potency; in particular, retaining the postulated salt bridge to Asp<sup>207</sup> seemed to be critical. Replacement of the linking -NH- group with the -O- group was well tolerated (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>: compound <b>47</b>). In summary, replacement of the <i>trans</i>-4-aminocyclohexylamino group with the (±)-3-piperidylamino group resulted in similar levels of potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>: compound <b>38</b> vs compound <b>44</b>) or a modest improvement in potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>: compound <b>35</b> vs compound <b>1</b>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Values for 5-Position Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0022.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0023.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">We subsequently showed that a methyl group at the 6-position in combination with the (±)-3-piperidylamino group at the 5-position was preferred over the ethyl or unsubstituted analogues. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, compound <b>48</b> showed MAPKAP-K2 inhibition with an IC<sub>50</sub> of 0.51 μM and, more importantly, improved selectivity over CDK2 compared to the other compounds (<b>35</b> and <b>49</b>). Finally, for compound <b>44</b>, we showed that the (<i>S</i>)-enantiomer of the 3-piperidylamino group exhibited better potency than the (<i>R</i>)-enantiomer at the 5-position (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). An increase in MAPKAP-K2 potency of up to 10-fold was achieved by the initial derivatization of the 5-, 6-, and 7-position substituents in compound <b>1</b> to provide (<i>S</i>)-<b>44</b>. The compounds with a 3-piperidinylamino group at the 5-position were observed to have better selectivity against CDK-2 compared to those with a 4-aminocyclohexylamino group (compound <b>35</b> vs <b>1</b> and compound <b>48</b> vs <b>25</b>). As a result of this improved selectivity, the 3-piperidinylamino group was selected as the preferred 5-position substituent for further optimization studies.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. IC<sub>50</sub> Values for 6-Position Derivatives with (<i>rac</i>)-3-Piperidylamino Group at the 5-Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0024.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>6</sup></th><th class="colsep0 rowsep0" align="center" char=".">MAPKAP-K2 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CDK2 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity CDK2/MAPKAP-K2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">34</td></tr></tbody></table></div></div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Determination of preferred enantiomer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Following up on these findings, we undertook a further round of optimization of the substituents at the 7-position. According to the predicted binding mode, it appeared that the NH group in this position is involved in hydrogen bonding to the carbonyl group of Leu141. Indeed, it was found that methylation of the 7-position NH group led to a complete loss in potency, which supports the involvement of this group in a key binding interaction (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>: compound <b>50</b>). Replacing a phenyl group in the 7-position by alkyl or benzyl groups led to a significant loss of potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>: compounds <b>51</b>–<b>53</b>), indicating the necessity for an aromatic ring at the 7-position. The SAR of the 7-aryl group was explored to further increase the activity against MAPKAP-K2. A positional scan of the substituents on the 7-phenyl group indicated that para-substitution was preferred and that a relatively large substituent, whether electron-withdrawing (compound <b>54</b>) or electron-donating (compound <b>55</b>) was tolerated. This is consistent with the predicted binding mode which indicated that substituents at the para-position of the phenyl group would be directed toward the external surface out of the ATP binding site. Taking this into account, we synthesized further analogues possessing hydrophilic groups in the para-position but little improvement was achieved (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, compounds <b>59</b> and <b>60</b>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. IC<sub>50</sub> Values for 7-Position Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0025.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0026.gif" alt="" id="fx7" /></img><div></div></div><div class="NLM_p">At this stage, we succeeded in solving the X-ray cocrystal structure of the complex of (<i>S</i>)-<b>44</b> with MAPKAP-K2<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and confirmed that the binding mode predicted from the homology model was essentially correct. However, as a result of a conformational change in the flexible glycine-rich loop (aka P-loop), the hydrophobic site in the region adjacent to the ligand was somewhat larger than was previously predicted. On the basis of this observation from the X-ray crystal structure, we synthesized further derivatives intended to pick up additional hydrogen bond interactions within this site. It was found to be difficult to improve the potency dramatically by the introduction of hydrogen bond donors and acceptors in the 7-position substituent. This is likely to be a consequence of the site being not just a hydrophobic site but also being exposed to the solvent surface. Analogues with bicyclic heteroaryl or biaryl groups in the 7-position were designed to expand the contact surface with this hydrophobic site (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). We were thus able to identify compound <b>64</b> as the most potent analogue in our series, and this compound showed a MAPKAP-K2 inhibition activity of less than 100 nM with greater than 400-fold selectivity over CDK2.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. IC<sub>50</sub> Values for 7-Position Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0027.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0028.gif" alt="" id="fx9" /></img><div></div></div><div class="NLM_p">As indicated above, we solved the X-ray cocrystal structure of the complex of (<i>S</i>)-<b>44</b> with MAPKAP-K2 at 2.9 Å resolution<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3A2C">3A2C</a>). MAPKAP-K2: (<i>S</i>)-<b>44</b> crystals belonged to the space group of <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>, and there were 12 molecules in each asymmetric unit. Surprisingly, it was found that each enzyme complex bound two molecules of (<i>S</i>)-<b>44</b>. One molecule of (<i>S</i>)-<b>44</b> was bound to the ATP-binding site between the N-terminal and C-terminal domains as expected, and the other molecule of (<i>S</i>)-<b>44</b> was bound near the substrate-binding site of the C-terminal domain as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>. Although there were two (<i>S</i>)-<b>44</b> molecules in each complex, the (<i>S</i>)-<b>44</b> molecule bound to the ATP-binding site is presumably the key interaction for the MAPKAP-K2 inhibitory activity as the analogous pyrazolo[1,5-<i>a</i>]pyrimidine derivative <b>1</b> exhibited clear ATP-competitive inhibitory activity. On the other hand, an assay to examine substrate competitivity failed to detect any binding of (<i>S</i>)-<b>44</b> in the substrate binding pocket. Therefore, the binding of (<i>S</i>)-<b>44</b> near the substrate-binding site is very weak and does not appear to contribute to the inhibitory activity against MAPKAP-K2. Interestingly, two recent reports indicate similar behavior in p38α MAP kinase, where lipid ligands<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> or small-molecule p38α inhibitors<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> bind to the C-terminal cap region formed from the conserved MAP kinase insert, in the latter case in addition to the ATP site as seen in this work; the binding affinity at this second site is suggested to be greater than observed herein for MAPKAP K2.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">We were able to use the binding mode of (<i>S</i>)-<b>44</b> in the ATP-binding site to rationalize the previously observed SAR of this series of analogues. A schematic representation of the observed interactions is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, these being largely consistent with those predicted from the homology model.</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Overlay of crystal structure of MAPKAP-K2 with (<i>S</i>)-<b>44</b> (gray and red) and MAPKAP-K2 with ADP (blue and green). There are two molecules of (<i>S</i>)-<b>44</b> in each monomer complex. One molecule of (<i>S</i>)-<b>44</b> was bound to the ATP-binding site between the N-terminal and C-terminal domains, and the other molecule of (<i>S</i>)-<b>44</b> was bound near the substrate-binding site of the C-terminal domain. The Gly-rich loop of MAPKAP-K2 with (<i>S</i>)-<b>44</b> took the α-helix conformation (α-form: shown in red), while MAPKAP-K2 with ADP showed the Gly-rich loop in a β-sheet conformation (β-form: shown in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. The binding interaction of compound (<i>S</i>)-<b>44</b> and MAPKAP-K2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound (<i>S</i>)-<b>44</b> makes two hydrogen bonds with the main chain NH and carbonyl oxygen of Leu<sup>141</sup> at the hinge region as expected. The charged amino group of the 5-(3<i>S</i>)-piperidyl moiety forms a salt bridge with the side-chain carboxyl group of Asp<sup>207</sup> together with bidentate hydrogen bonds to the main chain carbonyl oxygen of Glu<sup>190</sup> (2.84 Å) and the carbonyl oxygen on the side chain of Asn<sup>191</sup> (3.10 Å). The other significant interaction is the van der Waals contact between the 7-<i>p</i>-ethoxyphenyl group and the sulfur atom of Cys<sup>140</sup>. According to this X-ray cocrystal structure, there is little available space around the 3-position, and this is consistent with the SAR observations at this position.</div><figure id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. The ATP-binding pocket of (a) MAPKAP-K2 with (<i>S</i>)-<b>44</b> (α-form) PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3A2C">3A2C</a> and (b) MAPKAP-K2 with ADP (β-form) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NY3">1NY3</a>) viewed from the same angle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cocrystal structure of MAPKAP-K2 and (<i>S</i>)-<b>44</b> also provided useful information for understanding the improvement of selectivity for MAPKAP-K2 over CDK2. We found that the Gly-rich loop took the α-helical conformation (α-form), while other reported MAPKAP-K2 complexes with ADP, staurosporine, or various small molecule inhibitors showed the Gly-rich loop in a β-sheet conformation (β-form). As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>, it was found that the α-form had a slightly larger hydrophobic site compared to that of the β-form around the 7-position substituents. (<i>S</i>)-<b>44</b> exhibits a nonplanar conformation due to the repulsion of the 7-substituent and the methyl group at the 6-position, and this feature distinguishes it from other MAPKAP-K2 inhibitors. The interaction with the nonplanar form of (<i>S</i>)-<b>44</b> induces the secondary structural change of the Gly-rich loop from a β-sheet form to the α-helical form to avoid the conflict of the substituent at the 7-position with Leu<sup>70</sup>. As a result of this structural change, a new pocket composed of Asp<sup>142</sup>, Cys<sup>140</sup>, Gln<sup>80</sup>, and Leu<sup>79</sup> emerged and the <i>p</i>-ethoxyphenyl group at the 7-position of (<i>S</i>)-<b>44</b> bound in this new pocket.</div><div class="NLM_p">Notably, a significant improvement in selectivity over CDK2 was observed in the compounds with an ortho-substituted phenyl group at the 7-position; this trend became greater as the group at the 6-position became larger (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). The combined effect of these two substituents is to reinforce the nonplanarity of the 7-substituent and, owing to the larger hydrophobic pocket in MAPKAP-K2 compared to CDK2, this leads to an additive effect in terms of selectivity; however, the MAPKAP-K2 potency of these analogues was generally reduced.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. IC<sub>50</sub> Values for 7-Position Ortho-Substituted Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0029.gif" alt="" id="fx10" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>6</sup></th><th class="colsep0 rowsep0" align="center" char=".">MAPKAP-K2 IC<sub>50</sub>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">CDK2 IC<sub>50</sub>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity CDK2/MAPKAP-K2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">>300</td><td class="colsep0 rowsep0" align="char" char=".">>200</td></tr></tbody></table></div></div><div class="NLM_p">Recently, a structure of a CDK2–(<i>S</i>)-<b>44</b> complex was obtained in our laboratory. It was observed that the Gly-rich loop of CDK2 adopted the β-sheet conformation, with (<i>S</i>)-<b>44</b> taking a distorted planar conformation to avoid a clash of the 7-substituent with the Gly-rich loop as anticipated. Moreover, the 3-piperidylamino group at the 5-position did not make a favorable interaction similar to that observed in the MAPKAP-K2:(<i>S</i>)-<b>44</b> complex between the charged amino group and Asp<sup>207</sup>, Glu<sup>190</sup>, and Asn<sup>191</sup> as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">The kinase selectivity of (<i>S</i>)-<b>44</b> was evaluated in a single point assay at 10 μM against more than 100 kinases (<a class="ref internalNav" href="#notes-5" aria-label="Supporting Information Table S1">Supporting Information Table S1</a>). The majority of kinases (95) were inhibited by less than 30% at this concentration. Five kinases were inhibited by >75%, MAPKAP-K2, CHK2, Yes, Fes, and Flt3, with MAPKAP-K2 showing the highest levels of inhibition. The inhibition data against a subset of related kinases are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. It was observed that (<i>S</i>)-<b>44</b> exhibited very good levels of selectivity over this set of related kinases. Three of the kinases inhibited modestly by the initial hit compound <b>1</b>, i.e., MEK1, PRAK, and ROKII (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), were not inhibited to any significant extent by (<i>S</i>)-<b>44</b>.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Kinase Selectivity of Compound (<i>S</i>)-<b>44</b><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK1/cyclinB(h)</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="left">AMPK(r)</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2/cyclinE(h)</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="left">CaMK2(r)</td><td class="colsep0 rowsep0" align="char" char=".">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK2(h)</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left">CaMK4(h)</td><td class="colsep0 rowsep0" align="char" char=".">–38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IKKβ(h)</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left">CHK1(h)</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNK1α1(h)</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">PKBα(h)</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNK2α2(h)</td><td class="colsep0 rowsep0" align="char" char=".">–33</td><td class="colsep0 rowsep0" align="left">p70S6K(h)</td><td class="colsep0 rowsep0" align="char" char=".">–1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p38α(h)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">PDK1(h)</td><td class="colsep0 rowsep0" align="char" char=".">–9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p38ß(h)</td><td class="colsep0 rowsep0" align="char" char=".">–14</td><td class="colsep0 rowsep0" align="left">PKA(h)</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p38γ(h)</td><td class="colsep0 rowsep0" align="char" char=".">–2</td><td class="colsep0 rowsep0" align="left">PKCα(h)</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p38d(h)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">PKCγ(h)</td><td class="colsep0 rowsep0" align="char" char=".">–5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MKK4(m)</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">ROCK-II(h)</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MKK6 (h)</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="left">Rsk2(h)</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MKK7ß(h)</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="left">PRAK(h)</td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MEK1(h)</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">10 μM, single-point assay; (h) = human, (m) = mouse, (r) = rat. Inhibition of CHK2 by (<i>S</i>)-<b>44</b> was measured using a Cyclex assay (IC<sub>50</sub> >30 μM).</p></div></div></div><div class="NLM_p">The initial profiling round indicated that (<i>S</i>)-<b>44</b> had significant inhibitory activity (IC<sub>50</sub> 1.7 μM) toward CHK2 using a radiometric assay. The screening of further analogues (compounds <b>26</b>, <b>38</b>, and <b>65</b>) and the use of an orthogonal assay platform confirmed that these compounds showed no inhibition of CHK2 at 30 μM. While we were unable to determine the reason for the different activities demonstrated by (<i>S</i>)-<b>44</b> in the two assay formats, we concluded that the series was not significantly active against CHK2.</div><div class="NLM_p">In addition to demonstrating excellent selectivity over a panel of kinases, the series retained the good ADME properties of the initial hit compound <b>1</b> (i.e., high stability in human and mouse liver microsomes, good permeability in Caco-2 cells). A comparison of some ADME properties for <b>1</b> and (<i>S</i>)-<b>44</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. ADME Properties for <b>1</b> and (<i>S</i>)-<b>44</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center">(<i>S</i>)-<b>44</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility pH 7.4 (μg/mL)</td><td class="colsep0 rowsep0" align="center">75</td><td class="colsep0 rowsep0" align="center">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human microsomes (CL<sub>int</sub>μL/min/mg)</td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse microsomes (CL<sub>int</sub>μL/min/mg)</td><td class="colsep0 rowsep0" align="center">59</td><td class="colsep0 rowsep0" align="center">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 permeability (Papp A to B × 10<sup>–6</sup>cm/s)</td><td class="colsep0 rowsep0" align="center">7.1</td><td class="colsep0 rowsep0" align="center">28.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse PPB (fraction bound)</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">88.6%</td></tr></tbody></table></div></div><div class="NLM_p">Compounds (<i>S</i>)-<b>44</b>, <b>59</b>, and <b>64</b> were further tested in a cellular assay that measures LPS-stimulated TNF-α production from THP-1 cells (human acute monocytic leukemia cell line) and demonstrated good in vitro cellular potency as anti-TNF-α agents with no cytotoxic effects evident (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>) (see <a class="ref internalNav" href="#notes-5" aria-label="Supporting Information Figures S1–3">Supporting Information Figures S1–3</a>). (<i>S</i>)-<b>44</b> also demonstrated inhibition of LPS-stimulated TNF-α production in human and mouse whole blood assays. The observed drop-off in potency between the enzymatic assay and the cell-based or whole blood assays is typical of that seen in other similar programmes and can be attributed to the higher ATP concentration in the cells (typically 1–10 mM) compared to that in the enzymatic assay system (ATP concentration = 10 μM). It was also confirmed by Western blot (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>) that HSP27, the downstream substrate of MAPKAP-K2, was inhibited in THP-1 cells treated with (<i>S</i>)-<b>44</b> at 3 and 30 μM. These data are primarily qualitative but do show indications of a concentration-related effect of (<i>S</i>)-<b>44</b> and provide evidence that this compound was most likely acting ‘on-target’ on MAPKAP-K2 in cells. The pharmacokinetic properties of these compounds were also evaluated in mice and showed good absorption after oral administration (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>).</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. In Vitro Cellular Potency and Pharmacokinetic Profile<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0030.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>Table a</sup><p class="last">Dose: 1 mg/kg iv (0.5% Tween 80 in saline) and 1 mg/kg po (0.5% methyl cellulose) in male mice (three mice per group).</p></div><div class="footnote" id="t10fn2"><sup>Table b</sup><p class="last">Four-fold diluted blood was used.</p></div></div><div></div></div><figure id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (<i>S</i>)-<b>44</b> inhibits LPS-induced phosphorylation of HSP27 in cells. THP-1 cells were preincubated with vehicle or test compound prior to addition of LPS (10 μg/mL). Cell lysates were subjected to SDS-PAGE analysis (equivalent protein load in each lane: 20 μg) and transferred proteins subjected to immunoblotting with an antiphospho HSP27 antibody.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound (<i>S</i>)-<b>44</b> was used to evaluate the effect of MAPKAP-K2 inhibitors on the in vivo serum concentration of TNF-α in a murine model of endotoxin shock. Vehicle (5 mM HCl/saline) or compound (<i>S</i>)-<b>44</b> at each dose (mg/kg body weight) was administered orally into C57BL/6 mice (200 μL/mouse). LPS (0.5 mg/kg) was administeredintraperitoneally 30 min after the compound was injected. Sixty minutes after the LPS injection, blood was collected through the abdominal vein under barbiturate anesthesia. Serum was collected, and the TNF-α concentration was measured by an ELISA method. A dose-dependent decrease in serum TNF-α concentration was observed in the mice treated with (<i>S</i>)-<b>44</b> and was similar to the response seen with BIRB 796 as standard (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>). In the mice dosed orally at 100 mg (<i>S</i>)-<b>44</b>/kg body weight, the level of serum TNF-α was approximately 14% compared with that of the vehicle-administered group. The serum concentration of compound in the (<i>S</i>)-<b>44</b>-administered group dose-dependently increased from 2, 5, 8, to 10 μM following dosing at 10, 30, 60, and 100 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>), these concentrations being comparable to the IC<sub>50</sub> values obtained in the whole blood assay (mouse: IC<sub>50</sub> = 5 μM). We conclude that orally administered (<i>S</i>)-<b>44</b> was absorbed and was able to reach the concentrations necessary to effectively inhibit TNF-α production in a manner similar to that observed in the whole blood assay. Considering both the observed kinase selectivity profile of (<i>S</i>)-<b>44</b> and the observed repression of HSP27 phosphorylation in the cell-based assay, the inhibition of MAPKAP-K2 activity contributed to a decrease in the concentration of serum TNF-α. Further results of detailed preclinical studies will be disclosed in a forthcoming publication.</div><figure id="fig13" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. The effect of compound (<i>S</i>)-<b>44</b> on serum TNF-α concentration in mouse endotoxin shock model. Statistical analysis was carried out with the Dunnet’s multiple comparison test, with <i>P</i> < 0.05 considered as significant. *<i>P</i> < 0.05 and ***<i>P</i> < 0.001 (vs control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have demonstrated that novel pyrazolo[1,5-<i>a</i>]pyrimidine compounds are useful as MAPKAP-K2 inhibitors. SAR studies were conducted to optimize this series of pyrazolo[1,5-<i>a</i>]pyrimidine analogues, resulting in the identification of the highly potent and selective compound <b>64</b>. The MAPKAP-K2 inhibitory activity of <b>64</b> was increased by more than 20-fold over <b>1</b>, and selectivity over CDK2 was improved by more than 10 000-fold. According to the structural analysis of the MAPKAP-K2/(<i>S</i>)-<b>44</b> complex, the effect of the 6-substituent on the improvement of selectivity over CDK2 can be rationalized. Members of the pyrazolo[1,5-<i>a</i>]pyrimidine series exhibited good in vitro cellular potency in LPS-induced TNF-α secretion cell models and a favorable PK profile. Furthermore, we have also demonstrated the efficacy of (<i>S</i>)-<b>44</b> in reducing TNF-α production in the murine endotoxin shock model. The excellent in vitro kinase selectivity of (<i>S</i>)-<b>44</b> (see <a class="ref internalNav" href="#notes-5" aria-label="Supporting Information Table S1">Supporting Information Table S1</a>) plus its demonstrated inhibition of HSP27 phosphorylation, a direct substrate of MAPKAP-K2, provides confidence that this compound elicits its effect on TNF-α secretion through inhibition of MAPKAP-K2.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Commercial chemicals and solvents were of reagent grade and used without further purification. Reactions sensitive to moisture or air were performed under nitrogen using anhydrous solvents and reagents. The progress of reactions was determined by either analytical thin layer chromatography (TLC), performed with TLC Silica gel 60 F254, or liquid chromatography–mass spectrometry (LC-MS). Silica gel column chromatography was performed with the indicated solvent and using silica gel 60. Chemical yields are not optimized. The purity of all compounds screened in biological assays was determined to be >95% by HPLC/MS analysis. NMR experiments were recorded on a 400 MHz machine and are referenced to residual solvent signals: CDCl<sub>3</sub> (δ 7.26) or DMSO-<i>d</i><sub>6</sub> (δ 2.49). Chemical shifts are reported in δ units (parts per million) and are assigned as singlet (s), doublet (d), doublet of doublets (dd), triplet (t), multiplet (m), broad signal (br), or very broad signal (vbr). Coupling constants (<i>J</i>) are reported in hertz (Hz). High-resolution mass spectrometry (HRMS) measurement was performed on a LCMS-IT-TOF.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure A for the Synthesis of Compound <b>3</b></h3><div class="NLM_p last">To a stirred solution of sodium ethoxide (50 mmol) in EtOH (100 mL) were added the appropriately 2-substituted malonic acid diester (20 mmol) and appropriately substituted 3-aminopyrazole (20 mmol). The mixture was heated at reflux for 18 h, during which a precipitate was formed. (In several cases where the substituent was an alkyl chain, little or no precipitate was formed. In these situations, EtOH was removed under reduced pressure. The residue was partitioned between water and EtOAc, and the phases were separated. The aqueous phase was acidified (pH 2) with 12 N HCl and back-extracted with EtOAc (×2). The organic phase was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give crude compound <b>3</b>.) The reaction mixture was cooled to room temperature, and the precipitate was collected by filtration and washed with EtOH. The solid was dried under vacuum. The dried solid was dissolved in water (100 mL), and the resulting solution was acidified at pH 2 with 12 N HCl. The solid was collected by filtration and washed with water to give a crude compound <b>3</b>. This crude product was used in the next reaction without further purification.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure B for the Synthesis of Compound <b>4</b></h3><div class="NLM_p last">The crude compound <b>3</b> (10 mmol) was dissolved in phosphorus oxychloride (20 mL), and <i>N</i>,<i>N</i>-dimethylaniline (1.0 mL) was added. The mixture was heated at reflux for 18 h. Excess phosphorus oxychloride was removed in vacuo. The residue was poured onto ice (ca. 100 g) and extracted with EtOAc (×2). The combined organic phase was washed with 1 N HCl several times, until <i>N</i>,<i>N</i>-dimethylaniline was completely removed, and then washed with water and brine. The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by silica gel column chromatography to give compound <b>4</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 5,7-Dichloropyrazolo[1,5-<i>a</i>]pyrimidine (<b>13</b>)</h3><div class="NLM_p last">3-Aminopyrazole (4.2 g, 50 mmol) was reacted with diethyl malonate (8.1 g, 50 mmol) according to the general procedures A and B. The crude product was purified by silica gel column chromatography (hexane/EtOAc = 10:1) to give the title compound (3.0 g, 16 mmol, yield: 32% for two steps). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.23 (1H, d, <i>J</i> = 2.4 Hz), 7.00 (1H, s), 6.75 (1H, d, <i>J</i> = 2.4 Hz). HRMS calcd for C6H4Cl2N3 (M + H)<sup>+</sup>, 187.9777; found, 187.9768.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 5,7-Dichloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidine (<b>4e</b>)</h3><div class="NLM_p last">3-Aminopyrazole (2.2 g, 26 mmol) was reacted with diethyl methylmalonate (4.6 g, 26 mmol) according to the general procedure A and B. The crude product was purified by silica gel column chromatography (hexane/EtOAc = 10:1) to give the title compound (2.2 g, 11 mmol, yield: 42% for two steps). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.16 (1H, d, <i>J</i> = 2.4 Hz), 6.71 (1H, d, <i>J</i> = 2.4 Hz), 2.56 (3H, s). HRMS calcd for C<sub>7</sub>H<sub>6</sub>Cl<sub>2</sub>N<sub>3</sub> (M + H)<sup>+</sup>, 201.9933; found, 201.9935.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure C for the Synthesis of Compound <b>5</b></h3><div class="NLM_p last">To a stirred solution of a compound <b>4</b> (5.0 mmol) in 2-propanol (50 mL) containing triethylamine (10 mmol) was added the appropriate amine (6.0 mmol). The reaction was heated for 15 h at 80 °C and cooled to room temperature. In the case that a precipitate was formed, this was collected by filtration and washed with MeOH. The solid was dried under vacuum to give compound <b>5</b>. This product was used in the next reaction without further purification. In the case that a precipitate did not form, the reaction mixture was cooled to room temperature, the residue was partitioned between water and EtOAc, and the organic phase was separated. The aqueous phase was extracted with EtOAc (×2). The combined organic phase was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by silica gel column chromatography to give compound <b>5</b>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure D for the Synthesis of Compound <b>5</b></h3><div class="NLM_p last">To a stirred suspension of sodium hydride (3.0 mmol) in DMF (10 mL) were added the appropriate amine (2.4 mmol) and then a compound <b>4</b> (2.0 mmol) in THF (10 mL). The resulting mixture was stirred at room temperature to 50 °C for 2 h. The reaction was quenched with a saturated aqueous solution of NH<sub>4</sub>Cl. After extraction with EtOAc, the combined organic phase was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude product was purified by washing with MeOH or by silica gel column chromatography to give a compound <b>5</b>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-Chloro-<i>N</i>-(3-chloro-4-fluorophenyl)pyrazolo[1,5-<i>a</i>]pyrimidin-7-amine (<b>5a</b>)</h3><div class="NLM_p last">5,7-Dichloropyrazolo[1,5-<i>a</i>]pyrimidine (<b>13</b>) (0.51 g, 2.7 mmol) was reacted with 3-chloro-4-fluoroaniline (0.47 g, 3.3 mmol) according to the general procedure C to give the title compound (0.69 g, 2.3 mmol, yield: 85%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.07–8.04 (2H, m), 7.48–7.45 (1H, m), 7.32–7.28 (2H, m), 6.54–6.53 (1H, m), 6.18 (1H, s). HRMS calcd for C<sub>12</sub>H<sub>8</sub>Cl<sub>2</sub>FN<sub>4</sub> (M + H)<sup>+</sup>, 297.0105; found, 297.0107.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-[4-(Benzyloxy)phenyl]-5-chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-amine (<b>5p</b>)</h3><div class="NLM_p last">5,7-Dichloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidine (<b>4e</b>) (0.25 g, 1.2 mmol) was reacted with 4-benzyloxyaniline (0.30 g, 1.5 mmol) according to the general procedure C to give the title compound (0.36 g, 0.98 mmol, yield: 82%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.07 (1H, s), 8.00 (1H, d, <i>J</i> = 2.4 Hz), 7.46–7.35 (5H, m), 7.13–7.09 (2H, m), 7.02–6.98 (2H, m), 6.49 (1H, d, <i>J</i> = 2.4 Hz), 5.09 (2H, s), 1.90 (3H, s). HRMS calcd for C<sub>20</sub>H<sub>18</sub>ClN<sub>4</sub>O (M + H)<sup>+</sup>, 365.1164; found, 365.1153.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Ethyl 3-({5-Chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}amino)benzoate (<b>5r</b>)</h3><div class="NLM_p last">5,7-Dichloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidine (<b>4e</b>) (0.25 g, 1.2 mmol) was reacted with ethyl 3-aminobenzoate (0.25 g, 1.5 mmol) according to the general procedure C to give the title compound (0.32 g, 0.98 mmol, yield: 82%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.10 (1H, s), 8.02 (1H, d, <i>J</i> = 2.2 Hz), 7.92–7.90 (1H, m), 7.77–7.75 (1H, m), 7.48 (1H, t, <i>J</i> = 7.9 Hz), 7.28 (1H, dd, <i>J</i> = 7.9, 2.2 Hz), 6.55 (1H, d, <i>J</i> = 2.2 Hz), 4.40 (2H, q, <i>J</i> = 7.2 Hz), 1.95 (3H, s), 1.41 (3H, t, <i>J</i> = 7.2 Hz). HRMS calcd for C<sub>16</sub>H<sub>16</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup>, 331.0956; found, 331.0949.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 5-Chloro-<i>N</i>-(2-chlorophenyl)-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-amine (<b>5x</b>)</h3><div class="NLM_p last">5,7-Dichloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidine (<b>4e</b>) (0.25 g, 1.2 mmol) was reacted with 2-chloroaniline (0.19 g, 1.5 mmol) according to the general procedure D to give the title compound (0.22 g, 0.77 mmol, yield: 64%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.04 (1H, d, <i>J</i> = 2.4 Hz), 7.95 (1H, s), 7.51 (1H, dd, <i>J</i> = 7.9, 1.5 Hz), 7.30 (1H, td, <i>J</i> = 7.9, 1.5 Hz), 7.18 (1H, td, <i>J</i> = 7.9, 1.5 Hz), 7.03 (1H, dd, <i>J</i> = 7.9, 1.5 Hz), 6.56 (1H, d, <i>J</i> = 2.4 Hz), 1.95 (3H, s). HRMS calcd for C<sub>13</sub>H<sub>11</sub>Cl<sub>2</sub>N<sub>4</sub> (M + H)<sup>+</sup>, 293.0355; found, 293.0342.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure E for the Synthesis of Compound <b>6</b></h3><div class="NLM_p last">To a stirred solution of compound <b>5</b> (1.0 mmol) in 1,4-dioxane (5.0 mL) was added di-<i>tert</i>-butyl dicarbonate (2.0 mmol) followed by a catalytic amount of 4-dimethylaminopyridine. The reaction mixture was stirred at room temperature for 3 h. If starting material was detected by TLC, the reaction mixture was warmed to 60 °C and stirred for further 3 h. The reaction mixture was concentrated in vacuo. The residue was purified by silica gel column chromatography to give compound <b>6</b>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl <i>N</i>-(3-Chloro-4-fluorophenyl)-<i>N</i>-{5-chloropyrazolo[1,5-<i>a</i>]pyrimidin-7-yl} carbamate (<b>6a</b>)</h3><div class="NLM_p last">5-Chloro-<i>N</i>-(3-chloro-4-fluorophenyl)pyrazolo[1,5-<i>a</i>]pyrimidin-7-amine (<b>5a</b>) (0.30 g, 1.0 mmol) was reacted with di-<i>tert</i>-butyl dicarbonate (0.44 g, 2.0 mmol) according to the general procedure E. The crude product was purified by silica gel column chromatography (hexane/EtOAc = 8/1) to give the title compound (0.33 g, 0.83 mmol, yield: 83%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.16 (1H, d, <i>J</i> = 2.4 Hz), 7.45 (1H, dd, <i>J</i> = 6.3, 2.4 Hz), 7.26–7.22 (1H, m), 7.13 (1H, t, <i>J</i> = 8.5 Hz), 6.72–6.69 (2H, m), 1.37 (9H, s).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>tert</i>-Butyl <i>N</i>-{5-Chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}-<i>N</i>-(4-ethoxyphenyl)carbamate (<b>6m</b>)</h3><div class="NLM_p last">5-Chloro-<i>N</i>-(4-ethoxyphenyl)-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-amine (<b>5n</b>) (1.0 g, 3.3 mmol) was reacted with di-<i>tert</i>-butyl dicarbonate (1.4 g, 6.6 mmol) according to the general procedure E. The crude product was purified by silica gel column chromatography (hexane/EtOAc = 8/1) to give the title compound (1.1 g, 2.8 mmol, yield: 85%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.10 (1H, s), 7.25–7.20 (2H, m), 6.82 (2H, d, <i>J</i> = 8.8 Hz), 6.65 (1H, d, <i>J</i> = 2.0 Hz), 3.99 (2H, q, <i>J</i> = 6.9 Hz), 2.31 (3H, s), 1.39–1.32 (12H, m).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>tert</i>-Butyl <i>N</i>-[4-(Benzyloxy)phenyl]-<i>N</i>-{5-chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}carbamate (<b>6o</b>)</h3><div class="NLM_p last"><i>N</i>-[4-(Benzyloxy)phenyl]-5-chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-amine (<b>5p</b>) (0.36 g, 0.98 mmol) was reacted with di-<i>tert</i>-butyl dicarbonate (0.43 g, 2.0 mmol) according to the general procedure E. The crude product was purified by silica gel column chromatography (hexane/EtOAc = 8/1) to give the title compound (0.37 g, 0.80 mmol, yield: 82%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.10 (1H, d, <i>J</i> = 2.2 Hz), 7.41–7.31 (5H, m), 7.25–7.21 (2H, m), 6.90 (2H, d, <i>J</i> = 8.8 Hz), 6.65 (1H, d, <i>J</i> = 2.2 Hz), 5.02 (2H, s), 2.31 (3H, s), 1.30 (9H, s).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>tert</i>-Butyl <i>N</i>-{5-Chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}-<i>N</i>-(2-methyl-1,3-benzothiazol-6-yl)carbamate (<b>6u</b>)</h3><div class="NLM_p last"><i>N</i>-{5-Chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}-2-methyl-1,3-benzothiazol-6-amine (<b>5v</b>) (0.32 g, 0.98 mmol) was reacted with di-<i>tert</i>-butyl dicarbonate (0.43 g, 2.0 mmol) according to the general procedure E. The crude product was purified by silica gel column chromatography (hexane/EtOAc = 8/1) to give the title compound (0.29 g, 0.67 mmol, yield: 68%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.12 (1H, d, <i>J</i> = 2.2 Hz), 7.88 (1H, d, <i>J</i> = 8.8 Hz), 7.78 (1H, s), 7.35 (1H, d, <i>J</i> = 8.8 Hz), 6.69 (1H, d, <i>J</i> = 2.2 Hz), 2.82 (3H, s), 2.32 (3H, s), 1.35 (9H, s).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure F for the Synthesis of Compound <b>9</b></h3><div class="NLM_p last">A mixture of the compound <b>6</b> (1.0 mmol) and appropriate amine (1.0 g) was heated at 80–85 °C for 18 h. If the amine was not liquid at this reaction temperature, MeCN was added as a solvent. The crude material was then partitioned between EtOAc and water. The organic phase was then separated and washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5.0 mL) and TFA (3.0 mL). The reaction mixture was stirred for 1 h at room temperature and then evaporated in vacuo. The residue was partitioned between EtOAc and a saturated aqueous solution of NaHCO<sub>3</sub>. The organic phase was separated, washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified by preparative HPLC. To get a salt-free product, the purified product was dissolved in EtOAc and washed with saturated aqueous solution of NaHCO<sub>3</sub> and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give the title compound.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5-<i>N</i>-(<i>trans</i>-4-Aminocyclohexyl)-7-<i>N</i>-(3-chloro-4-fluorophenyl)pyrazolo[1,5-<i>a</i>]pyrimidine-5,7-diamine (<b>1</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl <i>N</i>-(3-chloro-4-fluorophenyl)-<i>N</i>-{5-chloropyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}carbamate (<b>6a</b>) (0.40 g, 1.0 mmol) was reacted with <i>trans</i>-1,4-cyclohexanediamine (1.0 g, 8.8 mmol) according to the general procedure F to get the title compound (0.20 g, 0.53 mmol, yield: 53%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 7.80 (1H, d, <i>J</i> = 2.0 Hz), 7.60 (1H, dd, <i>J</i> = 6.8, 2.4 Hz), 7.48 (1H, t, <i>J</i> = 9.0 Hz), 7.42–7.38 (1H, m), 6.77 (1H, d, <i>J</i> = 7.8 Hz), 5.94 (1H, d, <i>J</i> = 2.0 Hz), 5.57 (1H, s), 3.68 (1H, s), 2.85–2.80 (1H, m), 1.96–1.85 (4H, m), 1.34–1.11 (4H, m). HRMS calcd for C<sub>18</sub>H<sub>21</sub>ClFN<sub>6</sub> (M + H)<sup>+</sup>, 375.1495; found, 375.1497.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 7-<i>N</i>-(4-Ethoxyphenyl)-6-methyl-5-<i>N</i>-(<i>S</i>-piperidin-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-5,7-diamine (<b>44</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl <i>N</i>-{5-chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}-<i>N</i>-(4-ethoxyphenyl)carbamate (<b>6m</b>) (0.50 g, 1.2 mmol) was reacted with 3-amino-1-Boc-piperidine (1.0 g, 5.0 mmol) according to the general procedure F to get the title compound. For the syntheses of (<i>rac</i>)-<b>44</b>, (<i>S</i>)-<b>44</b>, and (<i><b>R</b></i>)-<b>44</b>, (±)-3-amino-1-Boc-piperidine, (<i>S</i>)-3-amino-1-Boc-piperidine, ]pyrimidin-7-yl}and (<i>R</i>)-3-amino-1-Boc-piperidine were used respectively (0.25 g, 0.68 mmol, yield: 57% for (<i>S</i>)-<b>44</b>. (<i>rac</i>)-<b>44</b> and (<i><b>R</b></i>)-<b>44</b> gave similar yields). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.54 (1H, s), 7.75 (1H, d, <i>J</i> = 2.0 Hz), 6.90–6.83 (4H, m), 6.05 (1H, d, <i>J</i> = 7.8 Hz), 5.98 (1H, d, <i>J</i> = 2.0 Hz), 4.17 (1H, s), 3.96 (2H, q, <i>J</i> = 6.8 Hz), 3.17 (1H, d, <i>J</i> = 7.8 Hz), 2.96–2.93 (1H, m), 2.58–2.52 (2H, m), 1.91–1.86 (1H, m), 1.74–1.70 (1H, m), 1.65 (3H, s), 1.57–1.52 (2H, m), 1.30 (3H, t, <i>J</i> = 6.8 Hz). HRMS calcd for C<sub>20</sub>H<sub>27</sub>N<sub>6</sub>O (M + H)<sup>+</sup>, 367.2241; found, 367.2243.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 6-Methyl-7-<i>N</i>-(2-methyl-1,3-benzothiazol-6-yl)-5-<i>N</i>-(S-piperidin-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-5,7-diamine (<b>64</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl <i>N</i>-{5-chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}-<i>N</i>-(2-methyl-1,3-benzothiazol-6-yl)carbamate (<b>6u</b>) (0.15 g, 0.35 mmol) was reacted with (<i>S</i>)-3-amino-1-Boc-piperidine (1.0 g, 5.0 mmol) according to the general procedure F to get the title compound (66 mg, 0.17 mmol, yield: 49%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.93 (1H, s), 7.76 (1H, d, <i>J</i> = 8.8 Hz), 7.74 (1H, d, <i>J</i> = 2.2 Hz), 7.37 (1H, d, <i>J</i> = 2.2 Hz), 7.10 (1H, dd, <i>J</i> = 8.8, 2.2 Hz), 6.10 (1H, d, <i>J</i> = 7.8 Hz), 6.02 (1H, d, <i>J</i> = 2.2 Hz), 4.15–4.07 (1H, m), 3.12 (1H, dd, <i>J</i> = 12.0, 3.4 Hz), 2.88–2.85 (1H, m), 2.72 (3H, s), 2.53–2.47 (2H, m), 1.88 (1H, s), 1.76 (3H, s), 1.72–1.65 (1H, m), 1.61–1.45 (2H, m). HRMS calcd for C<sub>20</sub>H<sub>24</sub>N<sub>7</sub>S (M + H)<sup>+</sup>, 394.1808; found, 394.1807.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>tert</i>-Butyl (<i>S</i>)-3-[(7-{[(<i>tert</i>-Butoxy)carbonyl](4-ethoxyphenyl)amino}-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-5-yl)amino]piperidine-1-carboxylate (<b>8a</b>)</h3><div class="NLM_p last">A mixture of <i>tert</i>-butyl <i>N</i>-{5-chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}-<i>N</i>-(4-ethoxyphenyl)carbamate (<b>6m</b>) (0.40 g, 0.99 mmol) and (<i>S</i>)-3-amino-1-Boc-piperidine (2.0 g, 10 mmol) was heated together at 80–85 °C for 18 h. The reaction mixture was cooled to room temperature and was directly purified by silica gel column chromatography (hexane/EtOAc = 8/1) to give the title compound (0.43 g, 0.76 mmol, yield: 77%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.84 (1H, d, <i>J</i> = 2.0 Hz), 7.29–7.26 (2H, m), 6.81–6.79 (2H, m), 6.16 (1H, d, <i>J</i> = 2.0 Hz), 4.22 (1H, s), 3.98 (2H, q, <i>J</i> = 7.0 Hz), 3.78–3.22 (4H, m), 2.02 (3H, s), 1.91–1.83 (2H, m), 1.73–1.61 (2H, m), 1.50–1.30 (21H, m).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl (<i>S</i>)-3-[(7-{[4-(Benzyloxy)phenyl][(<i>tert</i>-butoxy)carbonyl]amino}-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-5-yl)amino]piperidine-1-carboxylate (<b>15</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl <i>N</i>-[4-(benzyloxy)phenyl]-<i>N</i>-{5-chloro-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl}carbamate (<b>6o</b>) (0.47 g, 1.0 mmol) was reacted with (<i>S</i>)-3-amino-1-Boc-piperidine (2.0 g, 10 mmol) according to an analogous fashion to <b>8a</b>. The reaction mixture was purified by silica gel column chromatography (hexane/EtOAc = 8/1) to give the title compound (0.43 g, 0.68 mmol, yield: 68%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.84 (1H, d, <i>J</i> = 2.0 Hz), 7.40–7.29 (7H, m), 6.88 (2H, dd, <i>J</i> = 8.8, 2.0 Hz), 6.16 (1H, d, <i>J</i> = 2.0 Hz), 5.01 (2H, s), 4.22 (1H, s), 3.82–3.16 (4H, m), 2.02 (3H, s), 1.88 (1H, s), 1.77–1.56 (3H, m), 1.48–1.29 (18H, m).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 7-<i>N</i>-[4-(2-Methoxyethoxy)phenyl]-6-methyl-5-<i>N</i>-[(<i>S</i>)-piperidin-3-yl]pyrazolo[1,5-<i>a</i>]pyrimidine-5,7-diamine (<b>59</b>)</h3><div class="NLM_p">To a stirred solution of <i>tert</i>-butyl (<i>S</i>)-3-[(7-{[4-(benzyloxy)phenyl][(<i>tert</i>-butoxy)carbonyl]amino}-6-methylpyrazolo[1,5-<i>a</i>]pyrimidin-5-yl)amino]piperidine-1-carboxylate (<b>15</b>) (1.0 g, 1.6 mmol) in MeOH (50 mL) was added Pd(OH)<sub>2</sub>/C (50 mg, 10% on carbon) under nitrogen atmosphere. The reaction mixture was stirred at room temperature for 16 h under hydrogen atmosphere, and Pd(OH)<sub>2</sub>/C was filtered off. The solvent was removed in vacuo to give the crude alcohol product <b>16</b> (0.81 g, 1.5 mmol, yield: 94%). This crude product was used in the next reaction without further purification.</div><div class="NLM_p last">To a stirred solution of crude product <b>16</b> (81 mg, 0.15 mmol), 2-methoxyethanol (23 mg, 0.30 mmol), and triphenylphosphine (52 mg, 0.20 mmol) in THF (5.0 mL) was added a solution of diisopropyl azodicarboxylate (43 mg, 0.21 mmol) in toluene (0.11 mL) at 0 °C. The reaction mixture was stirred at room temperature for 10 h. The reaction was quenched by addition of water. EtOAc was added, and the organic phase was separated. The aqueous phase was extracted with EtOAc (×2), and the combined organic phase was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL). To this solution was added TFA (1.0 mL), and the reaction mixture was stirred for 3 h. The solvent was removed in vacuo. The residue was purified by preparative HPLC. To get a salt-free product, the purified product was dissolved in EtOAc, washed with a saturated aqueous solution of NaHCO<sub>3</sub> and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give the title compound (13 mg, 0.032 mmol, yield: 20% for two steps from <b>16</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 8.50 (1H, s), 7.73 (1H, d, <i>J</i> = 2.0 Hz), 6.91–6.84 (4H, m), 5.97 (1H, d, <i>J</i> = 2.0 Hz), 5.95 (1H, d, <i>J</i> = 7.8 Hz), 4.10–4.01 (3H, m), 3.64–3.62 (2H, m), 3.29 (3H, s), 3.07 (1H, dd, <i>J</i> = 11.7, 3.2 Hz), 2.85–2.80 (1H, m), 2.49–2.42 (2H, m), 1.89–1.82 (1H, m), 1.67–1.64 (1H, m), 1.66 (3H, s), 1.59–1.41 (2H, m). HRMS calcd for C<sub>21</sub>H<sub>29</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup>, 397.2347; found, 397.2338.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> General Procedure G for Measurement of Enzyme Activity Inhibition</h3><div id="sec4_23_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Compound Preparation</h4><div class="NLM_p last">Compounds were dissolved in DMSO at a concentration of 10 mM and stored in aliquots at −20 °C. Compounds in DMSO from these stock aliquots were diluted in DMSO to produce the required range of 30× stock solutions. These stock solutions were then subjected to 1:3 dilutions to prepare the required range of 10× stock solutions, and 5 μL of each solution was used in each 50 μL reaction. A final DMSO concentration of 3% was maintained throughout all compound dilution series to maximize compound solubility. Compounds were routinely tested at final concentrations ranging from 300 μM to 0.001 μM but may have been tested at lower concentrations depending upon their activity.</div></div><div id="sec4_23_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> MAPKAP-K2 Assay</h4><div class="NLM_p last">The kinase reaction was conducted in a round-bottomed polypropylene 96-well plate. MAPKAP-kinase 2 was diluted to 0.5 mU/μL in diluent buffer (50 mM Tris/HCl. pH7.5, 0.1 mM EGTA, 0.1% (v/v) β-mercaptoethanol, 1 mg/mL BSA). Five microliters of compound or 30% DMSO was added to each well followed by 25 μL of substrate cocktail (final concentration: 10 μM ATP, 30 μM peptide (KKLNRTLSVA), 0.5 μCi of <sup>33</sup>P-γ-ATP (or 1 μCi for kinetic determinations) in 50 mM Tris pH7.5, 0.1 mM EGTA, 10 mM Mg-acetate, and 0.1% β-mercaptoethanol). The reaction was initiated with the addition of 20 μL of enzyme solution per well or 20 μL of diluent buffer without enzyme. The plate was shaken for 10 s and then left at room temperature for 30 min. The reaction was terminated with 50 μL of 150 mM phosphoric acid. An amount of 90 μL of the reaction mixture was then transferred into a 96-well P81 filter plate (Whatmann) and incubated at room temperature for 5 min. The filter plate was then washed four times with 200 μL of 75 mM phosphoric acid per well on a plate vacuum manifold (Millipore) and dried in an oven for 2–3 h. Packard MicroScint ‘0’ (30 μL) was then added to each well, and the plate was mixed for 30 min and subjected to liquid scintillation counting on a Packard TopCount.</div></div><div id="sec4_23_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> CDK2 Assay</h4><div class="NLM_p last">The kinase reaction was conducted in a round-bottomed polypropylene 96-well plate. CDK2 was diluted to 0.5 ng/μL in diluent buffer (50 mM Tris/HCl. pH 7.5, 0.1 mM EGTA, 0.1% (v/v) β-mercaptoethanol, 1 mg/mL BSA). Five microliters of compound or 30% DMSO was added to each well followed by 25 μL of substrate cocktail (final 10 μM ATP, 0.1 mg/mL histone type III-S, 0.2 μCi <sup>33</sup>P-γ-ATP in 50 mM Tris-HCl (pH 7.5), 1 mM EGTA, 2 mM DTT, 10 mM MgCl<sub>2</sub>, 0.01% Brij-35). The reaction was initiated with the addition of 20 μL of enzyme solution per well or 20 μL of diluent buffer without enzyme. The plate was shaken for 10 s and then left at room temperature for 60 min. The reaction was terminated with 50 μL of 150 mM phosphoric acid. An amount of 90 μL of the reaction mixture was then transferred into a 96-well P81 filter plate (Whatman) and incubated at room temperature for 5 min. The filter plate was then washed four times with 200 μL of 75 mM phosphoric acid per well on a plate vacuum manifold (Millipore) and dried in an oven for 2–3 h. Packard MicroScint ‘0’ (30 μL) was then added to each well, the plate was mixed for 30 min and subjected to liquid scintillation counting on a Packard TopCount.</div></div><div id="sec4_23_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> LPS-Induced TNF-α Production in THP-1 Cells</h4><div class="NLM_p last">THP-1 cells (ATCC: TIB-202) were suspended in THP-1 media (90% RPMI 1640 containing 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 1.5 g/L sodium bicarbonate, 4.5 g/L <span class="smallcaps smallerCapital">d</span>-glucose, 10 mM HEPES, 1 mM sodium pyrubate, 0.05 mM 2-ME, 10% heat-inactivated FBS) at a density of 1 × 10<sup>5</sup> cells/mL. An amount of 100 μL of THP-1 cell suspension was then plated in a 96-well tissue culture plate and incubated in a CO<sub>2</sub> incubator for 2 h. Cells were pretreated for 1 h in a CO<sub>2</sub> incubator in the presence of a further 40 μL of THP-1 media and 50 μL of test compound (serial dilutions in DMSO). LPS was then added (10 μg/mL final), and the cells were further incubated for 18 h. The cell supernatants were harvested and measured for TNF-α concentration using a HTRF Human TNF-α kit (CisBio). Compound effects on cell growth during the assay period were assessed by assaying residual cells with the CellTiter 96 Aqueous One Solution Reagent (Promega).</div></div><div id="sec4_23_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Whole Blood Assays</h4><div class="NLM_p last">Mouse whole blood or human whole blood (from two healthy and nonmedicated volunteers in the latter case) was drawn and diluted four times in RPMI-1640. Diluted blood (360 μL per well) was dispensed into 48-well plates and test compound (0.4–100 μM) added in DMSO (20 μL). LPS (10 μg/mL) was added prior to an overnight incubation. The concentrations of TNF-α in the cell supernatants were measured by using an ELISA (R&D Systems, Inc.).</div></div><div id="sec4_23_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> LPS-Induced HSP27 Phosphorylation in THP-1 Cells</h4><div class="NLM_p last">THP-1 cells (5 × 10<sup>5</sup> cells/dish) were incubated in a CO<sub>2</sub> incubator for 1 h. The cells were then preincubated in the presence of test compound ((<i>S</i>)-<b>44</b>: 3 μM and 30 μM; BIRB796: 0.1 μM) for 1 h. After addition of LPS (10 μg/mL), the cells were further incubated for 1 h and then washed with PBS. Following lysis at 4 °C for 15 min, lysates were centrifuged and then subjected to SDS-PAGE analysis (20 μg protein/lane) followed by protein transfer and immunoblotting with an antiphospho-specific antibody (Cell Signaling Technology).</div></div><div id="sec4_23_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Pharmacokinetics</h4><div class="NLM_p last">The iv and po pharmacokinetic profile were investigated at a dose of 1 mg/kg in male mice. Formulations were 0.5% Tween 80 in saline for iv dosing and 0.5% methyl cellulose aqueous solution for po dosing. The plasma concentration was measured by LC/MS/MS after serial blood sampling. The individual pharmacokinetic parameters were calculated by noncompartmental analysis and the mean parameters calculated. AUC0–24 is the area under plasma concentration–time curve from time 0 to 24 h after oral administration. CL<sub>tot</sub> is the plasma total clearance obtained from iv administration.</div></div><div id="sec4_23_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Effect of (<i>S</i>)-<b>44</b> on TNF-α Production in Murine Endotoxin Shock Model</h4><div class="NLM_p last">Vehicle (5 mM HCl/saline) or 10, 30, 60, or 100 mg/kg body weight of (<i>S</i>)-<b>44</b> (5 mM HCl/saline) (n = 6) was administered orally to C57BL/6 mice (male, 8 week old; Charles River Japan). Thirty minutes later, 0.5 mg/kg body weight of lipopolysaccharide (LPS; <i>E. coli</i>. 055:B5, Sigma-Aldrich Co.) was administered intraperitoneally. Sixty minutes after the LPS administration, blood was collected through the abdominal vein under barbiturate anesthesia. Serum was prepared for measurement of TNF-α concentration by the ELISA method (R&D Systems, Inc.). Statistical analysis was carried out with the Dunnet’s multiple comparison test, with <i>P</i> < 0.05 being considered as significant.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51"><a href="/doi/suppl/10.1021/jm300411k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details for the synthesis of all compounds and spectral data of all intermediates and final compounds. Kinase selectivity panel for (<i>S</i>)-<b>44</b>. THP-1 cell based assay concentration effect curves for (<i>S</i>)-<b>44</b>, <b>59</b>, and <b>64</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300411k/suppl_file/jm300411k_si_001.pdf">jm300411k_si_001.pdf (555.06 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300411k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dale R. Mitchell</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2c4b0259424347456c584945464542024f4302465c0c484d4049024145584f444940406c4b405c4b024f4341"><span class="__cf_email__" data-cfemail="9afdb4eff4f5f1f3daeefff3f0f3f4b4f9f5b4f0ea">[email protected]</span> <span class="__cf_email__" data-cfemail="c5a1a4a9a0eba8acb1a6ada0a9a985a2a9b5a2eba6aaa8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gen Unoki</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1e79306b707175775e6a7b77747770307d7130746e3e7a7f727b3073776a7d767b72725e79726e79307d7173"><span class="__cf_email__" data-cfemail="6700491209080c0e2713020e0d0e09490408490d17">[email protected]</span> <span class="__cf_email__" data-cfemail="90f4f1fcf5befdf9e4f3f8f5fcfcd0f7fce0f7bef3fffd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomomi Kosugi</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aiko Fujino</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minoru Imai</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mika Kambe</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shinji Kobayashi</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroaki Makino</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yohei Matsueda</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasuhiro Oue</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kanji Komatsu</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keiichiro Imaizumi</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuri Sakai</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satoshi Sugiura</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Osami Takenouchi</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuko Yamakoshi</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vicky Cunliffe</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Frearson</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Gordon</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">C. John Harris</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heidi Kalloo-Hosein</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joelle Le</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gita Patel</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald J. Simpson</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brad Sherborne</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter S. Thomas</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden,
Essex, CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naotaka Suzuki</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Midori Takimoto-Kamimura</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken-ichiro Kataoka</span> - <span class="hlFld-Affiliation affiliation">Teijin Institute for Bio-medical
Research, Teijin Pharma Ltd., Hino, Tokyo
191-8512, Japan</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i52" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i52"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i53" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i53"> Abbreviations Used</h2><tr><td class="NLM_term">MAPKAP-K2</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase-activated protein kinase 2</p></td></tr><tr><td class="NLM_term">CDK2</td><td class="NLM_def"><p class="first last">cyclin dependent kinase 2</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α</p></td></tr><tr><td class="NLM_term">MAP</td><td class="NLM_def"><p class="first last">mitogen-activated protein</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">Ser</td><td class="NLM_def"><p class="first last">serine</p></td></tr><tr><td class="NLM_term">Thr</td><td class="NLM_def"><p class="first last">threonine</p></td></tr><tr><td class="NLM_term">mRNA</td><td class="NLM_def"><p class="first last">messenger ribonucleic acid</p></td></tr><tr><td class="NLM_term">SFK</td><td class="NLM_def"><p class="first last">SoftFocus kinase</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last">butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">Leu</td><td class="NLM_def"><p class="first last">leucine</p></td></tr><tr><td class="NLM_term">Asn</td><td class="NLM_def"><p class="first last">asparagine</p></td></tr><tr><td class="NLM_term">Asp</td><td class="NLM_def"><p class="first last">aspartic acid</p></td></tr><tr><td class="NLM_term">Phe</td><td class="NLM_def"><p class="first last">phenylalanine</p></td></tr><tr><td class="NLM_term">ADP</td><td class="NLM_def"><p class="first last">adenosine diphosphate</p></td></tr><tr><td class="NLM_term">Glu</td><td class="NLM_def"><p class="first last">glutamic acid</p></td></tr><tr><td class="NLM_term">Cys</td><td class="NLM_def"><p class="first last">cysteine</p></td></tr><tr><td class="NLM_term">CDK1</td><td class="NLM_def"><p class="first last">cyclin dependent kinase 1</p></td></tr><tr><td class="NLM_term">ERK2</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase 2</p></td></tr><tr><td class="NLM_term">IKKβ</td><td class="NLM_def"><p class="first last">inhibitor of nuclear factor kappa-B kinase subunit beta</p></td></tr><tr><td class="NLM_term">JNK1α1</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase 1 alpha 1</p></td></tr><tr><td class="NLM_term">JNK2α2</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase 2 alpha 2</p></td></tr><tr><td class="NLM_term">p38α</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase p38 alpha</p></td></tr><tr><td class="NLM_term">p38β</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase p38 beta</p></td></tr><tr><td class="NLM_term">p38γ</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase p38 gamma</p></td></tr><tr><td class="NLM_term">p38δ</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase p38 delta</p></td></tr><tr><td class="NLM_term">MKK4</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase 4</p></td></tr><tr><td class="NLM_term">MKK6</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase 6</p></td></tr><tr><td class="NLM_term">MKK7β</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase 7 beta</p></td></tr><tr><td class="NLM_term">MEK1</td><td class="NLM_def"><p class="first last">dual specificity mitogen-activated protein kinase kinase 1</p></td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">5′ adenosine monophosphate-activated protein kinase</p></td></tr><tr><td class="NLM_term">CaMK2</td><td class="NLM_def"><p class="first last">calmodulin-dependent protein kinase 2</p></td></tr><tr><td class="NLM_term">CaMK4</td><td class="NLM_def"><p class="first last">calmodulin-dependent protein kinase 4</p></td></tr><tr><td class="NLM_term">CHK1</td><td class="NLM_def"><p class="first last">checkpoint kinase 1</p></td></tr><tr><td class="NLM_term">CHK2</td><td class="NLM_def"><p class="first last">checkpoint kinase 2</p></td></tr><tr><td class="NLM_term">PKBα</td><td class="NLM_def"><p class="first last">protein kinase B alpha</p></td></tr><tr><td class="NLM_term">p70S6K</td><td class="NLM_def"><p class="first last">70 kDa ribosomal protein S6 kinase 1</p></td></tr><tr><td class="NLM_term">PDK1</td><td class="NLM_def"><p class="first last">3-phosphoinositide-dependent protein kinase 1</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">protein kinase A</p></td></tr><tr><td class="NLM_term">PKCα</td><td class="NLM_def"><p class="first last">protein kinase C alpha</p></td></tr><tr><td class="NLM_term">PKCγ</td><td class="NLM_def"><p class="first last">protein kinase C gamma</p></td></tr><tr><td class="NLM_term">ROCK-II</td><td class="NLM_def"><p class="first last">Rho-associated kinase 2</p></td></tr><tr><td class="NLM_term">Rsk2</td><td class="NLM_def"><p class="first last">ribosomal protein S6 kinase 2</p></td></tr><tr><td class="NLM_term">PRAK</td><td class="NLM_def"><p class="first last">p38-regulated and activated kinase</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Camussi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupia, E.</span><span> </span><span class="NLM_article-title">The future role of anti-tumor necrosis factor (TNF) products in the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1998&pages=613-620&issue=5&author=G.+Camussiauthor=E.+Lupia&title=The+future+role+of+anti-tumor+necrosis+factor+%28TNF%29+products+in+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamussi%26aufirst%3DG.%26aulast%3DLupia%26aufirst%3DE.%26atitle%3DThe%2520future%2520role%2520of%2520anti-tumor%2520necrosis%2520factor%2520%2528TNF%2529%2520products%2520in%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DDrugs%26date%3D1998%26volume%3D55%26issue%3D5%26spage%3D613%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Braun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieper, J.</span><span> </span><span class="NLM_article-title">Role of novel biological therapies in psoriatic arthritis: Effects on joints and skin</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=187-199&issue=3&author=J.+Braunauthor=J.+Sieper&title=Role+of+novel+biological+therapies+in+psoriatic+arthritis%3A+Effects+on+joints+and+skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraun%26aufirst%3DJ.%26aulast%3DSieper%26aufirst%3DJ.%26atitle%3DRole%2520of%2520novel%2520biological%2520therapies%2520in%2520psoriatic%2520arthritis%253A%2520Effects%2520on%2520joints%2520and%2520skin%26jtitle%3DBioDrugs%26date%3D2003%26volume%3D17%26issue%3D3%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Jarvis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds, D.</span><span> </span><span class="NLM_article-title">Etanercept: A review of its use in rheumatoid arthritis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=945-966&issue=6&author=B.+Jarvisauthor=D.+Faulds&title=Etanercept%3A+A+review+of+its+use+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DB.%26aulast%3DFaulds%26aufirst%3DD.%26atitle%3DEtanercept%253A%2520A%2520review%2520of%2520its%2520use%2520in%2520rheumatoid%2520arthritis%26jtitle%3DDrugs%26date%3D1999%26volume%3D57%26issue%3D6%26spage%3D945%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Richard-Miceli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougados, M.</span><span> </span><span class="NLM_article-title">Tumour necrosis factor-α blockers in rheumatoid arthritis: Review of the clinical experience</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=251-259&issue=4&author=C.+Richard-Miceliauthor=M.+Dougados&title=Tumour+necrosis+factor-%CE%B1+blockers+in+rheumatoid+arthritis%3A+Review+of+the+clinical+experience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichard-Miceli%26aufirst%3DC.%26aulast%3DDougados%26aufirst%3DM.%26atitle%3DTumour%2520necrosis%2520factor-%25CE%25B1%2520blockers%2520in%2520rheumatoid%2520arthritis%253A%2520Review%2520of%2520the%2520clinical%2520experience%26jtitle%3DBioDrugs%26date%3D2001%26volume%3D15%26issue%3D4%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Seymour, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worsley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. H. L.</span><span> </span><span class="NLM_article-title">Anti-TNF agents for rheumatoid arthritis</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1046%2Fj.1365-2125.2001.00321.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=11298065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVOntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2001&pages=201-208&issue=3&author=H.+E.+Seymourauthor=A.+Worsleyauthor=J.+M.+Smithauthor=S.+H.+L.+Thomas&title=Anti-TNF+agents+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-TNF agents for rheumatoid arthritis</span></div><div class="casAuthors">Seymour, H. E.; Worsley, A.; Smith, J. M.; Thomas, S. H. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-208</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 33 refs.  Rheumatoid arthritis (RA) is a chronic inflammatory, autoimmune disease with a prevalence of approx. 1% and an annual incidence of 0.04%.  Up to 50% of patients with RA are unable to work 10 yr after diagnosis.  The disease is assocd. with significant morbidity and mortality with assocd. medical costs to the UK of between £240 M and £600 M per yr.  Non steroidal anti-inflammatory drugs (NSAIDs) have little effect on the underlying course of RA, but they have some anti-inflammatory and analgesic properties.  Disease modifying antirheumatic drugs (DMARDs) have been shown to slow progression of RA and are currently recommended early in the course of treatment of RA which is when disease progression is most rapid.  Etanercept and infliximab belong to a new group of parentally administered anti-tumor necrosis factor (TNF) drugs.  Etanercept is licensed in the UK for the treatment of active rheumatoid arthritis in patients who have not responded to other DMARDs and in children with polyarticular-course juvenile arthritis who have not responded to or are intolerant of methotrexate.  In adults it produces significant improvements in all measures of rheumatic disease activity compared to placebo.  In patients whose disease remains active despite methotrexate treatment, further improvement in control is obtained with the addn. of etanercept without an increase in toxicity.  In one small trial, etanercept was found to be more effective than placebo in a selected group of children.  Infliximab is a monoclonal antibody which is currently licensed in the UK for Crohn's disease and, in combination with methotrexate for the treatment of rheumatoid arthritis in patients with active disease when the response to disease-modifying drugs, including methotrexate, has been inadequate.  In clin. trials infliximab produced significant improvements in all measures of rheumatic disease activity compared with placebo.  Infliximab in combination with methotrexate was shown to be superior to methotrexate or infliximab alone.  There are currently no predictors of a good response to anti-TNF drugs and a percentage of patients fail to respond to treatment (25% to 38% of etanercept patients; 21% to 42% of infliximab patients).  Infliximab monotherapy induces the prodn. of anti-infliximab antibodies, which may reduce its effectiveness.  Adding methotrexate to infliximab therapy may prevent this response.  Anti-TNF drugs may affect host defenses against infection and malignancy; whether these agents affect the development and course of malignancies and chronic infections is unknown and safety and efficacy in patients with immunosuppression or chronic infections has not been investigated.  With infliximab, upper respiratory tract infections, general infections and those requiring antimicrobial treatment were more common in patients than placebo.  Likewise, upper respiratory tract infections were more common in patients treated with etanercept than with placebo.  Injection site reactions occur with both infliximab (16%-20%) and etanercept (37%).  There are approx. 600 000 patients with RA in the UK, and of these between 2% and 3.5% may have severe disease which has failed to respond to conventional treatment and who might be eligible for anti-TNF therapy.  If between 50% and 70% of patients treated with anti-TNF drugs respond and continue on long-term treatment then the recurrent annual cost to the NHS could be between £48 M and £129 M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4PJCaIgeYt7Vg90H21EOLACvtfcHk0ljh_I8xzq_-ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVOntLc%253D&md5=2d1396b6777e673d9a81624d0c486c58</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.2001.00321.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.2001.00321.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeymour%26aufirst%3DH.%2BE.%26aulast%3DWorsley%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DThomas%26aufirst%3DS.%2BH.%2BL.%26atitle%3DAnti-TNF%2520agents%2520for%2520rheumatoid%2520arthritis%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2001%26volume%3D51%26issue%3D3%26spage%3D201%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">p38 MAP kinase: Molecular target for the inhibition of pro-inflammatory cytokines</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1016%2FS0079-6468%2808%2970091-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=11774793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVGntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=1-60&author=J.+L.+Adamsauthor=A.+M.+Badgerauthor=S.+Kumarauthor=J.+C.+Lee&title=p38+MAP+kinase%3A+Molecular+target+for+the+inhibition+of+pro-inflammatory+cytokines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines</span></div><div class="casAuthors">Adams, Jerry L.; Badger, Alison M.; Kumar, Sanjay; Lee, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-60</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 286 refs.  Topics discussed include the discovery of p38 kinase; the relationship of p38 to the MAP kinases; the p38 kinase family; upstream activators; downstream substrates; medicinal chem. preceding the discovery of p38; p38 structure-activity relationships; the structural basis of kinase selectivity; the pharmacol. of p38 inhibitors; and preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob8EiblMQiarVg90H21EOLACvtfcHk0ljh_I8xzq_-ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVGntbw%253D&md5=fb9d63787dfe16059715b6a68afa41a3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970091-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970091-2%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DBadger%26aufirst%3DA.%2BM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3Dp38%2520MAP%2520kinase%253A%2520Molecular%2520target%2520for%2520the%2520inhibition%2520of%2520pro-inflammatory%2520cytokines%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D38%26spage%3D1%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laydon, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenthal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvatter, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemens, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">A protein kinase involved in the regulation of inflammatory cytokine biosynthesis</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x"> (</span><span class="NLM_issue">6508</span><span class="NLM_x">) </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1038%2F372739a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=7997261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADyaK2MXisl2qu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=739-746&issue=6508&author=J.+C.+Leeauthor=J.+T.+Laydonauthor=P.+C.+McDonnellauthor=T.+F.+Gallagherauthor=S.+Kumarauthor=D.+Greenauthor=D.+McNultyauthor=M.+J.+Blumenthalauthor=J.+R.+Heyesauthor=S.+W.+Landvatterauthor=J.+E+Stricklerauthor=M.+M.+McLaughlinauthor=I.+R.+Siemensauthor=S.+M.+Fisherauthor=G.+P.+Liviauthor=J.+R.+Whiteauthor=J.+L.+Adamsauthor=P.+R.+Young&title=A+protein+kinase+involved+in+the+regulation+of+inflammatory+cytokine+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A protein kinase involved in the regulation of inflammatory cytokine biosynthesis</span></div><div class="casAuthors">Lee, John C.; Laydon, Jeffrey T.; McDonnell, Peter C.; Gallagher, Timothy F.; Kumar, Sanjay; Green, David; McNulty, Dean; Blumenthal, Mary Jane; Heyes, J. Richard; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">6508</span>),
    <span class="NLM_cas:pages">739-46</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Prodn. of interleukin-1 and tumor necrosis factor from stimulated human monocytes is inhibited by a new series of pyridinyl-imidazole compds.  Using radiolabeled and radio-photoaffinity-labeled chem. probes, the target of these compds. was identified as a pair of closely related mitogen-activated protein kinase homologues, termed CSBPs.  Binding of the pyridinyl-imidazole compds. inhibited CSBP kinase activity and could be directly correlated with their ability to inhibit cytokine prodn., suggesting that the CSBPs are crit. for cytokine prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpExKJsn1CnWrVg90H21EOLACvtfcHk0ljh_I8xzq_-ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisl2qu70%253D&md5=cfda8b8e5c29e323029c4f03056a1753</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F372739a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F372739a0%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DLaydon%26aufirst%3DJ.%2BT.%26aulast%3DMcDonnell%26aufirst%3DP.%2BC.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DMcNulty%26aufirst%3DD.%26aulast%3DBlumenthal%26aufirst%3DM.%2BJ.%26aulast%3DHeyes%26aufirst%3DJ.%2BR.%26aulast%3DLandvatter%26aufirst%3DS.%2BW.%26aulast%3DStrickler%26aufirst%3DJ.%2BE%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DSiemens%26aufirst%3DI.%2BR.%26aulast%3DFisher%26aufirst%3DS.%2BM.%26aulast%3DLivi%26aufirst%3DG.%2BP.%26aulast%3DWhite%26aufirst%3DJ.%2BR.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DA%2520protein%2520kinase%2520involved%2520in%2520the%2520regulation%2520of%2520inflammatory%2520cytokine%2520biosynthesis%26jtitle%3DNature%2520%2528London%2529%26date%3D1994%26volume%3D372%26issue%3D6508%26spage%3D739%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitfelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+from+lead+compound+to+clinical+candidate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0lg6zfAqedMu2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520from%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senftleben, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dadak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=221&author=K.+Tamuraauthor=T.+Sudoauthor=U.+Senftlebenauthor=A.+M.+Dadakauthor=R.+Johnsonauthor=M.+Karin&title=Requirement+for+p38alpha+in+erythropoietin+expression%3A+a+role+for+stress+kinases+in+erythropoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DSudo%26aufirst%3DT.%26aulast%3DSenftleben%26aufirst%3DU.%26aulast%3DDadak%26aufirst%3DA.%2BM.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DRequirement%2520for%2520p38alpha%2520in%2520erythropoietin%2520expression%253A%2520a%2520role%2520for%2520stress%2520kinases%2520in%2520erythropoiesis%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Adams, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vintersten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valladares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span> </span><span class="NLM_article-title">Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=109-116&author=R.+H.+Adamsauthor=A.+Porrasauthor=G.+Alonsoauthor=M.+Jonesauthor=K.+Vinterstenauthor=S.+Panelliauthor=A.+Valladaresauthor=L.+Perezauthor=R.+Kleinauthor=A.+R.+Nebreda&title=Essential+role+of+p38alpha+MAP+kinase+in+placental+but+not+embryonic+cardiovascular+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DR.%2BH.%26aulast%3DPorras%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DVintersten%26aufirst%3DK.%26aulast%3DPanelli%26aufirst%3DS.%26aulast%3DValladares%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26atitle%3DEssential%2520role%2520of%2520p38alpha%2520MAP%2520kinase%2520in%2520placental%2520but%2520not%2520embryonic%2520cardiovascular%2520development%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D109%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Targeting protein kinases for the development of antiinflammatory drugs</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1016%2Fj.ceb.2009.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=19217767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=317-324&author=P.+Cohen&title=Targeting+protein+kinases+for+the+development+of+antiinflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases for the development of anti-inflammatory drugs</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-324</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, protein kinases have become the pharmaceutical industry's most studied class of drug target, and some 10 protein kinase inhibitors have so far been approved for the treatment of cancer.  However, whether safe drugs that modulate protein kinase activities can also be developed for the treatment of chronic diseases, where they may need to be taken for decades, is an issue that is still unresolved.  A no. of compds. that inhibit the p38α MAPK have entered clin. trials for the treatment of rheumatoid arthritis and psoriasis, but side effects have prevented their progression to Phase III clin. trials.  Here the author briefly reviews the potential problems in targeting p38 MAPK and discusses other protein kinases that regulate the innate immune system, such as Tpl2, MAPKAP-K2/3, MSK1/2, and IRAK4, which may be better targets for the treatment of chronic inflammatory diseases, and NIK, which is an attractive target for the treatment of multiple myeloma, a late stage B-cell malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBhN9qJzqrVg90H21EOLACvtfcHk0lg6zfAqedMu2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D&md5=b7e7a33f18d0c8c1e33160c092cf411b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DTargeting%2520protein%2520kinases%2520for%2520the%2520development%2520of%2520antiinflammatory%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neininger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MAPKAP kinase 2 is essential for LPS induced TNF-a biosynthesis</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1038%2F10061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=10559880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVGqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=94-97&issue=2&author=A.+Kotlyarovauthor=A.+Neiningerauthor=C.+Schubertauthor=R.+Eckertauthor=C.+Birchmeierauthor=H.-D.+Volkauthor=M.+Gaestel&title=MAPKAP+kinase+2+is+essential+for+LPS+induced+TNF-a+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis</span></div><div class="casAuthors">Kotlyarov, Alexey; Neininger, Armin; Schubert, Carola; Eckert, Rolf; Birchmeier, Carmen; Volk, Hans-Dieter; Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">94-97</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines Ltd</span>)
        </div><div class="casAbstract">MAPKAP kinase 2 (MK2) is one of several kinases that are regulated through direct phosphorylation by p38 MAP kinase.  By introducing a targeted mutation into the mouse MK2 gene, the authors have detd. the physiol. function of MK2 in vivo.  Mice that lack MK2 show increased stress resistance and survive LPS-induced endotoxic shock.  This is due to a redn. of ∼90% in the prodn. of tumor necrosis factor-α (TNF-α) and not to a change in signaling from the TNF receptor.  The level and stability of TNF-α mRNA is not reduced and TNF-α secretion is not affected.  Thus, MK2 is an essential component in the inflammatory response which regulates biosynthesis of TNF-α at a post-transcriptional level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtiobBLSnV77Vg90H21EOLACvtfcHk0lg1liDbO2FEXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVGqsLY%253D&md5=5fb502616639b298341431eea8009cc2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F10061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10061%26sid%3Dliteratum%253Aachs%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DNeininger%26aufirst%3DA.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DEckert%26aufirst%3DR.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DVolk%26aufirst%3DH.-D.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMAPKAP%2520kinase%25202%2520is%2520essential%2520for%2520LPS%2520induced%2520TNF-a%2520biosynthesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D1999%26volume%3D1%26issue%3D2%26spage%3D94%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Winzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kracht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyu, A.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtmann, H.</span><span> </span><span class="NLM_article-title">The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4969</span><span class="NLM_x">–</span> <span class="NLM_lpage">4980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=4969-4980&issue=18&author=R.+Winzenauthor=M.+Krachtauthor=B.+Ritterauthor=A.+Wilhelmauthor=C.-Y.+A.+Chenauthor=A.-B.+Shyuauthor=M.+Mullerauthor=M.+Gaestelauthor=K.+Reschauthor=H.+Holtmann&title=The+p38+MAP+kinase+pathway+signals+for+cytokine-induced+mRNA+stabilization+via+MAP+kinase-activated+protein+kinase+2+and+an+AU-rich+region-targeted+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWinzen%26aufirst%3DR.%26aulast%3DKracht%26aufirst%3DM.%26aulast%3DRitter%26aufirst%3DB.%26aulast%3DWilhelm%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.-Y.%2BA.%26aulast%3DShyu%26aufirst%3DA.-B.%26aulast%3DMuller%26aufirst%3DM.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DResch%26aufirst%3DK.%26aulast%3DHoltmann%26aufirst%3DH.%26atitle%3DThe%2520p38%2520MAP%2520kinase%2520pathway%2520signals%2520for%2520cytokine-induced%2520mRNA%2520stabilization%2520via%2520MAP%2520kinase-activated%2520protein%2520kinase%25202%2520and%2520an%2520AU-rich%2520region-targeted%2520mechanism%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26issue%3D18%26spage%3D4969%26epage%3D4980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MAPKAP kinases - MKs - two’s company, three’s a crowd</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1038%2Fnrm1834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=16421520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=120-130&issue=2&author=M.+Gaestel&title=MAPKAP+kinases+-+MKs+-+two%E2%80%99s+company%2C+three%E2%80%99s+a+crowd"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">MAPKAP kinases - MKs - two's company, three's a crowd</span></div><div class="casAuthors">Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-130</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Downstream of MAP kinases (MAPKs), 3 structurally related MAPK-activated protein kinases (MAPKAPKs or MKs), MK2, MK3, and MK5, signal to diverse cellular targets.  Although there is no known common function for all 3 MKs, these kinases are involved in important processes.  MKs regulate gene expression at the transcriptional and post-transcriptional level, control cytoskeletal architecture and cell cycle progression, and are implicated in inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI91xfvhmqhrVg90H21EOLACvtfcHk0lg1liDbO2FEXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWntr4%253D&md5=1ae824b7d680a574a7c764bd61ac43aa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrm1834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1834%26sid%3Dliteratum%253Aachs%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMAPKAP%2520kinases%2520-%2520MKs%2520-%2520two%25E2%2580%2599s%2520company%252C%2520three%25E2%2580%2599s%2520a%2520crowd%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26issue%3D2%26spage%3D120%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ronkina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittrich-Breiholz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kracht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milarski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marusic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez., J.-B.</span><span> </span><span class="NLM_article-title">The Mitogen-activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPK</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">Jan 2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1128%2FMCB.01456-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=17030606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Oh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=Jan+2007&pages=170&author=N.+Ronkinaauthor=A.+Kotlyarovauthor=O.+Dittrich-Breiholzauthor=M.+Krachtauthor=E.+Hittiauthor=K.+Milarskiauthor=R.+Askewauthor=S.+Marusicauthor=L.-L.+Linauthor=M.+Gaestelauthor=J.-B.+Telliez.&title=The+Mitogen-activated+Protein+Kinase+%28MAPK%29-Activated+Protein+Kinases+MK2+and+MK3+Cooperate+in+Stimulation+of+Tumor+Necrosis+Factor+Biosynthesis+and+Stabilization+of+p38+MAPK"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK</span></div><div class="casAuthors">Ronkina, N.; Kotlyarov, A.; Dittrich-Breiholz, O.; Kracht, M.; Hitti, E.; Milarski, K.; Askew, R.; Marusic, S.; Lin, L.-L.; Gaestel, M.; Telliez, J.-B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-181</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">MK2 and MK3 represent protein kinases downstream of p38 mitogen-activated protein kinase (MAPK).  Deletion of the MK2 gene in mice resulted in an impaired inflammatory response although MK3, which displays extensive structural similarities and identical functional properties in vitro, is still present.  Here, the authors analyze tumor necrosis factor (TNF) prodn. and expression of p38 MAPK and tristetraprolin (TTP) in MK3-deficient mice and demonstrate that there are no significant differences with wild-type animals.  The authors show that in vivo MK2 and MK3 are expressed and activated in parallel.  However, the level of activity of MK2 is always significantly higher than that of MK3.  Accordingly, the authors hypothesized that MK3 could have significant effects only in an MK2-free background and generated MK2/MK3 double-knockout mice.  Unexpectedly, these mice are viable and show no obvious defects due to loss of compensation between MK2 and MK3.  However, there is a further redn. of TNF prodn. and expression of p38 and TTP in double-knockout mice compared to MK2-deficient mice.  This finding, together with the observation that ectopically expressed MK3 can rescue MK2 deficiency similarly to MK2, indicates that both kinases share the same physiol. function in vivo but are expressed to different levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdXOig9ZksrbVg90H21EOLACvtfcHk0lg1liDbO2FEXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Oh&md5=4dca45754c91bce57cf3c2063bf23a88</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.01456-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01456-06%26sid%3Dliteratum%253Aachs%26aulast%3DRonkina%26aufirst%3DN.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DDittrich-Breiholz%26aufirst%3DO.%26aulast%3DKracht%26aufirst%3DM.%26aulast%3DHitti%26aufirst%3DE.%26aulast%3DMilarski%26aufirst%3DK.%26aulast%3DAskew%26aufirst%3DR.%26aulast%3DMarusic%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DL.-L.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DTelliez.%26aufirst%3DJ.-B.%26atitle%3DThe%2520Mitogen-activated%2520Protein%2520Kinase%2520%2528MAPK%2529-Activated%2520Protein%2520Kinases%2520MK2%2520and%2520MK3%2520Cooperate%2520in%2520Stimulation%2520of%2520Tumor%2520Necrosis%2520Factor%2520Biosynthesis%2520and%2520Stabilization%2520of%2520p38%2520MAPK%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3DJan%25202007%26volume%3D27%26spage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J. B.</span><span> </span><span class="NLM_article-title">MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">1913</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2006&pages=1913-1917&author=M.+Hegenauthor=M.+Gaestelauthor=C.+L.+Nickerson-Nutterauthor=L.+L.+Linauthor=J.+B.+Telliez&title=MAPKAP+kinase+2-deficient+mice+are+resistant+to+collagen-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DTelliez%26aufirst%3DJ.%2BB.%26atitle%3DMAPKAP%2520kinase%25202-deficient%2520mice%2520are%2520resistant%2520to%2520collagen-induced%2520arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D177%26spage%3D1913%26epage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1016%2Fj.coph.2004.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=15251131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=372-377&author=J.+Saklatvala&title=The+p38+MAP+kinase+pathway+as+a+therapeutic+target+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span></div><div class="casAuthors">Saklatvala, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The p38 MAPK signalling pathway plays an important role in inflammation and other physiol. processes.  Specific inhibitors of p38 α and β MAPK block prodn. of the major inflammatory cytokines (i.e. tumor necrosis factor-α and interleukin-1) and other proteins (e.g. cyclooxygenase-2), and are anti-inflammatory in animal models of disease.  A major function of the pathway is post-transcriptional control of inflammatory gene expression.  Many of the mRNAs are unstable (or untranslatable) because of AU-rich elements in the 3'untranslated region.  Signalling in the p38 pathway counteracts these and stabilizes the mRNAs by preventing their otherwise rapid de-adenylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpglO4EVBhJ-LVg90H21EOLACvtfcHk0ljdBPSPIzg_Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D&md5=5678936250f1dbc9c27707bd7edf6108</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DThe%2520p38%2520MAP%2520kinase%2520pathway%2520as%2520a%2520therapeutic%2520target%2520in%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Neininger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontoyiannis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MK2 Targets AU-rich Elements and Regulates Biosynthesis of Tumor Necrosis Factor and Interleukin-6 Independently at Different Post-translational Levels</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">3065</span><span class="NLM_x">–</span> <span class="NLM_lpage">3068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=3065-3068&author=A.+Neiningerauthor=D.+Kontoyiannisauthor=A.+Kotlyarovauthor=R.+Winzenauthor=R.+Eckertauthor=H.-D.+Volkauthor=H.+Holtmannauthor=G.+Kolliasauthor=M.+Gaestel&title=MK2+Targets+AU-rich+Elements+and+Regulates+Biosynthesis+of+Tumor+Necrosis+Factor+and+Interleukin-6+Independently+at+Different+Post-translational+Levels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeininger%26aufirst%3DA.%26aulast%3DKontoyiannis%26aufirst%3DD.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DWinzen%26aufirst%3DR.%26aulast%3DEckert%26aufirst%3DR.%26aulast%3DVolk%26aufirst%3DH.-D.%26aulast%3DHoltmann%26aufirst%3DH.%26aulast%3DKollias%26aufirst%3DG.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMK2%2520Targets%2520AU-rich%2520Elements%2520and%2520Regulates%2520Biosynthesis%2520of%2520Tumor%2520Necrosis%2520Factor%2520and%2520Interleukin-6%2520Independently%2520at%2520Different%2520Post-translational%2520Levels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D3065%26epage%3D3068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Damjanov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer-Green, G. T.</span><span> </span><span class="NLM_article-title">Efficacy, Pharmacodynamics and Safety of VX-702, a Novel p38 MAPK Inhibitor, in Rhematoid Arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1232</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1002%2Fart.24485" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1232-1241&author=N.+Damjanovauthor=R.+S.+Kauffmanauthor=G.+T.+Spencer-Green&title=Efficacy%2C+Pharmacodynamics+and+Safety+of+VX-702%2C+a+Novel+p38+MAPK+Inhibitor%2C+in+Rhematoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fart.24485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24485%26sid%3Dliteratum%253Aachs%26aulast%3DDamjanov%26aufirst%3DN.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DSpencer-Green%26aufirst%3DG.%2BT.%26atitle%3DEfficacy%252C%2520Pharmacodynamics%2520and%2520Safety%2520of%2520VX-702%252C%2520a%2520Novel%2520p38%2520MAPK%2520Inhibitor%252C%2520in%2520Rhematoid%2520Arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D5%26spage%3D1232%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Clark, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, J. L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">The p38 MAPK pathway mediates both antiinflammatory and proinflammatory processes: comment on the article by Damjanov and the editorial by Genovese</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3513</span><span class="NLM_x">–</span> <span class="NLM_lpage">3514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1002%2Fart.24919" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=3513-3514&author=A.+R.+Clarkauthor=J.+L.+E.+Deanauthor=J.+Saklatvala&title=The+p38+MAPK+pathway+mediates+both+antiinflammatory+and+proinflammatory+processes%3A+comment+on+the+article+by+Damjanov+and+the+editorial+by+Genovese"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fart.24919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24919%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DA.%2BR.%26aulast%3DDean%26aufirst%3DJ.%2BL.%2BE.%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DThe%2520p38%2520MAPK%2520pathway%2520mediates%2520both%2520antiinflammatory%2520and%2520proinflammatory%2520processes%253A%2520comment%2520on%2520the%2520article%2520by%2520Damjanov%2520and%2520the%2520editorial%2520by%2520Genovese%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D5%26spage%3D3513%26epage%3D3514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masih, L.</span><span> </span><span class="NLM_article-title">Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1587-1590&author=D.+R.+Andersonauthor=S.+Hegdeauthor=E.+Reinhardauthor=L.+Gomezauthor=W.+F.+Vernierauthor=L.+Leeauthor=S.+Liuauthor=A.+Sambandamauthor=P.+A.+Sniderauthor=L.+Masih&title=Aminocyanopyridine+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DReinhard%26aufirst%3DE.%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSambandam%26aufirst%3DA.%26aulast%3DSnider%26aufirst%3DP.%2BA.%26aulast%3DMasih%26aufirst%3DL.%26atitle%3DAminocyanopyridine%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1587%26epage%3D1590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Trujillo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchler, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span> </span><span class="NLM_article-title">Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4657-4663&author=J.+I.+Trujilloauthor=M.+J.+Meyersauthor=D.+R.+Andersonauthor=S.+Hegdeauthor=M.+W.+Mahoneyauthor=W.+F.+Vernierauthor=I.+P.+Buchlerauthor=K.+K.+Wuauthor=S.+Yangauthor=S.+J.+Hartmannauthor=D.+B.+Reitz&title=Novel+tetrahydro-%CE%B2-carboline-1-carboxylic+acids+as+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DBuchler%26aufirst%3DI.%2BP.%26aulast%3DWu%26aufirst%3DK.%2BK.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DS.%2BJ.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26atitle%3DNovel%2520tetrahydro-%25CE%25B2-carboline-1-carboxylic%2520acids%2520as%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4657%26epage%3D4663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+Inhibitors+of+Mitogen-Activated+Protein+Kinase-Activated+Protein+Kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520Inhibitors%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Activated%2520Protein%2520Kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywardane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmanuel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautschi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargelis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span> </span><span class="NLM_article-title">The discovery of carboline analogs as potent MAPKAP-K2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4664</span><span class="NLM_x">–</span> <span class="NLM_lpage">4669</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4664-4669&author=J.-P.+Wuauthor=J.+Wangauthor=A.+Abeywardaneauthor=D.+Andersenauthor=M.+Emmanuelauthor=E.+Gautschiauthor=D.+R.+Goldbergauthor=M.+A.+Kashemauthor=S.+Lukasauthor=W.+Maoauthor=L.+Martinauthor=T.+Morwickauthor=N.+Mossauthor=C.+Pargelisauthor=U.+R.+Patelauthor=L.+Patnaudeauthor=G.+W.+Peetauthor=D.+Skowauthor=R.+J.+Snowauthor=Y.+Wardauthor=B.+Werneburgauthor=A.+White&title=The+discovery+of+carboline+analogs+as+potent+MAPKAP-K2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-P.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DAndersen%26aufirst%3DD.%26aulast%3DEmmanuel%26aufirst%3DM.%26aulast%3DGautschi%26aufirst%3DE.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DMorwick%26aufirst%3DT.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargelis%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DU.%2BR.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DWard%26aufirst%3DY.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520carboline%2520analogs%2520as%2520potent%2520MAPKAP-K2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4664%26epage%3D4669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLeon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenbaum, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netherton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcelini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z.</span><span> </span><span class="NLM_article-title">Pyrazinoindolone inhibitors of MAPKAP-K2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">938</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1016%2Fj.bmcl.2007.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=18221871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=938-941&author=D.+R.+Goldbergauthor=Y.+Choiauthor=D.+Coganauthor=M.+Corsonauthor=R.+DeLeonauthor=A.+Gaoauthor=L.+Gruenbaumauthor=M.+H.+Haoauthor=D.+Josephauthor=M.+A.+Kashemauthor=C.+Millerauthor=N.+Mossauthor=M.+R.+Nethertonauthor=C.+P.+Pargellisauthor=J.+Pelletierauthor=R.+Sellatiauthor=D.+Skowauthor=C.+Torceliniauthor=Y.-C.+Tsengauthor=J.+Wangauthor=R.+Watsiauthor=B.+Werneburgauthor=J.+P.+Wuauthor=Z.+Xiong&title=Pyrazinoindolone+inhibitors+of+MAPKAP-K2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazinoindolone inhibitors of MAPKAP-K2</span></div><div class="casAuthors">Goldberg, D. R.; Choi, Y.; Cogan, D.; Corson, M.; DeLeon, R.; Gao, A.; Gruenbaum, L.; Hao, M. H.; Joseph, D.; Kashem, M. A.; Miller, C.; Moss, N.; Netherton, M. R.; Pargellis, C. P.; Pelletier, J.; Sellati, R.; Skow, D.; Torcellini, C.; Tseng, Y.-C.; Wang, J.; Wasti, R.; Werneburg, B.; Wu, J. P.; Xiong, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">938-941</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Optimization of pyrazinoindolone inhibitors of MAPKAP-K2 (MK2) provides a reasonable balance of cellular potency and physicochem. properties.  Mechanistic studies support the inhibition of MK2 which is responsible for the sub-micromolar cellular efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHMw6FxuAeyLVg90H21EOLACvtfcHk0lgMilBMweiqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D&md5=55a46852c9ccf52c8350d0a26de3e41d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCogan%26aufirst%3DD.%26aulast%3DCorson%26aufirst%3DM.%26aulast%3DDeLeon%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DGruenbaum%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DM.%2BH.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DNetherton%26aufirst%3DM.%2BR.%26aulast%3DPargellis%26aufirst%3DC.%2BP.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTorcelini%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DY.-C.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWatsi%26aufirst%3DR.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%2BP.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DPyrazinoindolone%2520inhibitors%2520of%2520MAPKAP-K2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D938%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Xiong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, M.-H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargelis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieselmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of indole-based MK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1999</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1994-1999&author=Z.+Xiongauthor=D.+A.+Gaoauthor=D.+A.+Coganauthor=M.-H.+H.+Goldbergauthor=N.+Mossauthor=E.+Packauthor=C.+Pargelisauthor=D.+Skowauthor=T.+Trieselmannauthor=B.+Werneburgauthor=A.+White&title=Synthesis+and+SAR+studies+of+indole-based+MK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DD.%2BA.%26aulast%3DCogan%26aufirst%3DD.%2BA.%26aulast%3DGoldberg%26aufirst%3DM.-H.%2BH.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DPargelis%26aufirst%3DC.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTrieselmann%26aufirst%3DT.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520indole-based%2520MK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1994%26epage%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waelchli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">Pyrrolo-pyrimidones: A novel class of MK2 inhibitors with potent cellular activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6142</span><span class="NLM_x">–</span> <span class="NLM_lpage">6146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6142-6146&author=A.+Schlapbachauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=G.+Kochauthor=H.+Moebitzauthor=L.+Reveszauthor=C.+Scheuflerauthor=J.+Velcickyauthor=R.+Waelchliauthor=C.+Huppertz&title=Pyrrolo-pyrimidones%3A+A+novel+class+of+MK2+inhibitors+with+potent+cellular+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DMoebitz%26aufirst%3DH.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DWaelchli%26aufirst%3DR.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DPyrrolo-pyrimidones%253A%2520A%2520novel%2520class%2520of%2520MK2%2520inhibitors%2520with%2520potent%2520cellular%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6142%26epage%3D6146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Benzothiophene inhibitors of MK2. Part 1: Structure–activity relationships, assessments of selectivity and cellular potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4878</span><span class="NLM_x">–</span> <span class="NLM_lpage">4881</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4878-4881&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=S.+A.+Longauthor=B.+S.+Pierceauthor=M.+W.+Mahoneyauthor=R.+J.+Mourey&title=Benzothiophene+inhibitors+of+MK2.+Part+1%3A+Structure%E2%80%93activity+relationships%2C+assessments+of+selectivity+and+cellular+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DBenzothiophene%2520inhibitors%2520of%2520MK2.%2520Part%25201%253A%2520Structure%25E2%2580%2593activity%2520relationships%252C%2520assessments%2520of%2520selectivity%2520and%2520cellular%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4878%26epage%3D4881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, M. D.</span><span> </span><span class="NLM_article-title">Benzothiophene inhibitors of MK2. Part 2: Improvements in kinase selectivity and cell potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">–</span> <span class="NLM_lpage">4884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4882-4884&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=R.+G.+Kurumbailauthor=N+Caspersauthor=G.+I.+Podaauthor=S.+A.+Longauthor=B.+S.+Pierceauthor=M.+W.+Mahoneyauthor=R.+J.+Moureyauthor=M.+D.+Parikh&title=Benzothiophene+inhibitors+of+MK2.+Part+2%3A+Improvements+in+kinase+selectivity+and+cell+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DParikh%26aufirst%3DM.%2BD.%26atitle%3DBenzothiophene%2520inhibitors%2520of%2520MK2.%2520Part%25202%253A%2520Improvements%2520in%2520kinase%2520selectivity%2520and%2520cell%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4882%26epage%3D4884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">Low-molecular-weight MK2 inhibitors a tough nut to crack!</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.4155%2Ffmc.09.98" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=21426101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOisL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1243-1257&issue=7&author=A.+Schlapbachauthor=C.+Huppertz&title=Low-molecular-weight+MK2+inhibitors+a+tough+nut+to+crack%21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Low-molecular-weight MK2 inhibitors: a tough nut to crack!</span></div><div class="casAuthors">Schlapbach, Achim; Huppertz, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1243-1257</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 pathway was at the center of interest for anti-inflammatory drug discovery for many years as it is crucial for the biosynthesis of TNF-α, IL-1β, and other mediators.  Most of the anti-inflammatory effects of p38 inhibition are mediated through MAPK-activated protein kinase-2 (MK2), a direct downstream target of p38, which makes MK2 a very interesting drug target.  Within the last 5 years, several classes of low-mol.-wt. MK2 inhibitors were disclosed in the patent and primary literature.  Advanced compds. could be optimized to nanomolar potencies and inhibit TNF-α release, as well as the phosphorylation of the MK2 substrate heat-shock protein 27 in cellular assays.  This article will review the recent progress in this field and will highlight and discuss the most promising compd. series disclosed so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4u3apT9vA-rVg90H21EOLACvtfcHk0lhsWBcQxFsKPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOisL7K&md5=0b950af46215982d171a6c8b6de98fd0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.98%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DLow-molecular-weight%2520MK2%2520inhibitors%2520a%2520tough%2520nut%2520to%2520crack%2521%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26issue%3D7%26spage%3D1243%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4715</span><span class="NLM_x">–</span> <span class="NLM_lpage">4718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4715-4718&author=L.+Reveszauthor=A.+Schlapbachauthor=R.+Aichholzauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=P.+Hiestandauthor=W.+Jahnkeauthor=G.+Kochauthor=M.+Kroemerauthor=H.+M%C3%B6bitzauthor=C.+Scheuflerauthor=J.+Velcickyauthor=C.+Huppertz&title=In+vivo+and+in+vitro+SAR+of+tetracyclic+MAPKAP-K2+%28MK2%29+inhibitors.+Part+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520SAR%2520of%2520tetracyclic%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors.%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4715%26epage%3D4718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlewood-Evans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4719</span><span class="NLM_x">–</span> <span class="NLM_lpage">4723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4719-4723&author=L.+Reveszauthor=A.+Schlapbachauthor=R.+Aichholzauthor=J.+Dawsonauthor=R.+Feifelauthor=S.+Hawtinauthor=A.+Littlewood-Evansauthor=G.+Kochauthor=M.+Kroemerauthor=H.+M%C3%B6bitzauthor=C.+Scheuflerauthor=J.+Velcickyauthor=C.+Huppertz&title=In+vivo+and+in+vitro+SAR+of+tetracyclic+MAPKAP-K2+%28MK2%29+inhibitors.+Part+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520SAR%2520of%2520tetracyclic%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors.%2520Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4719%26epage%3D4723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustkern, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saabye, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span> </span><span class="NLM_article-title">A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1124%2Fjpet.110.166173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=20237073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFClsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=797-807&author=R.+J.+Moureyauthor=B.+L.+Burnetteauthor=S.+J.+Brustkernauthor=J.+S.+Danielsauthor=J.+L.+Hirschauthor=W.+F.+Hoodauthor=M.+J.+Meyersauthor=S.+J.+Mnichauthor=B.+S.+Pierceauthor=M.+J.+Saabyeauthor=J.+F.+Schindlerauthor=S.+A.+Southauthor=E.+G.+Webbauthor=J.+Zhangauthor=D.+R.+Anderson&title=A+Benzothiophene+Inhibitor+of+Mitogen-Activated+Protein+Kinase-Activated+Protein+Kinase+2+Inhibits+Tumor+Necrosis+Factor+%CE%B1+Production+and+Has+Oral+Anti-Inflammatory+Efficacy+in+Acute+and+Chronic+Models+of+Inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor α production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation</span></div><div class="casAuthors">Mourey, Robert J.; Burnette, Barry L.; Brustkern, Sarah J.; Daniels, J. Scott; Hirsch, Jeffrey L.; Hood, William F.; Meyers, Marvin J.; Mnich, Stephen J.; Pierce, Betsy S.; Saabye, Matthew J.; Schindler, John F.; South, Sarah A.; Webb, Elizabeth G.; Zhang, Jian; Anderson, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">797-807</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Activation of the p38 kinase pathway in immune cells leads to the transcriptional and translational regulation of proinflammatory cytokines.  Mitogen-activated protein kinase-activated protein kinase 2 (MK2), a direct downstream substrate of p38 kinase, regulates lipopolysaccharide (LPS)-stimulated tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) prodn. through modulating the stability and translation of these mRNAs.  Developing small-mol. inhibitors of MK2 may yield anti-inflammatory efficacy with a different safety profile relative to p38 kinase inhibitors.  This article describes the pharmacol. properties of a benzothiophene MK2 inhibitor, PF-3644022 [(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one].  PF-3644022 is a potent freely reversible ATP-competitive compd. that inhibits MK2 activity (Ki = 3 nM) with good selectivity when profiled against 200 human kinases.  In the human U937 monocytic cell line or peripheral blood mononuclear cells, PF-3644022 potently inhibits TNFα prodn. with similar activity (IC50 = 160 nM).  PF-3644022 blocks TNFα and IL-6 prodn. in LPS-stimulated human whole blood with IC50 values of 1.6 and 10.3 μM, resp.  Inhibition of TNFα in U937 cells and blood correlates closely with inhibition of phospho-heat shock protein 27, a target biomarker of MK2 activity.  PF-3644022 displays good pharmacokinetic parameters in rats and is orally efficacious in both the rat acute LPS-induced TNFα model and the chronic streptococcal cell wall-induced arthritis model.  Dose-dependent inhibition of TNFα prodn. in the acute model and inhibition of paw swelling in the chronic model is obsd. with ED50 values of 6.9 and 20 mg/kg, resp.  PF-3644022 efficacy in the chronic inflammation model is strongly correlated with maintaining a Cmin higher than the EC50 measured in the rat LPS-induced TNFα model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrKp-1XQ0NyLVg90H21EOLACvtfcHk0liEjgND3lBuHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFClsLg%253D&md5=312670776fbb3fd39fc2247eba48eb6e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166173%26sid%3Dliteratum%253Aachs%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DBurnette%26aufirst%3DB.%2BL.%26aulast%3DBrustkern%26aufirst%3DS.%2BJ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DHood%26aufirst%3DW.%2BF.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DSaabye%26aufirst%3DM.%2BJ.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DSouth%26aufirst%3DS.%2BA.%26aulast%3DWebb%26aufirst%3DE.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26atitle%3DA%2520Benzothiophene%2520Inhibitor%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Activated%2520Protein%2520Kinase%25202%2520Inhibits%2520Tumor%2520Necrosis%2520Factor%2520%25CE%25B1%2520Production%2520and%2520Has%2520Oral%2520Anti-Inflammatory%2520Efficacy%2520in%2520Acute%2520and%2520Chronic%2520Models%2520of%2520Inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D797%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span>Kinase focused libraries from BioFocus were used. BioFocus URL: <a href="http://www.biofocus.com/" class="extLink">http://www.biofocus.com/</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kinase+focused+libraries+from+BioFocus+were+used.+BioFocus+URL%3A+http%3A%2F%2Fwww.biofocus.com%2F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">The protein structure of Phosphorylase Kinase (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PHK">1PHK</a>) was used.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="note"><p class="first last">The protein structure of cAMP-dependent protein kinase (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BX6">1BX6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1STC">1STC</a>) was used.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>TRIPOS URL: <a href="http://www.tripos.com/" class="extLink">http://www.tripos.com/</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TRIPOS+URL%3A+http%3A%2F%2Fwww.tripos.com%2F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">The crystal structure of purvalnol B in CDK (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CKP%29">1CKP)</a> was used.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokurno, P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebdon, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunns, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, C. J.</span><span> </span><span class="NLM_article-title">Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=863-867&author=D.+S.+Williamsonauthor=M.+J.+Parrattauthor=J.+F.+Bowerauthor=J.+D.+Mooreauthor=C.+M.+Richardsonauthor=P+Dokurnoauthor=A.+D.+Cansfieldauthor=G.+L.+Francisauthor=R.+J.+Hebdonauthor=R.+Howesauthor=P.+S.+Jacksonauthor=A.+M.+Lockieauthor=J.+B.+Murrayauthor=C.+L.+Nunnsauthor=J.+Powlesauthor=A.+Robertsonauthor=A.+E.+Surgenorauthor=C.+J.+Torrance&title=Structure-guided+design+of+pyrazolo%5B1%2C5-a%5Dpyrimidines+as+inhibitors+of+human+cyclin-dependent+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DParratt%26aufirst%3DM.%2BJ.%26aulast%3DBower%26aufirst%3DJ.%2BF.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DDokurno%26aufirst%3DP%26aulast%3DCansfield%26aufirst%3DA.%2BD.%26aulast%3DFrancis%26aufirst%3DG.%2BL.%26aulast%3DHebdon%26aufirst%3DR.%2BJ.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DP.%2BS.%26aulast%3DLockie%26aufirst%3DA.%2BM.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DNunns%26aufirst%3DC.%2BL.%26aulast%3DPowles%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26atitle%3DStructure-guided%2520design%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidines%2520as%2520inhibitors%2520of%2520human%2520cyclin-dependent%2520kinase%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D863%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namiki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span> </span><span class="NLM_article-title">Structural analysis of an MK2–inhibitor complex: insight into the regulation of the secondary structure of the Gly-rich loop by TEI-I01800</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=80-87&author=A.+Fujinoauthor=K.+Fukushimaauthor=N.+Namikiauthor=T.+Kosugiauthor=M.+Takimoto-Kamimura&title=Structural+analysis+of+an+MK2%E2%80%93inhibitor+complex%3A+insight+into+the+regulation+of+the+secondary+structure+of+the+Gly-rich+loop+by+TEI-I01800"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DNamiki%26aufirst%3DN.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26atitle%3DStructural%2520analysis%2520of%2520an%2520MK2%25E2%2580%2593inhibitor%2520complex%253A%2520insight%2520into%2520the%2520regulation%2520of%2520the%2520secondary%2520structure%2520of%2520the%2520Gly-rich%2520loop%2520by%2520TEI-I01800%26jtitle%3DActa%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D80%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Diskin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livnah, O.</span><span> </span><span class="NLM_article-title">A Novel Lipid-binding site formed by the MAP Kinase Insert in p38α</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2008&pages=70-79&author=R.+Diskinauthor=D.+Engelbergauthor=O.+Livnah&title=A+Novel+Lipid-binding+site+formed+by+the+MAP+Kinase+Insert+in+p38%CE%B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiskin%26aufirst%3DR.%26aulast%3DEngelberg%26aufirst%3DD.%26aulast%3DLivnah%26aufirst%3DO.%26atitle%3DA%2520Novel%2520Lipid-binding%2520site%2520formed%2520by%2520the%2520MAP%2520Kinase%2520Insert%2520in%2520p38%25CE%25B1%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D375%26spage%3D70%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Perry, J. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moiani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainer, J. A.</span><span> </span><span class="NLM_article-title">p38α. MAP Kinase C-Terminal Domain Binding Pocket Characterized by Crystallographic and Computational Analyses</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2009&pages=1-11&author=J.+J.+P.+Perryauthor=R.+M.+Harrisauthor=D.+Moianiauthor=A.+J.+Olsonauthor=J.+A.+Tainer&title=p38%CE%B1.+MAP+Kinase+C-Terminal+Domain+Binding+Pocket+Characterized+by+Crystallographic+and+Computational+Analyses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DHarris%26aufirst%3DR.%2BM.%26aulast%3DMoiani%26aufirst%3DD.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DTainer%26aufirst%3DJ.%2BA.%26atitle%3Dp38%25CE%25B1.%2520MAP%2520Kinase%2520C-Terminal%2520Domain%2520Binding%2520Pocket%2520Characterized%2520by%2520Crystallographic%2520and%2520Computational%2520Analyses%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D391%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_etal"></span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fujino%2C+A.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':[],'ref36':[],'ref37':['cit37'],'ref38':[],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 24 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mario  Fiore</span>, <span class="hlFld-ContribAuthor ">Stefano  Forli</span>, and <span class="hlFld-ContribAuthor ">Fabrizio  Manetti</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3609-3634. <a href="https://doi.org/10.1021/acs.jmedchem.5b01457" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01457%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BMitogen-Activated%252BProtein%252BKinase-Activated%252BProtein%252BKinase%252B2%252B%252528MAPKAPK2%25252C%252BMK2%252529%25253A%252BMedicinal%252BChemistry%252BEfforts%252BTo%252BLead%252BSmall%252BMolecule%252BInhibitors%252Bto%252BClinical%252BTrials%26aulast%3DFiore%26aufirst%3DMario%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D18092015%26date%3D09112015%26date%3D28042016%26date%3D26102015%26volume%3D59%26issue%3D8%26spage%3D3609%26epage%3D3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John G.  Cumming</span>, <span class="hlFld-ContribAuthor ">Judit É.  Debreczeni</span>, <span class="hlFld-ContribAuthor ">Fredrik  Edfeldt</span>, <span class="hlFld-ContribAuthor ">Emma  Evertsson</span>, <span class="hlFld-ContribAuthor ">Martin  Harrison</span>, <span class="hlFld-ContribAuthor ">Geoffrey A.  Holdgate</span>, <span class="hlFld-ContribAuthor ">Michael J.  James</span>, <span class="hlFld-ContribAuthor ">Scott G.  Lamont</span>, <span class="hlFld-ContribAuthor ">Keith  Oldham</span>, <span class="hlFld-ContribAuthor ">Jane E.  Sullivan</span>, and <span class="hlFld-ContribAuthor ">Stuart L.  Wells</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of MAPK-activated Protein Kinase-2 Prevention of Activation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 278-293. <a href="https://doi.org/10.1021/jm501038s" title="DOI URL">https://doi.org/10.1021/jm501038s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501038s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501038s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BMAPK-activated%252BProtein%252BKinase-2%252BPrevention%252Bof%252BActivation%252BInhibitors%26aulast%3DCumming%26aufirst%3DJohn%2BG.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D10072014%26date%3D09102014%26date%3D08012015%26date%3D25092014%26volume%3D58%26issue%3D1%26spage%3D278%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Badr  Jismy</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Abdellatif  Tikad</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abarbri</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient microwave-assisted Suzuki–Miyaura cross-coupling reaction of 3-bromo pyrazolo[1,5-
              a
              ]pyrimidin-5(4
              H
              )-one: towards a new access to 3,5-diarylated 7-(trifluoromethyl)pyrazolo[1,5-
              a
              ]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 1287-1302. <a href="https://doi.org/10.1039/D0RA07959F" title="DOI URL">https://doi.org/10.1039/D0RA07959F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA07959F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA07959F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DEfficient%252Bmicrowave-assisted%252BSuzuki%2525E2%252580%252593Miyaura%252Bcross-coupling%252Breaction%252Bof%252B3-bromo%252Bpyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidin-5%2525284%252BH%252B%252529-one%25253A%252Btowards%252Ba%252Bnew%252Baccess%252Bto%252B3%25252C5-diarylated%252B7-%252528trifluoromethyl%252529pyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidine%252Bderivatives%26aulast%3DJismy%26aufirst%3DBadr%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D1287%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amal  Al-Azmi</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[1,5-a]pyrimidines: A Close Look into their Synthesis and Applications. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2019,</strong> <em>23 </em>
                                    (6)
                                     , 721-743. <a href="https://doi.org/10.2174/1385272823666190410145238" title="DOI URL">https://doi.org/10.2174/1385272823666190410145238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666190410145238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666190410145238%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DPyrazolo%25255B1%25252C5-a%25255Dpyrimidines%25253A%252BA%252BClose%252BLook%252Binto%252Btheir%252BSynthesis%252Band%252BApplications%26aulast%3DAl-Azmi%26aufirst%3DAmal%26date%3D2019%26volume%3D23%26issue%3D6%26spage%3D721%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Diethelm-Varela</span>, <span class="hlFld-ContribAuthor ">Yong  Ai</span>, <span class="hlFld-ContribAuthor ">Dongdong  Liang</span>, <span class="hlFld-ContribAuthor ">Fengtian  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (9)
                                     , 691-712. <a href="https://doi.org/10.2174/1568026619666190401100519" title="DOI URL">https://doi.org/10.2174/1568026619666190401100519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190401100519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190401100519%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DNitrogen%252BMustards%252Bas%252BAnticancer%252BChemotherapies%25253A%252BHistoric%252BPerspective%25252C%252BCurrent%252BDevelopments%252Band%252BFuture%252BTrends%26aulast%3DDiethelm-Varela%26aufirst%3DBenjamin%26date%3D2019%26volume%3D19%26issue%3D9%26spage%3D691%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nejc  Petek</span>, <span class="hlFld-ContribAuthor ">Bogdan  Štefane</span>, <span class="hlFld-ContribAuthor ">Marko  Novinec</span>, <span class="hlFld-ContribAuthor ">Jurij  Svete</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 7-(aminoalkyl)pyrazolo[1,5-a]pyrimidine derivatives as cathepsin K inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>, 226-238. <a href="https://doi.org/10.1016/j.bioorg.2018.11.029" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.11.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.11.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B7-%252528aminoalkyl%252529pyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%252Bas%252Bcathepsin%252BK%252Binhibitors%26aulast%3DPetek%26aufirst%3DNejc%26date%3D2019%26volume%3D84%26spage%3D226%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">András  Demjén</span>, <span class="hlFld-ContribAuthor ">Róbert  Alföldi</span>, <span class="hlFld-ContribAuthor ">Anikó  Angyal</span>, <span class="hlFld-ContribAuthor ">Márió  Gyuris</span>, <span class="hlFld-ContribAuthor ">László  Hackler</span>, <span class="hlFld-ContribAuthor ">Gábor J.  Szebeni</span>, <span class="hlFld-ContribAuthor ">János  Wölfling</span>, <span class="hlFld-ContribAuthor ">László G.  Puskás</span>, <span class="hlFld-ContribAuthor ">Iván  Kanizsai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, cytotoxic characterization, and SAR study of imidazo[1,2-
              b
              ]pyrazole-7-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (7)
                                     , 1800062. <a href="https://doi.org/10.1002/ardp.201800062" title="DOI URL">https://doi.org/10.1002/ardp.201800062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800062%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%25252C%252Bcytotoxic%252Bcharacterization%25252C%252Band%252BSAR%252Bstudy%252Bof%252Bimidazo%25255B1%25252C2-%252Bb%252B%25255Dpyrazole-7-carboxamides%26aulast%3DDemj%25C3%25A9n%26aufirst%3DAndr%25C3%25A1s%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D7%26spage%3D1800062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Badr  Jismy</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Hassan  Allouchi</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abarbri</span>. </span><span class="cited-content_cbyCitation_article-title">Concise and Efficient Access to 5,7-Disubstituted Pyrazolo[1,5-
              a
              ]pyrimidines by Pd-Catalyzed Sequential Arylation, Alkynylation and SN
              Ar
              Reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (41)
                                     , 6168-6178. <a href="https://doi.org/10.1002/ejoc.201701024" title="DOI URL">https://doi.org/10.1002/ejoc.201701024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConcise%252Band%252BEfficient%252BAccess%252Bto%252B5%25252C7-Disubstituted%252BPyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidines%252Bby%252BPd-Catalyzed%252BSequential%252BArylation%25252C%252BAlkynylation%252Band%252BSN%252BAr%252BReaction%26aulast%3DJismy%26aufirst%3DBadr%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D41%26spage%3D6168%26epage%3D6178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>, <span class="hlFld-ContribAuthor ">Balakumar  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Girish. A.  Hampannavar</span>, <span class="hlFld-ContribAuthor ">Neeta  Thapliyal</span>, <span class="hlFld-ContribAuthor ">Venkata Narayana  Palakollu</span>. </span><span class="cited-content_cbyCitation_article-title">An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 298-352. <a href="https://doi.org/10.1016/j.ejmech.2016.11.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Binsight%252Bon%252Bsynthetic%252Band%252Bmedicinal%252Baspects%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bscaffold%26aulast%3DCherukupalli%26aufirst%3DSrinivasulu%26date%3D2017%26volume%3D126%26spage%3D298%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongyu  Ren</span>, <span class="hlFld-ContribAuthor ">Jin  Chang</span>, <span class="hlFld-ContribAuthor ">Diqin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yating  Yang</span>, <span class="hlFld-ContribAuthor ">Yong  He</span>, <span class="hlFld-ContribAuthor ">Chuanmin  Qi</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>119 </em>, 183-196. <a href="https://doi.org/10.1016/j.ejmech.2016.04.068" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.068%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%252Bbearing%252Bnitrogen%252Bmustard%252Bmoiety%252Band%252Bevaluation%252Bof%252Btheir%252Bantitumor%252Bactivity%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DZhao%26aufirst%3DMingxia%26date%3D2016%26volume%3D119%26spage%3D183%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  WANG</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric synthesis of N-protected 3-methylpiperidin-2-one and its diastereoisomer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Zhejiang University Science A</span><span> <strong>2016,</strong> <em>17 </em>, 163-170. <a href="https://doi.org/10.1631/jzus.A1500008" title="DOI URL">https://doi.org/10.1631/jzus.A1500008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1631/jzus.A1500008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1631%2Fjzus.A1500008%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Zhejiang%2520University%2520Science%2520A%26atitle%3DAsymmetric%252Bsynthesis%252Bof%252BN-protected%252B3-methylpiperidin-2-one%252Band%252Bits%252Bdiastereoisomer%26aulast%3DWANG%26aufirst%3DXia%26date%3D2016%26volume%3D17%26spage%3D163%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibtissam  Bassoude</span>, <span class="hlFld-ContribAuthor ">Zahira  Tber</span>, <span class="hlFld-ContribAuthor ">El Mokhtar  Essassi</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Sabine  Berteina-Raboin</span>. </span><span class="cited-content_cbyCitation_article-title">A one-pot process for the microwave-assisted synthesis of 7-substituted pyrazolo[1,5-a]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (4)
                                     , 3301-3306. <a href="https://doi.org/10.1039/C5RA23417D" title="DOI URL">https://doi.org/10.1039/C5RA23417D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA23417D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA23417D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bone-pot%252Bprocess%252Bfor%252Bthe%252Bmicrowave-assisted%252Bsynthesis%252Bof%252B7-substituted%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%26aulast%3DBassoude%26aufirst%3DIbtissam%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D4%26spage%3D3301%26epage%3D3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranjana  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Gulshan  Singh</span>, <span class="hlFld-ContribAuthor ">Pawan  Kaushik</span>, <span class="hlFld-ContribAuthor ">Dhirender  Kaushik</span>, <span class="hlFld-ContribAuthor ">Deepika  Paliwal</span>, <span class="hlFld-ContribAuthor ">Ajay  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking design and one-pot expeditious synthesis of novel 2,5-diarylpyrazolo[1,5- a ]pyrimidin-7-amines as anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>101 </em>, 326-333. <a href="https://doi.org/10.1016/j.ejmech.2015.06.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.06.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.06.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252Bdocking%252Bdesign%252Band%252Bone-pot%252Bexpeditious%252Bsynthesis%252Bof%252Bnovel%252B2%25252C5-diarylpyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidin-7-amines%252Bas%252Banti-inflammatory%252Bagents%26aulast%3DAggarwal%26aufirst%3DRanjana%26date%3D2015%26volume%3D101%26spage%3D326%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tan  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Ji-hong  Zhao</span>, <span class="hlFld-ContribAuthor ">Xin  Zhou</span>, <span class="hlFld-ContribAuthor ">Yu-ming  Li</span>, <span class="hlFld-ContribAuthor ">Hong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Pseudolaric acid B inhibits T-cell mediated immune response in vivo via p38MAPK signal cascades and PPARγ activation. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2015,</strong> <em>121 </em>, 88-96. <a href="https://doi.org/10.1016/j.lfs.2014.11.020" title="DOI URL">https://doi.org/10.1016/j.lfs.2014.11.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2014.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2014.11.020%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DPseudolaric%252Bacid%252BB%252Binhibits%252BT-cell%252Bmediated%252Bimmune%252Bresponse%252Bin%252Bvivo%252Bvia%252Bp38MAPK%252Bsignal%252Bcascades%252Band%252BPPAR%2525CE%2525B3%252Bactivation%26aulast%3DLi%26aufirst%3DTan%26date%3D2015%26volume%3D121%26spage%3D88%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miha  Drev</span>, <span class="hlFld-ContribAuthor ">Uroš  Grošelj</span>, <span class="hlFld-ContribAuthor ">Špela  Mevec</span>, <span class="hlFld-ContribAuthor ">Eva  Pušavec</span>, <span class="hlFld-ContribAuthor ">Janja  Štrekelj</span>, <span class="hlFld-ContribAuthor ">Amalija  Golobič</span>, <span class="hlFld-ContribAuthor ">Georg  Dahmann</span>, <span class="hlFld-ContribAuthor ">Branko  Stanovnik</span>, <span class="hlFld-ContribAuthor ">Jurij  Svete</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of 1- and 4-substituted 7-oxopyrazolo[1,5-a]pyrimidine-3-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (44)
                                     , 8267-8279. <a href="https://doi.org/10.1016/j.tet.2014.09.020" title="DOI URL">https://doi.org/10.1016/j.tet.2014.09.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.09.020%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRegioselective%252Bsynthesis%252Bof%252B1-%252Band%252B4-substituted%252B7-oxopyrazolo%25255B1%25252C5-a%25255Dpyrimidine-3-carboxamides%26aulast%3DDrev%26aufirst%3DMiha%26date%3D2014%26volume%3D70%26issue%3D44%26spage%3D8267%26epage%3D8279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Li</span>, <span class="hlFld-ContribAuthor ">Bao-Xiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Progress of the synthesis of condensed pyrazole derivatives (from 2010 to mid-2013). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 311-340. <a href="https://doi.org/10.1016/j.ejmech.2014.07.102" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.102%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bof%252Bthe%252Bsynthesis%252Bof%252Bcondensed%252Bpyrazole%252Bderivatives%252B%252528from%252B2010%252Bto%252Bmid-2013%252529%26aulast%3DLi%26aufirst%3DMeng%26date%3D2014%26volume%3D85%26spage%3D311%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eslam  Pourbasheer</span>, <span class="hlFld-ContribAuthor ">Roya  Bazl</span>, <span class="hlFld-ContribAuthor ">Massoud  Amanlou</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking and 3D-QSAR studies on the MAPKAP-K2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (5)
                                     , 2252-2263. <a href="https://doi.org/10.1007/s00044-013-0820-0" title="DOI URL">https://doi.org/10.1007/s00044-013-0820-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-013-0820-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-013-0820-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DMolecular%252Bdocking%252Band%252B3D-QSAR%252Bstudies%252Bon%252Bthe%252BMAPKAP-K2%252Binhibitors%26aulast%3DPourbasheer%26aufirst%3DEslam%26date%3D2014%26date%3D2013%26volume%3D23%26issue%3D5%26spage%3D2252%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Deping  Du</span>, <span class="hlFld-ContribAuthor ">Diwakar  Rai</span>, <span class="hlFld-ContribAuthor ">Liu  Wang</span>, <span class="hlFld-ContribAuthor ">Huiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: Design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (7)
                                     , 2052-2059. <a href="https://doi.org/10.1016/j.bmc.2014.02.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.02.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.02.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFused%252Bheterocyclic%252Bcompounds%252Bbearing%252Bbridgehead%252Bnitrogen%252Bas%252Bpotent%252BHIV-1%252BNNRTIs.%252BPart%252B1%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B5%25252C7-disubstituted%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%26aulast%3DTian%26aufirst%3DYe%26date%3D2014%26volume%3D22%26issue%3D7%26spage%3D2052%26epage%3D2059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aiko  Fujino</span>, <span class="hlFld-ContribAuthor ">Kei  Fukushima</span>, <span class="hlFld-ContribAuthor ">Takaharu  Kubota</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Midori  Takimoto-Kamimura</span>. </span><span class="cited-content_cbyCitation_article-title">Structure of the β-form of human MK2 in complex with the non-selective kinase inhibitor TEI-L03090. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section F Structural Biology and Crystallization Communications</span><span> <strong>2013,</strong> <em>69 </em>
                                    (12)
                                     , 1344-1348. <a href="https://doi.org/10.1107/S1744309113030534" title="DOI URL">https://doi.org/10.1107/S1744309113030534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S1744309113030534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS1744309113030534%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520F%2520Structural%2520Biology%2520and%2520Crystallization%2520Communications%26atitle%3DStructure%252Bof%252Bthe%252B%2525CE%2525B2-form%252Bof%252Bhuman%252BMK2%252Bin%252Bcomplex%252Bwith%252Bthe%252Bnon-selective%252Bkinase%252Binhibitor%252BTEI-L03090%26aulast%3DFujino%26aufirst%3DAiko%26date%3D2013%26date%3D2013%26volume%3D69%26issue%3D12%26spage%3D1344%26epage%3D1348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sizana  Ahmetaj</span>, <span class="hlFld-ContribAuthor ">Nina  Velikanje</span>, <span class="hlFld-ContribAuthor ">Uroš  Grošelj</span>, <span class="hlFld-ContribAuthor ">Ines  Šterbal</span>, <span class="hlFld-ContribAuthor ">Benjamin  Prek</span>, <span class="hlFld-ContribAuthor ">Amalija  Golobič</span>, <span class="hlFld-ContribAuthor ">Drago  Kočar</span>, <span class="hlFld-ContribAuthor ">Georg  Dahmann</span>, <span class="hlFld-ContribAuthor ">Branko  Stanovnik</span>, <span class="hlFld-ContribAuthor ">Jurij  Svete</span>. </span><span class="cited-content_cbyCitation_article-title">Parallel synthesis of 7-heteroaryl-pyrazolo[1,5-a]pyrimidine-3-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2013,</strong> <em>17 </em>
                                    (4)
                                     , 731-743. <a href="https://doi.org/10.1007/s11030-013-9469-3" title="DOI URL">https://doi.org/10.1007/s11030-013-9469-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-013-9469-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-013-9469-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DParallel%252Bsynthesis%252Bof%252B7-heteroaryl-pyrazolo%25255B1%25252C5-a%25255Dpyrimidine-3-carboxamides%26aulast%3DAhmetaj%26aufirst%3DSizana%26date%3D2013%26date%3D2013%26volume%3D17%26issue%3D4%26spage%3D731%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aiko  Fujino</span>, <span class="hlFld-ContribAuthor ">Kei  Fukushima</span>, <span class="hlFld-ContribAuthor ">Takaharu  Kubota</span>, <span class="hlFld-ContribAuthor ">Tomomi  Kosugi</span>, <span class="hlFld-ContribAuthor ">Midori  Takimoto-Kamimura</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Synchrotron Radiation</span><span> <strong>2013,</strong> <em>20 </em>
                                    (6)
                                     , 905-909. <a href="https://doi.org/10.1107/S0909049513020736" title="DOI URL">https://doi.org/10.1107/S0909049513020736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S0909049513020736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS0909049513020736%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Synchrotron%2520Radiation%26atitle%3DCrystal%252Bstructure%252Bof%252Bhuman%252Bcyclin-dependent%252Bkinase-2%252Bcomplex%252Bwith%252BMK2%252Binhibitor%252BTEI-I01800%25253A%252Binsight%252Binto%252Bthe%252Bselectivity%26aulast%3DFujino%26aufirst%3DAiko%26date%3D2013%26date%3D2013%26volume%3D20%26issue%3D6%26spage%3D905%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ugo  Moens</span>, <span class="hlFld-ContribAuthor ">Sergiy  Kostenko</span>, <span class="hlFld-ContribAuthor ">Baldur  Sveinbjørnsson</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Genes</span><span> <strong>2013,</strong> <em>4 </em>
                                    (2)
                                     , 101-133. <a href="https://doi.org/10.3390/genes4020101" title="DOI URL">https://doi.org/10.3390/genes4020101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/genes4020101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fgenes4020101%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%26atitle%3DThe%252BRole%252Bof%252BMitogen-Activated%252BProtein%252BKinase-Activated%252BProtein%252BKinases%252B%252528MAPKAPKs%252529%252Bin%252BInflammation%26aulast%3DMoens%26aufirst%3DUgo%26date%3D2013%26date%3D2013%26volume%3D4%26issue%3D2%26spage%3D101%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hassen  Bel Abed</span>, <span class="hlFld-ContribAuthor ">Oscar  Mammoliti</span>, <span class="hlFld-ContribAuthor ">Guy  Van Lommen</span>, <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>. </span><span class="cited-content_cbyCitation_article-title">Simple approach to the synthesis of 3-fluoro pyrazolo[1,5-a]pyrimidine analogues. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (21)
                                     , 2612-2614. <a href="https://doi.org/10.1016/j.tetlet.2013.03.015" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSimple%252Bapproach%252Bto%252Bthe%252Bsynthesis%252Bof%252B3-fluoro%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Banalogues%26aulast%3DBel%2BAbed%26aufirst%3DHassen%26date%3D2013%26volume%3D54%26issue%3D21%26spage%3D2612%26epage%3D2614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0031.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported MAPKAP-K2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MAPKAP-K2 inhibitors demonstrating in vivo efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure and kinase selectivity of hit compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IC<sub>50</sub> analysis of staurosporine and compound <b>1</b>. MAPKAP-K2 assay performed at 30 μM peptide, 10 μM ATP, 0.5 μCi <sup>33</sup>P-γ-ATP/well for 10 min at room temperature. Data shown are mean ± SEM of duplicate determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mechanism of action/<i>K</i><sub>i</sub> determination for compound <b>1</b>. (a) Primary plot: Rate vs [ATP]. (b) Secondary Lineweaver–Burke plot of 1/<i>V</i> vs 1/[ATP]. (c) Secondary plot of 1/Vm<sub>app</sub> vs [I]. (d) Secondary plot of Km<sub>app</sub>/Vm<sub>app</sub> vs [I]. MAPKAP-K2 assay was performed at 30 μM peptide under a matrix range of concentrations of ATP (4–150 μM) and compound (0–20 μM) in the presence of 1 μCi <sup>33</sup>P-γ-ATP/well for 10 min. Reaction rates are expressed as femtomoles of peptide phosphorylated per minute per mU MAPKAP-K2. Data shown are mean of duplicate data points; experiments were conducted across three independent determinations yielding <i>K</i><sub>i</sub> values of 7 μM, 7 μM, and 6 μM, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>6</sup>-CH(COOEt)<sub>2</sub>, EtONa, EtOH, reflux; (b) HCl aq; (c) POCl<sub>3</sub>, Me<sub>2</sub>NPh, reflux; (d) H<sub>2</sub>N-R<sup>7</sup>, Et<sub>3</sub>N, <sup><i>i</i></sup>PrOH, reflux; (e) H<sub>2</sub>N-R<sup>7</sup>, NaH, DMF/THF, room temp to −50 °C; (f) Boc<sub>2</sub>O, DMAP (cat.), 1,4-dioxane, room temp; (g) excess H<sub>2</sub>N-R<sup>5</sup> (<b>7</b>), 90 °C; (h) HO-R<sup>5</sup> (<b>10</b>), NaH, THF, 0 °C to room temp; (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (a) <i>N</i>-chlorosuccinimide or <i>N</i>-bromosuccinimide, CHCl<sub>3</sub>, room temp.</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (a) Pd(OH)<sub>2</sub>/C, H<sub>2</sub>, MeOH; (b) 2-methoxyethanol, PPh<sub>3</sub>, diisopropyl azodicarboxylate in toluene, THF, room temp; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp.</p></p></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (a) NaOH aq, MeOH, room temp then HCl aq; (b) carbonyldiimidazole, cyclopentylamine, DMF, room temp; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp.</p></p></figure><figure data-id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (a) 5-acetyl-2-thiopheneboronic acid, Pd(OAc)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, PPh<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp.</p></p></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of purvalanol B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Predicted binding mode of compound (<b>1</b>) in the MAPKAP-K2 homology model. Equivalent residue numbers in CDK2 are shown in parentheses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Determination of preferred enantiomer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Overlay of crystal structure of MAPKAP-K2 with (<i>S</i>)-<b>44</b> (gray and red) and MAPKAP-K2 with ADP (blue and green). There are two molecules of (<i>S</i>)-<b>44</b> in each monomer complex. One molecule of (<i>S</i>)-<b>44</b> was bound to the ATP-binding site between the N-terminal and C-terminal domains, and the other molecule of (<i>S</i>)-<b>44</b> was bound near the substrate-binding site of the C-terminal domain. The Gly-rich loop of MAPKAP-K2 with (<i>S</i>)-<b>44</b> took the α-helix conformation (α-form: shown in red), while MAPKAP-K2 with ADP showed the Gly-rich loop in a β-sheet conformation (β-form: shown in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. The binding interaction of compound (<i>S</i>)-<b>44</b> and MAPKAP-K2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. The ATP-binding pocket of (a) MAPKAP-K2 with (<i>S</i>)-<b>44</b> (α-form) PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3A2C">3A2C</a> and (b) MAPKAP-K2 with ADP (β-form) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NY3">1NY3</a>) viewed from the same angle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (<i>S</i>)-<b>44</b> inhibits LPS-induced phosphorylation of HSP27 in cells. THP-1 cells were preincubated with vehicle or test compound prior to addition of LPS (10 μg/mL). Cell lysates were subjected to SDS-PAGE analysis (equivalent protein load in each lane: 20 μg) and transferred proteins subjected to immunoblotting with an antiphospho HSP27 antibody.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/medium/jm-2012-00411k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. The effect of compound (<i>S</i>)-<b>44</b> on serum TNF-α concentration in mouse endotoxin shock model. Statistical analysis was carried out with the Dunnet’s multiple comparison test, with <i>P</i> < 0.05 considered as significant. *<i>P</i> < 0.05 and ***<i>P</i> < 0.001 (vs control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300411k/production/images/large/jm-2012-00411k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300411k&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40316" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40316" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Camussi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupia, E.</span><span> </span><span class="NLM_article-title">The future role of anti-tumor necrosis factor (TNF) products in the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1998&pages=613-620&issue=5&author=G.+Camussiauthor=E.+Lupia&title=The+future+role+of+anti-tumor+necrosis+factor+%28TNF%29+products+in+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamussi%26aufirst%3DG.%26aulast%3DLupia%26aufirst%3DE.%26atitle%3DThe%2520future%2520role%2520of%2520anti-tumor%2520necrosis%2520factor%2520%2528TNF%2529%2520products%2520in%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DDrugs%26date%3D1998%26volume%3D55%26issue%3D5%26spage%3D613%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Braun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieper, J.</span><span> </span><span class="NLM_article-title">Role of novel biological therapies in psoriatic arthritis: Effects on joints and skin</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=187-199&issue=3&author=J.+Braunauthor=J.+Sieper&title=Role+of+novel+biological+therapies+in+psoriatic+arthritis%3A+Effects+on+joints+and+skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraun%26aufirst%3DJ.%26aulast%3DSieper%26aufirst%3DJ.%26atitle%3DRole%2520of%2520novel%2520biological%2520therapies%2520in%2520psoriatic%2520arthritis%253A%2520Effects%2520on%2520joints%2520and%2520skin%26jtitle%3DBioDrugs%26date%3D2003%26volume%3D17%26issue%3D3%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Jarvis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds, D.</span><span> </span><span class="NLM_article-title">Etanercept: A review of its use in rheumatoid arthritis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=945-966&issue=6&author=B.+Jarvisauthor=D.+Faulds&title=Etanercept%3A+A+review+of+its+use+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DB.%26aulast%3DFaulds%26aufirst%3DD.%26atitle%3DEtanercept%253A%2520A%2520review%2520of%2520its%2520use%2520in%2520rheumatoid%2520arthritis%26jtitle%3DDrugs%26date%3D1999%26volume%3D57%26issue%3D6%26spage%3D945%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Richard-Miceli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougados, M.</span><span> </span><span class="NLM_article-title">Tumour necrosis factor-α blockers in rheumatoid arthritis: Review of the clinical experience</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=251-259&issue=4&author=C.+Richard-Miceliauthor=M.+Dougados&title=Tumour+necrosis+factor-%CE%B1+blockers+in+rheumatoid+arthritis%3A+Review+of+the+clinical+experience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichard-Miceli%26aufirst%3DC.%26aulast%3DDougados%26aufirst%3DM.%26atitle%3DTumour%2520necrosis%2520factor-%25CE%25B1%2520blockers%2520in%2520rheumatoid%2520arthritis%253A%2520Review%2520of%2520the%2520clinical%2520experience%26jtitle%3DBioDrugs%26date%3D2001%26volume%3D15%26issue%3D4%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Seymour, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worsley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. H. L.</span><span> </span><span class="NLM_article-title">Anti-TNF agents for rheumatoid arthritis</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1046%2Fj.1365-2125.2001.00321.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=11298065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVOntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2001&pages=201-208&issue=3&author=H.+E.+Seymourauthor=A.+Worsleyauthor=J.+M.+Smithauthor=S.+H.+L.+Thomas&title=Anti-TNF+agents+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-TNF agents for rheumatoid arthritis</span></div><div class="casAuthors">Seymour, H. E.; Worsley, A.; Smith, J. M.; Thomas, S. H. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-208</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 33 refs.  Rheumatoid arthritis (RA) is a chronic inflammatory, autoimmune disease with a prevalence of approx. 1% and an annual incidence of 0.04%.  Up to 50% of patients with RA are unable to work 10 yr after diagnosis.  The disease is assocd. with significant morbidity and mortality with assocd. medical costs to the UK of between £240 M and £600 M per yr.  Non steroidal anti-inflammatory drugs (NSAIDs) have little effect on the underlying course of RA, but they have some anti-inflammatory and analgesic properties.  Disease modifying antirheumatic drugs (DMARDs) have been shown to slow progression of RA and are currently recommended early in the course of treatment of RA which is when disease progression is most rapid.  Etanercept and infliximab belong to a new group of parentally administered anti-tumor necrosis factor (TNF) drugs.  Etanercept is licensed in the UK for the treatment of active rheumatoid arthritis in patients who have not responded to other DMARDs and in children with polyarticular-course juvenile arthritis who have not responded to or are intolerant of methotrexate.  In adults it produces significant improvements in all measures of rheumatic disease activity compared to placebo.  In patients whose disease remains active despite methotrexate treatment, further improvement in control is obtained with the addn. of etanercept without an increase in toxicity.  In one small trial, etanercept was found to be more effective than placebo in a selected group of children.  Infliximab is a monoclonal antibody which is currently licensed in the UK for Crohn's disease and, in combination with methotrexate for the treatment of rheumatoid arthritis in patients with active disease when the response to disease-modifying drugs, including methotrexate, has been inadequate.  In clin. trials infliximab produced significant improvements in all measures of rheumatic disease activity compared with placebo.  Infliximab in combination with methotrexate was shown to be superior to methotrexate or infliximab alone.  There are currently no predictors of a good response to anti-TNF drugs and a percentage of patients fail to respond to treatment (25% to 38% of etanercept patients; 21% to 42% of infliximab patients).  Infliximab monotherapy induces the prodn. of anti-infliximab antibodies, which may reduce its effectiveness.  Adding methotrexate to infliximab therapy may prevent this response.  Anti-TNF drugs may affect host defenses against infection and malignancy; whether these agents affect the development and course of malignancies and chronic infections is unknown and safety and efficacy in patients with immunosuppression or chronic infections has not been investigated.  With infliximab, upper respiratory tract infections, general infections and those requiring antimicrobial treatment were more common in patients than placebo.  Likewise, upper respiratory tract infections were more common in patients treated with etanercept than with placebo.  Injection site reactions occur with both infliximab (16%-20%) and etanercept (37%).  There are approx. 600 000 patients with RA in the UK, and of these between 2% and 3.5% may have severe disease which has failed to respond to conventional treatment and who might be eligible for anti-TNF therapy.  If between 50% and 70% of patients treated with anti-TNF drugs respond and continue on long-term treatment then the recurrent annual cost to the NHS could be between £48 M and £129 M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4PJCaIgeYt7Vg90H21EOLACvtfcHk0ljj-29MX-AjjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVOntLc%253D&md5=2d1396b6777e673d9a81624d0c486c58</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.2001.00321.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.2001.00321.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeymour%26aufirst%3DH.%2BE.%26aulast%3DWorsley%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DThomas%26aufirst%3DS.%2BH.%2BL.%26atitle%3DAnti-TNF%2520agents%2520for%2520rheumatoid%2520arthritis%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2001%26volume%3D51%26issue%3D3%26spage%3D201%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">p38 MAP kinase: Molecular target for the inhibition of pro-inflammatory cytokines</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1016%2FS0079-6468%2808%2970091-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=11774793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVGntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=1-60&author=J.+L.+Adamsauthor=A.+M.+Badgerauthor=S.+Kumarauthor=J.+C.+Lee&title=p38+MAP+kinase%3A+Molecular+target+for+the+inhibition+of+pro-inflammatory+cytokines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines</span></div><div class="casAuthors">Adams, Jerry L.; Badger, Alison M.; Kumar, Sanjay; Lee, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-60</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 286 refs.  Topics discussed include the discovery of p38 kinase; the relationship of p38 to the MAP kinases; the p38 kinase family; upstream activators; downstream substrates; medicinal chem. preceding the discovery of p38; p38 structure-activity relationships; the structural basis of kinase selectivity; the pharmacol. of p38 inhibitors; and preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob8EiblMQiarVg90H21EOLACvtfcHk0ljj-29MX-AjjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVGntbw%253D&md5=fb9d63787dfe16059715b6a68afa41a3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970091-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970091-2%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DBadger%26aufirst%3DA.%2BM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3Dp38%2520MAP%2520kinase%253A%2520Molecular%2520target%2520for%2520the%2520inhibition%2520of%2520pro-inflammatory%2520cytokines%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D38%26spage%3D1%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laydon, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenthal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvatter, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemens, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">A protein kinase involved in the regulation of inflammatory cytokine biosynthesis</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x"> (</span><span class="NLM_issue">6508</span><span class="NLM_x">) </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1038%2F372739a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=7997261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADyaK2MXisl2qu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=739-746&issue=6508&author=J.+C.+Leeauthor=J.+T.+Laydonauthor=P.+C.+McDonnellauthor=T.+F.+Gallagherauthor=S.+Kumarauthor=D.+Greenauthor=D.+McNultyauthor=M.+J.+Blumenthalauthor=J.+R.+Heyesauthor=S.+W.+Landvatterauthor=J.+E+Stricklerauthor=M.+M.+McLaughlinauthor=I.+R.+Siemensauthor=S.+M.+Fisherauthor=G.+P.+Liviauthor=J.+R.+Whiteauthor=J.+L.+Adamsauthor=P.+R.+Young&title=A+protein+kinase+involved+in+the+regulation+of+inflammatory+cytokine+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A protein kinase involved in the regulation of inflammatory cytokine biosynthesis</span></div><div class="casAuthors">Lee, John C.; Laydon, Jeffrey T.; McDonnell, Peter C.; Gallagher, Timothy F.; Kumar, Sanjay; Green, David; McNulty, Dean; Blumenthal, Mary Jane; Heyes, J. Richard; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">6508</span>),
    <span class="NLM_cas:pages">739-46</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Prodn. of interleukin-1 and tumor necrosis factor from stimulated human monocytes is inhibited by a new series of pyridinyl-imidazole compds.  Using radiolabeled and radio-photoaffinity-labeled chem. probes, the target of these compds. was identified as a pair of closely related mitogen-activated protein kinase homologues, termed CSBPs.  Binding of the pyridinyl-imidazole compds. inhibited CSBP kinase activity and could be directly correlated with their ability to inhibit cytokine prodn., suggesting that the CSBPs are crit. for cytokine prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpExKJsn1CnWrVg90H21EOLACvtfcHk0liOrP-UvQF59A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisl2qu70%253D&md5=cfda8b8e5c29e323029c4f03056a1753</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F372739a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F372739a0%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DLaydon%26aufirst%3DJ.%2BT.%26aulast%3DMcDonnell%26aufirst%3DP.%2BC.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DMcNulty%26aufirst%3DD.%26aulast%3DBlumenthal%26aufirst%3DM.%2BJ.%26aulast%3DHeyes%26aufirst%3DJ.%2BR.%26aulast%3DLandvatter%26aufirst%3DS.%2BW.%26aulast%3DStrickler%26aufirst%3DJ.%2BE%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DSiemens%26aufirst%3DI.%2BR.%26aulast%3DFisher%26aufirst%3DS.%2BM.%26aulast%3DLivi%26aufirst%3DG.%2BP.%26aulast%3DWhite%26aufirst%3DJ.%2BR.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DA%2520protein%2520kinase%2520involved%2520in%2520the%2520regulation%2520of%2520inflammatory%2520cytokine%2520biosynthesis%26jtitle%3DNature%2520%2528London%2529%26date%3D1994%26volume%3D372%26issue%3D6508%26spage%3D739%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitfelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+from+lead+compound+to+clinical+candidate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0liOrP-UvQF59A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520from%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senftleben, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dadak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=221&author=K.+Tamuraauthor=T.+Sudoauthor=U.+Senftlebenauthor=A.+M.+Dadakauthor=R.+Johnsonauthor=M.+Karin&title=Requirement+for+p38alpha+in+erythropoietin+expression%3A+a+role+for+stress+kinases+in+erythropoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DK.%26aulast%3DSudo%26aufirst%3DT.%26aulast%3DSenftleben%26aufirst%3DU.%26aulast%3DDadak%26aufirst%3DA.%2BM.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DRequirement%2520for%2520p38alpha%2520in%2520erythropoietin%2520expression%253A%2520a%2520role%2520for%2520stress%2520kinases%2520in%2520erythropoiesis%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Adams, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vintersten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valladares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span> </span><span class="NLM_article-title">Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=109-116&author=R.+H.+Adamsauthor=A.+Porrasauthor=G.+Alonsoauthor=M.+Jonesauthor=K.+Vinterstenauthor=S.+Panelliauthor=A.+Valladaresauthor=L.+Perezauthor=R.+Kleinauthor=A.+R.+Nebreda&title=Essential+role+of+p38alpha+MAP+kinase+in+placental+but+not+embryonic+cardiovascular+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DR.%2BH.%26aulast%3DPorras%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DVintersten%26aufirst%3DK.%26aulast%3DPanelli%26aufirst%3DS.%26aulast%3DValladares%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26atitle%3DEssential%2520role%2520of%2520p38alpha%2520MAP%2520kinase%2520in%2520placental%2520but%2520not%2520embryonic%2520cardiovascular%2520development%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D109%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Targeting protein kinases for the development of antiinflammatory drugs</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1016%2Fj.ceb.2009.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=19217767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=317-324&author=P.+Cohen&title=Targeting+protein+kinases+for+the+development+of+antiinflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases for the development of anti-inflammatory drugs</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-324</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, protein kinases have become the pharmaceutical industry's most studied class of drug target, and some 10 protein kinase inhibitors have so far been approved for the treatment of cancer.  However, whether safe drugs that modulate protein kinase activities can also be developed for the treatment of chronic diseases, where they may need to be taken for decades, is an issue that is still unresolved.  A no. of compds. that inhibit the p38α MAPK have entered clin. trials for the treatment of rheumatoid arthritis and psoriasis, but side effects have prevented their progression to Phase III clin. trials.  Here the author briefly reviews the potential problems in targeting p38 MAPK and discusses other protein kinases that regulate the innate immune system, such as Tpl2, MAPKAP-K2/3, MSK1/2, and IRAK4, which may be better targets for the treatment of chronic inflammatory diseases, and NIK, which is an attractive target for the treatment of multiple myeloma, a late stage B-cell malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeBhN9qJzqrVg90H21EOLACvtfcHk0liOrP-UvQF59A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCksrg%253D&md5=b7e7a33f18d0c8c1e33160c092cf411b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DTargeting%2520protein%2520kinases%2520for%2520the%2520development%2520of%2520antiinflammatory%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neininger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MAPKAP kinase 2 is essential for LPS induced TNF-a biosynthesis</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1038%2F10061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=10559880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVGqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=94-97&issue=2&author=A.+Kotlyarovauthor=A.+Neiningerauthor=C.+Schubertauthor=R.+Eckertauthor=C.+Birchmeierauthor=H.-D.+Volkauthor=M.+Gaestel&title=MAPKAP+kinase+2+is+essential+for+LPS+induced+TNF-a+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis</span></div><div class="casAuthors">Kotlyarov, Alexey; Neininger, Armin; Schubert, Carola; Eckert, Rolf; Birchmeier, Carmen; Volk, Hans-Dieter; Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">94-97</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines Ltd</span>)
        </div><div class="casAbstract">MAPKAP kinase 2 (MK2) is one of several kinases that are regulated through direct phosphorylation by p38 MAP kinase.  By introducing a targeted mutation into the mouse MK2 gene, the authors have detd. the physiol. function of MK2 in vivo.  Mice that lack MK2 show increased stress resistance and survive LPS-induced endotoxic shock.  This is due to a redn. of ∼90% in the prodn. of tumor necrosis factor-α (TNF-α) and not to a change in signaling from the TNF receptor.  The level and stability of TNF-α mRNA is not reduced and TNF-α secretion is not affected.  Thus, MK2 is an essential component in the inflammatory response which regulates biosynthesis of TNF-α at a post-transcriptional level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtiobBLSnV77Vg90H21EOLACvtfcHk0lgAqUAyI7U5og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVGqsLY%253D&md5=5fb502616639b298341431eea8009cc2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F10061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10061%26sid%3Dliteratum%253Aachs%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DNeininger%26aufirst%3DA.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DEckert%26aufirst%3DR.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DVolk%26aufirst%3DH.-D.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMAPKAP%2520kinase%25202%2520is%2520essential%2520for%2520LPS%2520induced%2520TNF-a%2520biosynthesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D1999%26volume%3D1%26issue%3D2%26spage%3D94%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Winzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kracht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyu, A.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtmann, H.</span><span> </span><span class="NLM_article-title">The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4969</span><span class="NLM_x">–</span> <span class="NLM_lpage">4980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=4969-4980&issue=18&author=R.+Winzenauthor=M.+Krachtauthor=B.+Ritterauthor=A.+Wilhelmauthor=C.-Y.+A.+Chenauthor=A.-B.+Shyuauthor=M.+Mullerauthor=M.+Gaestelauthor=K.+Reschauthor=H.+Holtmann&title=The+p38+MAP+kinase+pathway+signals+for+cytokine-induced+mRNA+stabilization+via+MAP+kinase-activated+protein+kinase+2+and+an+AU-rich+region-targeted+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWinzen%26aufirst%3DR.%26aulast%3DKracht%26aufirst%3DM.%26aulast%3DRitter%26aufirst%3DB.%26aulast%3DWilhelm%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.-Y.%2BA.%26aulast%3DShyu%26aufirst%3DA.-B.%26aulast%3DMuller%26aufirst%3DM.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DResch%26aufirst%3DK.%26aulast%3DHoltmann%26aufirst%3DH.%26atitle%3DThe%2520p38%2520MAP%2520kinase%2520pathway%2520signals%2520for%2520cytokine-induced%2520mRNA%2520stabilization%2520via%2520MAP%2520kinase-activated%2520protein%2520kinase%25202%2520and%2520an%2520AU-rich%2520region-targeted%2520mechanism%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26issue%3D18%26spage%3D4969%26epage%3D4980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MAPKAP kinases - MKs - two’s company, three’s a crowd</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1038%2Fnrm1834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=16421520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=120-130&issue=2&author=M.+Gaestel&title=MAPKAP+kinases+-+MKs+-+two%E2%80%99s+company%2C+three%E2%80%99s+a+crowd"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">MAPKAP kinases - MKs - two's company, three's a crowd</span></div><div class="casAuthors">Gaestel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-130</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Downstream of MAP kinases (MAPKs), 3 structurally related MAPK-activated protein kinases (MAPKAPKs or MKs), MK2, MK3, and MK5, signal to diverse cellular targets.  Although there is no known common function for all 3 MKs, these kinases are involved in important processes.  MKs regulate gene expression at the transcriptional and post-transcriptional level, control cytoskeletal architecture and cell cycle progression, and are implicated in inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI91xfvhmqhrVg90H21EOLACvtfcHk0lgAqUAyI7U5og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWntr4%253D&md5=1ae824b7d680a574a7c764bd61ac43aa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrm1834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1834%26sid%3Dliteratum%253Aachs%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMAPKAP%2520kinases%2520-%2520MKs%2520-%2520two%25E2%2580%2599s%2520company%252C%2520three%25E2%2580%2599s%2520a%2520crowd%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26issue%3D2%26spage%3D120%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ronkina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittrich-Breiholz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kracht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milarski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marusic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez., J.-B.</span><span> </span><span class="NLM_article-title">The Mitogen-activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPK</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">Jan 2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1128%2FMCB.01456-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=17030606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Oh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=Jan+2007&pages=170&author=N.+Ronkinaauthor=A.+Kotlyarovauthor=O.+Dittrich-Breiholzauthor=M.+Krachtauthor=E.+Hittiauthor=K.+Milarskiauthor=R.+Askewauthor=S.+Marusicauthor=L.-L.+Linauthor=M.+Gaestelauthor=J.-B.+Telliez.&title=The+Mitogen-activated+Protein+Kinase+%28MAPK%29-Activated+Protein+Kinases+MK2+and+MK3+Cooperate+in+Stimulation+of+Tumor+Necrosis+Factor+Biosynthesis+and+Stabilization+of+p38+MAPK"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK</span></div><div class="casAuthors">Ronkina, N.; Kotlyarov, A.; Dittrich-Breiholz, O.; Kracht, M.; Hitti, E.; Milarski, K.; Askew, R.; Marusic, S.; Lin, L.-L.; Gaestel, M.; Telliez, J.-B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-181</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">MK2 and MK3 represent protein kinases downstream of p38 mitogen-activated protein kinase (MAPK).  Deletion of the MK2 gene in mice resulted in an impaired inflammatory response although MK3, which displays extensive structural similarities and identical functional properties in vitro, is still present.  Here, the authors analyze tumor necrosis factor (TNF) prodn. and expression of p38 MAPK and tristetraprolin (TTP) in MK3-deficient mice and demonstrate that there are no significant differences with wild-type animals.  The authors show that in vivo MK2 and MK3 are expressed and activated in parallel.  However, the level of activity of MK2 is always significantly higher than that of MK3.  Accordingly, the authors hypothesized that MK3 could have significant effects only in an MK2-free background and generated MK2/MK3 double-knockout mice.  Unexpectedly, these mice are viable and show no obvious defects due to loss of compensation between MK2 and MK3.  However, there is a further redn. of TNF prodn. and expression of p38 and TTP in double-knockout mice compared to MK2-deficient mice.  This finding, together with the observation that ectopically expressed MK3 can rescue MK2 deficiency similarly to MK2, indicates that both kinases share the same physiol. function in vivo but are expressed to different levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdXOig9ZksrbVg90H21EOLACvtfcHk0lgAqUAyI7U5og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Oh&md5=4dca45754c91bce57cf3c2063bf23a88</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.01456-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01456-06%26sid%3Dliteratum%253Aachs%26aulast%3DRonkina%26aufirst%3DN.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DDittrich-Breiholz%26aufirst%3DO.%26aulast%3DKracht%26aufirst%3DM.%26aulast%3DHitti%26aufirst%3DE.%26aulast%3DMilarski%26aufirst%3DK.%26aulast%3DAskew%26aufirst%3DR.%26aulast%3DMarusic%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DL.-L.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DTelliez.%26aufirst%3DJ.-B.%26atitle%3DThe%2520Mitogen-activated%2520Protein%2520Kinase%2520%2528MAPK%2529-Activated%2520Protein%2520Kinases%2520MK2%2520and%2520MK3%2520Cooperate%2520in%2520Stimulation%2520of%2520Tumor%2520Necrosis%2520Factor%2520Biosynthesis%2520and%2520Stabilization%2520of%2520p38%2520MAPK%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3DJan%25202007%26volume%3D27%26spage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telliez, J. B.</span><span> </span><span class="NLM_article-title">MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">1913</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2006&pages=1913-1917&author=M.+Hegenauthor=M.+Gaestelauthor=C.+L.+Nickerson-Nutterauthor=L.+L.+Linauthor=J.+B.+Telliez&title=MAPKAP+kinase+2-deficient+mice+are+resistant+to+collagen-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DGaestel%26aufirst%3DM.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DTelliez%26aufirst%3DJ.%2BB.%26atitle%3DMAPKAP%2520kinase%25202-deficient%2520mice%2520are%2520resistant%2520to%2520collagen-induced%2520arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D177%26spage%3D1913%26epage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1016%2Fj.coph.2004.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=15251131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=372-377&author=J.+Saklatvala&title=The+p38+MAP+kinase+pathway+as+a+therapeutic+target+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The p38 MAP kinase pathway as a therapeutic target in inflammatory disease</span></div><div class="casAuthors">Saklatvala, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The p38 MAPK signalling pathway plays an important role in inflammation and other physiol. processes.  Specific inhibitors of p38 α and β MAPK block prodn. of the major inflammatory cytokines (i.e. tumor necrosis factor-α and interleukin-1) and other proteins (e.g. cyclooxygenase-2), and are anti-inflammatory in animal models of disease.  A major function of the pathway is post-transcriptional control of inflammatory gene expression.  Many of the mRNAs are unstable (or untranslatable) because of AU-rich elements in the 3'untranslated region.  Signalling in the p38 pathway counteracts these and stabilizes the mRNAs by preventing their otherwise rapid de-adenylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpglO4EVBhJ-LVg90H21EOLACvtfcHk0lhFALMGjoK83w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Wgu7s%253D&md5=5678936250f1dbc9c27707bd7edf6108</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DThe%2520p38%2520MAP%2520kinase%2520pathway%2520as%2520a%2520therapeutic%2520target%2520in%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Neininger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontoyiannis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaestel, M.</span><span> </span><span class="NLM_article-title">MK2 Targets AU-rich Elements and Regulates Biosynthesis of Tumor Necrosis Factor and Interleukin-6 Independently at Different Post-translational Levels</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">3065</span><span class="NLM_x">–</span> <span class="NLM_lpage">3068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=3065-3068&author=A.+Neiningerauthor=D.+Kontoyiannisauthor=A.+Kotlyarovauthor=R.+Winzenauthor=R.+Eckertauthor=H.-D.+Volkauthor=H.+Holtmannauthor=G.+Kolliasauthor=M.+Gaestel&title=MK2+Targets+AU-rich+Elements+and+Regulates+Biosynthesis+of+Tumor+Necrosis+Factor+and+Interleukin-6+Independently+at+Different+Post-translational+Levels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeininger%26aufirst%3DA.%26aulast%3DKontoyiannis%26aufirst%3DD.%26aulast%3DKotlyarov%26aufirst%3DA.%26aulast%3DWinzen%26aufirst%3DR.%26aulast%3DEckert%26aufirst%3DR.%26aulast%3DVolk%26aufirst%3DH.-D.%26aulast%3DHoltmann%26aufirst%3DH.%26aulast%3DKollias%26aufirst%3DG.%26aulast%3DGaestel%26aufirst%3DM.%26atitle%3DMK2%2520Targets%2520AU-rich%2520Elements%2520and%2520Regulates%2520Biosynthesis%2520of%2520Tumor%2520Necrosis%2520Factor%2520and%2520Interleukin-6%2520Independently%2520at%2520Different%2520Post-translational%2520Levels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D3065%26epage%3D3068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Damjanov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer-Green, G. T.</span><span> </span><span class="NLM_article-title">Efficacy, Pharmacodynamics and Safety of VX-702, a Novel p38 MAPK Inhibitor, in Rhematoid Arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1232</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1002%2Fart.24485" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1232-1241&author=N.+Damjanovauthor=R.+S.+Kauffmanauthor=G.+T.+Spencer-Green&title=Efficacy%2C+Pharmacodynamics+and+Safety+of+VX-702%2C+a+Novel+p38+MAPK+Inhibitor%2C+in+Rhematoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fart.24485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24485%26sid%3Dliteratum%253Aachs%26aulast%3DDamjanov%26aufirst%3DN.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DSpencer-Green%26aufirst%3DG.%2BT.%26atitle%3DEfficacy%252C%2520Pharmacodynamics%2520and%2520Safety%2520of%2520VX-702%252C%2520a%2520Novel%2520p38%2520MAPK%2520Inhibitor%252C%2520in%2520Rhematoid%2520Arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D5%26spage%3D1232%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Clark, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, J. L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saklatvala, J.</span><span> </span><span class="NLM_article-title">The p38 MAPK pathway mediates both antiinflammatory and proinflammatory processes: comment on the article by Damjanov and the editorial by Genovese</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3513</span><span class="NLM_x">–</span> <span class="NLM_lpage">3514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1002%2Fart.24919" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=3513-3514&author=A.+R.+Clarkauthor=J.+L.+E.+Deanauthor=J.+Saklatvala&title=The+p38+MAPK+pathway+mediates+both+antiinflammatory+and+proinflammatory+processes%3A+comment+on+the+article+by+Damjanov+and+the+editorial+by+Genovese"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fart.24919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24919%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DA.%2BR.%26aulast%3DDean%26aufirst%3DJ.%2BL.%2BE.%26aulast%3DSaklatvala%26aufirst%3DJ.%26atitle%3DThe%2520p38%2520MAPK%2520pathway%2520mediates%2520both%2520antiinflammatory%2520and%2520proinflammatory%2520processes%253A%2520comment%2520on%2520the%2520article%2520by%2520Damjanov%2520and%2520the%2520editorial%2520by%2520Genovese%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D5%26spage%3D3513%26epage%3D3514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masih, L.</span><span> </span><span class="NLM_article-title">Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1587-1590&author=D.+R.+Andersonauthor=S.+Hegdeauthor=E.+Reinhardauthor=L.+Gomezauthor=W.+F.+Vernierauthor=L.+Leeauthor=S.+Liuauthor=A.+Sambandamauthor=P.+A.+Sniderauthor=L.+Masih&title=Aminocyanopyridine+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DReinhard%26aufirst%3DE.%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSambandam%26aufirst%3DA.%26aulast%3DSnider%26aufirst%3DP.%2BA.%26aulast%3DMasih%26aufirst%3DL.%26atitle%3DAminocyanopyridine%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1587%26epage%3D1590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Trujillo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchler, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span> </span><span class="NLM_article-title">Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4657-4663&author=J.+I.+Trujilloauthor=M.+J.+Meyersauthor=D.+R.+Andersonauthor=S.+Hegdeauthor=M.+W.+Mahoneyauthor=W.+F.+Vernierauthor=I.+P.+Buchlerauthor=K.+K.+Wuauthor=S.+Yangauthor=S.+J.+Hartmannauthor=D.+B.+Reitz&title=Novel+tetrahydro-%CE%B2-carboline-1-carboxylic+acids+as+inhibitors+of+mitogen+activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DBuchler%26aufirst%3DI.%2BP.%26aulast%3DWu%26aufirst%3DK.%2BK.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DS.%2BJ.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26atitle%3DNovel%2520tetrahydro-%25CE%25B2-carboline-1-carboxylic%2520acids%2520as%2520inhibitors%2520of%2520mitogen%2520activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4657%26epage%3D4663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+Inhibitors+of+Mitogen-Activated+Protein+Kinase-Activated+Protein+Kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520Inhibitors%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Activated%2520Protein%2520Kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywardane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmanuel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautschi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargelis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span> </span><span class="NLM_article-title">The discovery of carboline analogs as potent MAPKAP-K2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4664</span><span class="NLM_x">–</span> <span class="NLM_lpage">4669</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4664-4669&author=J.-P.+Wuauthor=J.+Wangauthor=A.+Abeywardaneauthor=D.+Andersenauthor=M.+Emmanuelauthor=E.+Gautschiauthor=D.+R.+Goldbergauthor=M.+A.+Kashemauthor=S.+Lukasauthor=W.+Maoauthor=L.+Martinauthor=T.+Morwickauthor=N.+Mossauthor=C.+Pargelisauthor=U.+R.+Patelauthor=L.+Patnaudeauthor=G.+W.+Peetauthor=D.+Skowauthor=R.+J.+Snowauthor=Y.+Wardauthor=B.+Werneburgauthor=A.+White&title=The+discovery+of+carboline+analogs+as+potent+MAPKAP-K2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-P.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DAndersen%26aufirst%3DD.%26aulast%3DEmmanuel%26aufirst%3DM.%26aulast%3DGautschi%26aufirst%3DE.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DMorwick%26aufirst%3DT.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargelis%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DU.%2BR.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DWard%26aufirst%3DY.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520carboline%2520analogs%2520as%2520potent%2520MAPKAP-K2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4664%26epage%3D4669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLeon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenbaum, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netherton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcelini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z.</span><span> </span><span class="NLM_article-title">Pyrazinoindolone inhibitors of MAPKAP-K2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">938</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1016%2Fj.bmcl.2007.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=18221871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=938-941&author=D.+R.+Goldbergauthor=Y.+Choiauthor=D.+Coganauthor=M.+Corsonauthor=R.+DeLeonauthor=A.+Gaoauthor=L.+Gruenbaumauthor=M.+H.+Haoauthor=D.+Josephauthor=M.+A.+Kashemauthor=C.+Millerauthor=N.+Mossauthor=M.+R.+Nethertonauthor=C.+P.+Pargellisauthor=J.+Pelletierauthor=R.+Sellatiauthor=D.+Skowauthor=C.+Torceliniauthor=Y.-C.+Tsengauthor=J.+Wangauthor=R.+Watsiauthor=B.+Werneburgauthor=J.+P.+Wuauthor=Z.+Xiong&title=Pyrazinoindolone+inhibitors+of+MAPKAP-K2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazinoindolone inhibitors of MAPKAP-K2</span></div><div class="casAuthors">Goldberg, D. R.; Choi, Y.; Cogan, D.; Corson, M.; DeLeon, R.; Gao, A.; Gruenbaum, L.; Hao, M. H.; Joseph, D.; Kashem, M. A.; Miller, C.; Moss, N.; Netherton, M. R.; Pargellis, C. P.; Pelletier, J.; Sellati, R.; Skow, D.; Torcellini, C.; Tseng, Y.-C.; Wang, J.; Wasti, R.; Werneburg, B.; Wu, J. P.; Xiong, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">938-941</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Optimization of pyrazinoindolone inhibitors of MAPKAP-K2 (MK2) provides a reasonable balance of cellular potency and physicochem. properties.  Mechanistic studies support the inhibition of MK2 which is responsible for the sub-micromolar cellular efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHMw6FxuAeyLVg90H21EOLACvtfcHk0lht4Bq5wy49BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D&md5=55a46852c9ccf52c8350d0a26de3e41d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCogan%26aufirst%3DD.%26aulast%3DCorson%26aufirst%3DM.%26aulast%3DDeLeon%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DGruenbaum%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DM.%2BH.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DNetherton%26aufirst%3DM.%2BR.%26aulast%3DPargellis%26aufirst%3DC.%2BP.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTorcelini%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DY.-C.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWatsi%26aufirst%3DR.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%2BP.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DPyrazinoindolone%2520inhibitors%2520of%2520MAPKAP-K2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D938%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Xiong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, M.-H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargelis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieselmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werneburg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of indole-based MK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1999</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1994-1999&author=Z.+Xiongauthor=D.+A.+Gaoauthor=D.+A.+Coganauthor=M.-H.+H.+Goldbergauthor=N.+Mossauthor=E.+Packauthor=C.+Pargelisauthor=D.+Skowauthor=T.+Trieselmannauthor=B.+Werneburgauthor=A.+White&title=Synthesis+and+SAR+studies+of+indole-based+MK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DD.%2BA.%26aulast%3DCogan%26aufirst%3DD.%2BA.%26aulast%3DGoldberg%26aufirst%3DM.-H.%2BH.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DPargelis%26aufirst%3DC.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTrieselmann%26aufirst%3DT.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWhite%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520indole-based%2520MK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1994%26epage%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moebitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waelchli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">Pyrrolo-pyrimidones: A novel class of MK2 inhibitors with potent cellular activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6142</span><span class="NLM_x">–</span> <span class="NLM_lpage">6146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6142-6146&author=A.+Schlapbachauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=G.+Kochauthor=H.+Moebitzauthor=L.+Reveszauthor=C.+Scheuflerauthor=J.+Velcickyauthor=R.+Waelchliauthor=C.+Huppertz&title=Pyrrolo-pyrimidones%3A+A+novel+class+of+MK2+inhibitors+with+potent+cellular+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DMoebitz%26aufirst%3DH.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DWaelchli%26aufirst%3DR.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DPyrrolo-pyrimidones%253A%2520A%2520novel%2520class%2520of%2520MK2%2520inhibitors%2520with%2520potent%2520cellular%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6142%26epage%3D6146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Benzothiophene inhibitors of MK2. Part 1: Structure–activity relationships, assessments of selectivity and cellular potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4878</span><span class="NLM_x">–</span> <span class="NLM_lpage">4881</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4878-4881&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=S.+A.+Longauthor=B.+S.+Pierceauthor=M.+W.+Mahoneyauthor=R.+J.+Mourey&title=Benzothiophene+inhibitors+of+MK2.+Part+1%3A+Structure%E2%80%93activity+relationships%2C+assessments+of+selectivity+and+cellular+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DBenzothiophene%2520inhibitors%2520of%2520MK2.%2520Part%25201%253A%2520Structure%25E2%2580%2593activity%2520relationships%252C%2520assessments%2520of%2520selectivity%2520and%2520cellular%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4878%26epage%3D4881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, M. D.</span><span> </span><span class="NLM_article-title">Benzothiophene inhibitors of MK2. Part 2: Improvements in kinase selectivity and cell potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">–</span> <span class="NLM_lpage">4884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4882-4884&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=R.+G.+Kurumbailauthor=N+Caspersauthor=G.+I.+Podaauthor=S.+A.+Longauthor=B.+S.+Pierceauthor=M.+W.+Mahoneyauthor=R.+J.+Moureyauthor=M.+D.+Parikh&title=Benzothiophene+inhibitors+of+MK2.+Part+2%3A+Improvements+in+kinase+selectivity+and+cell+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DParikh%26aufirst%3DM.%2BD.%26atitle%3DBenzothiophene%2520inhibitors%2520of%2520MK2.%2520Part%25202%253A%2520Improvements%2520in%2520kinase%2520selectivity%2520and%2520cell%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4882%26epage%3D4884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">Low-molecular-weight MK2 inhibitors a tough nut to crack!</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.4155%2Ffmc.09.98" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=21426101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOisL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1243-1257&issue=7&author=A.+Schlapbachauthor=C.+Huppertz&title=Low-molecular-weight+MK2+inhibitors+a+tough+nut+to+crack%21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Low-molecular-weight MK2 inhibitors: a tough nut to crack!</span></div><div class="casAuthors">Schlapbach, Achim; Huppertz, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1243-1257</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 pathway was at the center of interest for anti-inflammatory drug discovery for many years as it is crucial for the biosynthesis of TNF-α, IL-1β, and other mediators.  Most of the anti-inflammatory effects of p38 inhibition are mediated through MAPK-activated protein kinase-2 (MK2), a direct downstream target of p38, which makes MK2 a very interesting drug target.  Within the last 5 years, several classes of low-mol.-wt. MK2 inhibitors were disclosed in the patent and primary literature.  Advanced compds. could be optimized to nanomolar potencies and inhibit TNF-α release, as well as the phosphorylation of the MK2 substrate heat-shock protein 27 in cellular assays.  This article will review the recent progress in this field and will highlight and discuss the most promising compd. series disclosed so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4u3apT9vA-rVg90H21EOLACvtfcHk0lg6g5jg_w3C7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOisL7K&md5=0b950af46215982d171a6c8b6de98fd0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.98%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DLow-molecular-weight%2520MK2%2520inhibitors%2520a%2520tough%2520nut%2520to%2520crack%2521%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26issue%3D7%26spage%3D1243%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4715</span><span class="NLM_x">–</span> <span class="NLM_lpage">4718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4715-4718&author=L.+Reveszauthor=A.+Schlapbachauthor=R.+Aichholzauthor=R.+Feifelauthor=S.+Hawtinauthor=R.+Hengauthor=P.+Hiestandauthor=W.+Jahnkeauthor=G.+Kochauthor=M.+Kroemerauthor=H.+M%C3%B6bitzauthor=C.+Scheuflerauthor=J.+Velcickyauthor=C.+Huppertz&title=In+vivo+and+in+vitro+SAR+of+tetracyclic+MAPKAP-K2+%28MK2%29+inhibitors.+Part+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520SAR%2520of%2520tetracyclic%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors.%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4715%26epage%3D4718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlewood-Evans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheufler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velcicky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, C.</span><span> </span><span class="NLM_article-title">In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4719</span><span class="NLM_x">–</span> <span class="NLM_lpage">4723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4719-4723&author=L.+Reveszauthor=A.+Schlapbachauthor=R.+Aichholzauthor=J.+Dawsonauthor=R.+Feifelauthor=S.+Hawtinauthor=A.+Littlewood-Evansauthor=G.+Kochauthor=M.+Kroemerauthor=H.+M%C3%B6bitzauthor=C.+Scheuflerauthor=J.+Velcickyauthor=C.+Huppertz&title=In+vivo+and+in+vitro+SAR+of+tetracyclic+MAPKAP-K2+%28MK2%29+inhibitors.+Part+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DM.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DHuppertz%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520SAR%2520of%2520tetracyclic%2520MAPKAP-K2%2520%2528MK2%2529%2520inhibitors.%2520Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4719%26epage%3D4723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustkern, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saabye, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span> </span><span class="NLM_article-title">A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300411k&amp;key=10.1124%2Fjpet.110.166173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300411k&amp;key=20237073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300411k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFClsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=797-807&author=R.+J.+Moureyauthor=B.+L.+Burnetteauthor=S.+J.+Brustkernauthor=J.+S.+Danielsauthor=J.+L.+Hirschauthor=W.+F.+Hoodauthor=M.+J.+Meyersauthor=S.+J.+Mnichauthor=B.+S.+Pierceauthor=M.+J.+Saabyeauthor=J.+F.+Schindlerauthor=S.+A.+Southauthor=E.+G.+Webbauthor=J.+Zhangauthor=D.+R.+Anderson&title=A+Benzothiophene+Inhibitor+of+Mitogen-Activated+Protein+Kinase-Activated+Protein+Kinase+2+Inhibits+Tumor+Necrosis+Factor+%CE%B1+Production+and+Has+Oral+Anti-Inflammatory+Efficacy+in+Acute+and+Chronic+Models+of+Inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor α production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation</span></div><div class="casAuthors">Mourey, Robert J.; Burnette, Barry L.; Brustkern, Sarah J.; Daniels, J. Scott; Hirsch, Jeffrey L.; Hood, William F.; Meyers, Marvin J.; Mnich, Stephen J.; Pierce, Betsy S.; Saabye, Matthew J.; Schindler, John F.; South, Sarah A.; Webb, Elizabeth G.; Zhang, Jian; Anderson, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">797-807</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Activation of the p38 kinase pathway in immune cells leads to the transcriptional and translational regulation of proinflammatory cytokines.  Mitogen-activated protein kinase-activated protein kinase 2 (MK2), a direct downstream substrate of p38 kinase, regulates lipopolysaccharide (LPS)-stimulated tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) prodn. through modulating the stability and translation of these mRNAs.  Developing small-mol. inhibitors of MK2 may yield anti-inflammatory efficacy with a different safety profile relative to p38 kinase inhibitors.  This article describes the pharmacol. properties of a benzothiophene MK2 inhibitor, PF-3644022 [(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one].  PF-3644022 is a potent freely reversible ATP-competitive compd. that inhibits MK2 activity (Ki = 3 nM) with good selectivity when profiled against 200 human kinases.  In the human U937 monocytic cell line or peripheral blood mononuclear cells, PF-3644022 potently inhibits TNFα prodn. with similar activity (IC50 = 160 nM).  PF-3644022 blocks TNFα and IL-6 prodn. in LPS-stimulated human whole blood with IC50 values of 1.6 and 10.3 μM, resp.  Inhibition of TNFα in U937 cells and blood correlates closely with inhibition of phospho-heat shock protein 27, a target biomarker of MK2 activity.  PF-3644022 displays good pharmacokinetic parameters in rats and is orally efficacious in both the rat acute LPS-induced TNFα model and the chronic streptococcal cell wall-induced arthritis model.  Dose-dependent inhibition of TNFα prodn. in the acute model and inhibition of paw swelling in the chronic model is obsd. with ED50 values of 6.9 and 20 mg/kg, resp.  PF-3644022 efficacy in the chronic inflammation model is strongly correlated with maintaining a Cmin higher than the EC50 measured in the rat LPS-induced TNFα model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrKp-1XQ0NyLVg90H21EOLACvtfcHk0lhy4j00NLl8Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFClsLg%253D&md5=312670776fbb3fd39fc2247eba48eb6e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166173%26sid%3Dliteratum%253Aachs%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DBurnette%26aufirst%3DB.%2BL.%26aulast%3DBrustkern%26aufirst%3DS.%2BJ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DHood%26aufirst%3DW.%2BF.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DSaabye%26aufirst%3DM.%2BJ.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DSouth%26aufirst%3DS.%2BA.%26aulast%3DWebb%26aufirst%3DE.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26atitle%3DA%2520Benzothiophene%2520Inhibitor%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Activated%2520Protein%2520Kinase%25202%2520Inhibits%2520Tumor%2520Necrosis%2520Factor%2520%25CE%25B1%2520Production%2520and%2520Has%2520Oral%2520Anti-Inflammatory%2520Efficacy%2520in%2520Acute%2520and%2520Chronic%2520Models%2520of%2520Inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D797%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span>Kinase focused libraries from BioFocus were used. BioFocus URL: <a href="http://www.biofocus.com/" class="extLink">http://www.biofocus.com/</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kinase+focused+libraries+from+BioFocus+were+used.+BioFocus+URL%3A+http%3A%2F%2Fwww.biofocus.com%2F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">The protein structure of Phosphorylase Kinase (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PHK">1PHK</a>) was used.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="note"><p class="first last">The protein structure of cAMP-dependent protein kinase (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BX6">1BX6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1STC">1STC</a>) was used.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>TRIPOS URL: <a href="http://www.tripos.com/" class="extLink">http://www.tripos.com/</a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TRIPOS+URL%3A+http%3A%2F%2Fwww.tripos.com%2F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">The crystal structure of purvalnol B in CDK (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CKP%29">1CKP)</a> was used.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokurno, P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebdon, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunns, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrance, C. J.</span><span> </span><span class="NLM_article-title">Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=863-867&author=D.+S.+Williamsonauthor=M.+J.+Parrattauthor=J.+F.+Bowerauthor=J.+D.+Mooreauthor=C.+M.+Richardsonauthor=P+Dokurnoauthor=A.+D.+Cansfieldauthor=G.+L.+Francisauthor=R.+J.+Hebdonauthor=R.+Howesauthor=P.+S.+Jacksonauthor=A.+M.+Lockieauthor=J.+B.+Murrayauthor=C.+L.+Nunnsauthor=J.+Powlesauthor=A.+Robertsonauthor=A.+E.+Surgenorauthor=C.+J.+Torrance&title=Structure-guided+design+of+pyrazolo%5B1%2C5-a%5Dpyrimidines+as+inhibitors+of+human+cyclin-dependent+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DParratt%26aufirst%3DM.%2BJ.%26aulast%3DBower%26aufirst%3DJ.%2BF.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DDokurno%26aufirst%3DP%26aulast%3DCansfield%26aufirst%3DA.%2BD.%26aulast%3DFrancis%26aufirst%3DG.%2BL.%26aulast%3DHebdon%26aufirst%3DR.%2BJ.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DP.%2BS.%26aulast%3DLockie%26aufirst%3DA.%2BM.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DNunns%26aufirst%3DC.%2BL.%26aulast%3DPowles%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26atitle%3DStructure-guided%2520design%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidines%2520as%2520inhibitors%2520of%2520human%2520cyclin-dependent%2520kinase%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D863%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namiki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takimoto-Kamimura, M.</span><span> </span><span class="NLM_article-title">Structural analysis of an MK2–inhibitor complex: insight into the regulation of the secondary structure of the Gly-rich loop by TEI-I01800</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=80-87&author=A.+Fujinoauthor=K.+Fukushimaauthor=N.+Namikiauthor=T.+Kosugiauthor=M.+Takimoto-Kamimura&title=Structural+analysis+of+an+MK2%E2%80%93inhibitor+complex%3A+insight+into+the+regulation+of+the+secondary+structure+of+the+Gly-rich+loop+by+TEI-I01800"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DK.%26aulast%3DNamiki%26aufirst%3DN.%26aulast%3DKosugi%26aufirst%3DT.%26aulast%3DTakimoto-Kamimura%26aufirst%3DM.%26atitle%3DStructural%2520analysis%2520of%2520an%2520MK2%25E2%2580%2593inhibitor%2520complex%253A%2520insight%2520into%2520the%2520regulation%2520of%2520the%2520secondary%2520structure%2520of%2520the%2520Gly-rich%2520loop%2520by%2520TEI-I01800%26jtitle%3DActa%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D80%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Diskin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livnah, O.</span><span> </span><span class="NLM_article-title">A Novel Lipid-binding site formed by the MAP Kinase Insert in p38α</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2008&pages=70-79&author=R.+Diskinauthor=D.+Engelbergauthor=O.+Livnah&title=A+Novel+Lipid-binding+site+formed+by+the+MAP+Kinase+Insert+in+p38%CE%B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiskin%26aufirst%3DR.%26aulast%3DEngelberg%26aufirst%3DD.%26aulast%3DLivnah%26aufirst%3DO.%26atitle%3DA%2520Novel%2520Lipid-binding%2520site%2520formed%2520by%2520the%2520MAP%2520Kinase%2520Insert%2520in%2520p38%25CE%25B1%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D375%26spage%3D70%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Perry, J. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moiani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainer, J. A.</span><span> </span><span class="NLM_article-title">p38α. MAP Kinase C-Terminal Domain Binding Pocket Characterized by Crystallographic and Computational Analyses</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2009&pages=1-11&author=J.+J.+P.+Perryauthor=R.+M.+Harrisauthor=D.+Moianiauthor=A.+J.+Olsonauthor=J.+A.+Tainer&title=p38%CE%B1.+MAP+Kinase+C-Terminal+Domain+Binding+Pocket+Characterized+by+Crystallographic+and+Computational+Analyses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DHarris%26aufirst%3DR.%2BM.%26aulast%3DMoiani%26aufirst%3DD.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DTainer%26aufirst%3DJ.%2BA.%26atitle%3Dp38%25CE%25B1.%2520MAP%2520Kinase%2520C-Terminal%2520Domain%2520Binding%2520Pocket%2520Characterized%2520by%2520Crystallographic%2520and%2520Computational%2520Analyses%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D391%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Fujino, A.</span><span class="NLM_etal"></span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fujino%2C+A.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3A2C" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3A2C','PDB','3A2C'); return false;">PDB: 3A2C</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NY3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NY3','PDB','1NY3'); return false;">PDB: 1NY3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PHK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PHK','PDB','1PHK'); return false;">PDB: 1PHK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BX6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BX6','PDB','1BX6'); return false;">PDB: 1BX6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1STC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1STC','PDB','1STC'); return false;">PDB: 1STC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CKP%29" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CKP%29','PDB','1CKP)'); return false;">PDB: 1CKP)</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i51"><a href="/doi/suppl/10.1021/jm300411k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_12786"></div></div></div></div></div><hr /></hr><p class="last">Experimental details for the synthesis of all compounds and spectral data of all intermediates and final compounds. Kinase selectivity panel for (<i>S</i>)-<b>44</b>. THP-1 cell based assay concentration effect curves for (<i>S</i>)-<b>44</b>, <b>59</b>, and <b>64</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300411k/suppl_file/jm300411k_si_001.pdf">jm300411k_si_001.pdf (555.06 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300411k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-15%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm300411k%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300411k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a2e4969c0123e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
